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ABSTRACT 
 
Non-heme carboxylate-bridged diiron centers in the hydroxylase components of the bacterial 
multicomponent monooxygenases activate dioxygen at structurally homologous active sites. 
Catalysis requires the management of four substrates: electrons, protons, dioxygen, and 
hydrocarbons. Protein component complexes control the delivery of these substrates to the diiron 
center in the hydroxylase ensuring selective hydrocarbon oxidation. A detailed mechanistic 
understanding of structural and chemical consequences of such interactions is a significant challenge. 
This thesis begins with an overview of our current understanding of these processes. The 
discussion is primarily on the methane monooxygenase systems (MMO) because these have been the 
most extensively studied BMMs to date. Recent results for the toluene/o-xylene monooxygenase 
(ToMO) and phenol hydroxylase systems from Pseudomonas sporium OX1 are also briefly 
summarized, the former being the research focus of this dissertation. 
Restricting access to the diiron center in ToMOH and other non-heme carboxylate-bridged 
diiron proteins was proposed to facilitate observation of oxygenated intermediates. To examine this 
hypothesis, dioxygen activation in ToMOH mutants that were predicted to occlude this channel was 
investigated by rapid-freeze quench (RFQ) EPR, Mössbauer, and ENDOR spectroscopy and stopped-
flow optical spectroscopy. For the I100W mutant, a transient species is observed with an absorption 
maximum at 500 nm. EPR and Mössbauer spectra of RFQ samples identified this species as a 
diiron(III,IV) cluster spin-coupled to a neutral W radical. ENDOR spectra of this intermediate 
confirmed the protonation state and type of the amino acid radical and also identified a labile 
terminal water or hydroxide on the diiron center. Decay of this intermediate results in hydroxylation 
of the W radical. A diamagnetic precursor to the mixed-valent diiron(III,IV) center was also 
observed at an earlier time-point, with Mössbauer parameters typical of high-spin FeIII. We have 
tentatively assigned this antiferromagnetically-coupled diiron(III) intermediate as a peroxo-bridged 
cluster.  
A similar diiron(III) species is observed in RFQ Mössbauer samples from the reaction of 
reduced wild type hydroxylase with dioxygen. Substrate accelerates the decay rate of this species, 
providing evidence for the diiron(III) transient as the active oxidant. Under steady state conditions, 
hydrogen peroxide was generated in the absence of substrate. The oxidized hydroxylase also 
decomposed hydrogen peroxide to liberate dioxygen if no reducing equivalents were present. This 
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catalase activity suggests that dioxygen activation could be reversible. The linear free energy 
relationship determined from steady state hydroxylation of para substituted phenols has a negative 
slope. A value of ρ < 0 is indicative of electrophilic attack on the aromatic substrate by the oxidizing 
diiron(III) intermediate. The results from these steady state and pre-steady experiments provide 
compelling evidence that the diiron(III) transient is the active oxidant in ToMO and is a 
peroxodiiron(III) transient, despite differences between the optical and Mössbauer spectroscopic 
parameters and those of other peroxodiiron(III) centers. 
Enzymatic oxidation of the radical clock substrate probe, norcarane, by ToMO gives rise to both 
desaturation and hydroxylation products, norcarenes and norcaranols respectively. Norcarenes are 
better substrates for this enzyme system than norcarane, producing additional oxidation products. In 
all, more than twenty oxidation products were characterized in these reaction mixtures, half of which 
arose from norcarene oxidation. Accounting for these secondary oxidation products, we determined 
that no substrate radical intermediates with a significant lifetime (τ < 25 ps) are formed during 
catalysis. 
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CHAPTER 1 
SUBSTRATE TRAFFICKING AND DIOXYGEN ACTIVATION 
IN BACTERIAL MULTICOMPONENT MONOOXYGENASES 
 
 
 
 
 
 
 
 
 
* Reproduced in part with permission from Acc. Chem. Res. 2007, 40 (7), 466-474. 
Copyright 2007 American Chemical Society 
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INTRODUCTION 
The biological activation of small substrates, such as dioxygen and dinitrogen, is carried out by 
large proteins comprising multiple subunits and containing metal cofactors. Examples of these 
remarkable enzymes include nitrogenase, cytochromes P450, tyrosinase, hydrogenase, cytochrome c 
oxidase, and the non-heme carboxylate-bridged diiron proteins. Members of the last family, which 
include the BMMs, RNR-R2, and Δ9D, activate dioxygen at structurally homologous diiron centers 
housed within a four-helix bundle. The metal atoms in this bundle are coordinated by the side-chains 
of two E(D/H)XXH motifs.1,2 The BMMs exquisitely couple the consumption of electrons and 
protons to dioxygen activation and substrate hydroxylation. Understanding the management of four 
substrates (electrons, protons, dioxygen, and hydrocarbons) in these enzyme systems is a central goal 
of ongoing research. 
The mechanism of dioxygen activation in the carboxylate-bridged diiron family of enzymes is 
the subject of intense investigation. In the systems studied thus far, the resting state of the enzyme is 
a diiron(III) cluster with bridging oxo or hydroxo ligands, as observed in RNR-R2 and MMOH 
respectively. This state is unreactive toward dioxygen. Catalysis is initiated by two-electron 
reduction of the resting state to the reactive diiron(II) state. In systems where structures of the 
diiron(III) and diiron(II) forms of the enzymes, or analogues thereof, have been solved, reduction is 
accompanied by reorganization of the dimetallic cluster, whereby a dangling, or non-bonded, oxygen 
atom of a terminal carboxylate ligand shifts so that it bridges the metal ions. To maintain charge 
neutrality at the active site, proton transfers are predicted to occur during the reduction process. 
These protons may protonate the bridging hydroxo or oxo ligands, and the formed water dissociates 
from the dimetallic center.3,4 The resulting diiron(II) form rapidly reacts with dioxygen to form a 
peroxodiiron(III) intermediate, which has been characterized by a number of spectroscopic methods 
(Table 1.1).1 In MMO and RNR-R2, this intermediate evolves to higher-valent species Q and X, 
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respectively, which carry out methane hydroxylation or the one-electron oxidation of aromatic amino 
acid residues (Figure 1.1). In MMOH, both the peroxodiiron(III) (MMOHperoxo) and Q intermediates 
are reactive toward substrates,5 similar to the reactivity observed for oxygenated intermediates in the 
cytochrome P450 family6 and some dicopper systems.7 The catalytic cycle is closed as the 
 
Figure 1.1. Dioxygen activation at non-heme carboxylate-bridged diiron 
centers. Reaction of the reduced diiron(II) state with dioxygen affords a 
peroxide-bridged intermediate, which can evolve to a high-valent species or 
decay to the resting diiron(III) state. In MMOH, intermediate Q can oxidize 
substrates, denoted as S, or decay via other pathways to the resting state. The 
peroxo intermediate in RNR-R2 oxidizes Trp48 to form X, which then oxidizes 
Tyr122 to restore the resting diiron(III) state. 
Table 1.1. Spectroscopic Parameters for Peroxodiiron(III) Intermediates at Non-heme Diiron Centers 
  Opticala  Mössbauera  Resonance Ramana 
  λmax [nm] ε [M-1cm-1] δ [mm/s] ΔEQ [mm/s]  O-O [cm-1]  Fe-O [cm-1] 
MMO (M. caps.)  700  1800  0.66  1.51  -  - 
MMO (M. trich.)  725  2500  0.67  1.51  -  - 
RNR-R2b  700  1500  0.63  1.74  -  - 
RNR-R2 D84E  700  1500  0.63  1.58  890  - 
RNR-R2 D84E/W48F  700  -  -  -  870  458 
Δ9D  700  1200  0.68  1.90  898  442 
       0.64  1.06     
Frog M Ft  650  -  0.62  1.08  851  458 
cis-μ-1,2-peroxo Fe2III  694  2650  0.66  1.40  888   
aAll parameters are reported from reference 1. b Reported in reference 42. 
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oxygenated intermediates return to the resting diiron(III) state following substrate hydroxylation or 
electron abstraction. In the absence of substrate, intermediate Q decays by a yet to be determined 
pathway to the resting state.  
This discussion begins with a description of the protein components and their interactions. We 
then proceed through the stages of the catalytic cycle, examining first the ET events, followed by 
dioxygen activation and, finally, substrate hydroxylation. The role of protein component interactions 
in these processes is also highlighted.  
 
BMM PROTEIN COMPONENTS 
The BMMs are subdivided into different families, but all contain at least three components in 
the enzymatic system: a hydroxylase, an NADH oxidoreductase, and a regulatory protein. A fourth, 
Rieske protein, is also utilized in toluene/alkene monooxygenases.8 In MMO, ToMO, and PH, the 
hydroxylase is a dimer of three polypeptide chains, (αβγ)2, with each α-subunit housing the 
carboxylate-bridged diiron center, the site of substrate hydroxylation. The hydroxylase molecular 
mass varies from 220 kDa in ToMO and PH to 251 kDa in MMOH. The 38-kDa oxidoreductase 
component shuttles electrons from NADH through its bound FAD and [2Fe-2S] cofactors to the 
hydroxylase either directly, as in MMO and PH, or indirectly via the Rieske component. The 10 to 
15-kDa cofactor-less regulatory proteins bind to the hydroxylase and couple electron consumption to 
hydrocarbon oxidation.9-11 The precise mechanistic consequences of these protein-protein 
interactions on ET and dioxygen activation are the subject of ongoing research. Very recently, the 
structure of PHH complexed to its regulatory protein, PHM, was solved, providing the first detailed 
picture of such an interaction.
12 
 
COMPONENT INTERACTIONS 
The assembly of protein complexes during the reductive and oxidative phases of the catalytic 
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cycle must be finely orchestrated to ensure that electron consumption is linked to substrate 
hydroxylation. For example, reactive oxygenated diiron intermediates in the hydroxylase must not 
undergo adventitious reduction by the reductase or Rieske protein components.13 The regulatory 
protein is proposed to compete with the reductase for a shared binding site on the hydroxylase,10 
thereby protecting oxygenated intermediates formed at the diiron center from undesired reductive 
quenching following dioxygen activation.12 On the other hand, ET from these reducing components 
to the resting, diiron(III) state of the hydroxylase must occur to initiate catalysis. In this section, we 
first discuss studies of the structures and interactions between the regulatory proteins and their 
respective hydroxylases and then turn our attention to the ternary system comprising the regulatory, 
hydroxylase, and reductase/Rieske components. 
Crystal structures of BMM hydroxylases from MMO, ToMO, and PH have been solved. Three 
structurally conserved features of note are hydrocarbon access routes, a likely ET pathway to the 
diiron core, and a pore through the four-helix bundle housing the diiron center for possible dioxygen 
or proton translocation. Soaking or pressurizing crystals of these proteins with substrate or product 
analogues has revealed the first of the three shared features, a potential pathway for the entrance or 
egress of hydrocarbon substrates or products. Soaking ToMOH crystals with the product analogue p-
bromophenol revealed a large channel that delineates an access pathway from the exterior of the 
protein through the α-subunit to the active site (Figure 1.2).14 When MMOH crystals were treated 
with xenon, bromomethanes, or iodoethane, these small hydrophobic species were detected in a 
series of adjacent hydrophobic pockets within the protein that trace a pathway from the protein 
surface to the diiron center.15 The distinct pockets are capable of forming a contiguous pathway, as 
evidenced by structures of crystals soaked with ω-halogenated alcohols. In these structures, several 
residues, including Leu110 and Leu289, shift to allow the substrate analogues to traverse the protein 
cavities.16 The structure of MMOH crystals soaked with 6-bromohexan-1-ol revealed another 
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property of note. Residues 212-216 in helix E of the α-subunit unwind to extend the π-character of 
this helix, increasing the active site volume and reorienting Thr213 and Asn214, residues strictly 
conserved among the BMMs. The structure of PHH complexed to PHM contains a similarly 
extended π-helix, providing strong evidence that the binding of BMM regulatory proteins to their 
respective hydroxylases gives rise to specific conformational changes in helix E that directly affect 
the configuration of the active site pocket.12 The environment around the diiron cluster was predicted 
from XAS studies of ToMOH and MMOH in complex with their regulatory proteins17 to undergo 
conformational changes, and the PHH-PHM structure provides the first evidence for the nature of 
these changes. 
PHM binds in the canyon region of PHH, specifically on helices E and F, and covers a 
hydrogen-bonding network that extends from the exterior to the iron-coordinated histidine residues at 
the active site. This feature is the second one conserved among the BMMs (Figures 1.3 and 1.4). The 
 
Figure 1.2. Substrate access channel and the conserved 
pore in ToMOH. The access channel (magenta) 
delineates a path from the diiron center (orange atoms) 
to the protein surface through the α-subunit (grey). The 
conserved pore (green), which is gated by Asn202, 
extends from the active site pocket to the protein 
surface. One half of the dimer is depicted. 
 
Figure 1.3. Crystal structure of PHH in complex with 
PHM shows the binding of the regulatory protein in the 
canyon region. The surface of PHH is rendered 
translucent with the α-, β-, and γ-subunits depicted in 
grey, purple, and blue, respectively. The iron atoms are 
depicted as orange spheres and denoted by arrows. PHM 
(red) binds to the α-subunit in a location similar to that 
predicted for binding of other regulatory proteins to their 
hydroxylases. 
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locus on PHH where PHM binds, and the predominantly hydrophobic contacts between the proteins, 
agrees with the predictions of early NMR line-broadening studies carried out on MMOB and MMOH 
from M. caps.18 The binding site of the regulatory proteins in the BMMs may therefore be conserved 
throughout the family. The hydrogen-bonding network that is covered by PHM, and presumably 
MMOB, is spatially homologous to the proposed ET pathway in other non-heme diiron proteins.14 
Binding of the BMM regulatory proteins to this surface, therefore, would interfere with ET for the 
reasons described above.13 
 
The third structurally conserved feature among BMMs is a small pore through the four helix 
bundle, which is proximal to the proposed ET pathway and extends from the active site pocket to the 
protein surface. In most of the crystal structures of BMM hydroxylases, this pore is closed, with a 
strictly conserved Asn residue (214, 202, and 204 in MMOH, ToMOH, and PHH respectively) 
serving as a gate to the opening. Crystallographic studies reveal this Asn residue to shift in a redox-
dependent manner. Its side chain is oriented away from the active site in the oxidized form and points 
inward in the reduced or Mn(II)-reconstituted forms of the hydroxylase. This motion correlates with 
Figure 1.4. PHM binds to PHH at the proposed ET pathway and interacts with Asn204. (A) The surface-exposed 
residues, Arg235 and Lys68, of the conserved hydrogen-bonding network in the α-subunit are highlighted in yellow 
on a surface-rendered diagram of PHH. The α-, β-, and γ-subunits are depicted in grey, purple, and blue, 
respectively. (B) Diagram A with PHM (red) included. PHM covers this network when complexed to PHH and may 
prevent the reductase from binding at this locus. (C) A cutaway view, perpendicular to that in A and B, shows that 
this network, which extends from the iron atoms (orange spheres) to the surface, lies at the interface between the 
two proteins. PHM also interacts with Asn204 (green sticks), the side chain of which is oriented away from the 
diiron center as in the oxidized form of the hydroxylase and forms a hydrogen bond with Ser72 of the latter. 
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the carboxylate shift that occurs upon reduction of the dimetallic center (Figure 1.5).3,4 DFT 
calculations predict that dioxygen activation at the diiron(II) core of MMOH is accompanied by 
dissociation of this carboxylate group from its bridging position.19 The Asn gate is open and the pore 
provides direct access to the diiron center in the bromohexanol-soaked structure of MMOH due to 
the increased π-character of helix E.16  
 
In the α-subunits of PHH, helix E adopts π-character similar to that in the MMOH 
bromohexanol-soaked structure, orients Asn204 away from the active site, and opens the pore.12 
PHM is bound only to one face of the PHH dimer and restricts access through this pore for the 
α−subunit to which it is bound, but for the other, the pore allows access to the diiron center (Figure 
1.6). The opening of the pore by the shift in Asn204 on the face opposite that to which PHM binds 
may be an allosteric effect transmitted through the protein dimer interface, arise from interactions 
 
Figure 1.5. Redox-state-dependent conformations of 
residues in the active site pocket of MMOH. The amino 
acid residues depicted in gray correspond to the reduced 
state. Residues Glu243 and Asn214 shift upon oxidation 
(yellow) with Glu243 changing its coordination mode to 
the dimetallic center. 
 
 
Figure 1.6. A surface-rendered representation of the 
pore in the α-subunit of PHH to which PHM is not 
bound. Asn204 (blue) is oriented away from the diiron 
center, opens the pore (red), and allows access from the 
protein exterior to the diiron center (orange spheres). 
Four iron-binding ligands, Glu108, Glu139, His236, and 
His141, are identified. This structural change may arise 
from PHM binding at the opposing face, interactions 
with the N-terminus of the β-subunit from the opposing 
monomer (purple), or packing in the crystal. 
 
26
  
with the N-terminus of the α-subunit of the adjacent monomer, or be a consequence of crystal 
packing. Residue Asn204 in PHH interacts with the hydroxyl side chain of a serine residue of the 
regulatory protein (Figure 1.4C), suggesting that mechanical strain created when the latter binds to 
the hydroxylase could promote rearrangement of the shifting carboxylate.12 The hypothesis20 that the 
regulatory protein binds to the MMO hydroxylase and provides a sieve for methane access to the 
active site at that position is inconsistent with the PHH-PHM structure. Moreover, we have not been 
able to rationalize this alternative proposal with the observation of CH2Br2, Xe, and other methane 
substrate analogues bound in the hydrophobic cavities of MMOH during structure determinations of 
crystals exposed to these agents. Finally, we note the possibility that dioxygen or protons may enter 
the active site via the pore. Additional structures of hydroxylases in complex with their respective 
regulatory proteins are required to evaluate further these possibilities.  
Among the BMMs, component interactions in MMO isolated either from M. caps. or M. trich. 
have been the most extensively studied. Similar interactions were proposed for the binding of 
MMOB and MMOR to MMOH from studies using chemically modified MMOH.21 The nature of 
these similar interactions was proposed to be electrostatic in contrast to the NMR line-broadening 
experiments mentioned above and the crystal structure of PHH-PHM. Whereas the binding face may 
have predominantly hydrophobic contacts, important electrostatic interactions, possibly to Arg245 
and Lys74 in MMOH, may be essential for catalysis. A higher resolution structure of PHH-PHM 
with greater occupancy of PHM would be invaluable in resolving this apparent contradiction. The 
efficiency of cross-linking MMOB to MMOH decreases in the presence of MMOR,9 suggesting that 
these components may share, either partially or completely, the same binding site on the hydroxylase. 
Both MMOR and MMOB bind to MMOH with a 2:1 stoichiometry in the M. caps. system, with 
MMOR binding being an order of magnitude stronger to MMOH than MMOB.10 A 1:1 
MMOB:MMOH complex has been proposed for the analogous M. trich. enzyme system.9 In M. 
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trich., MMOB binds thirty-fold more weakly to reduced versus oxidized MMOH.22 The Kd values 
determined from the formation and dissociation rate constants of these complexes disagree with the 
thermodynamic ones, indicative of rapid pre-equilibrium complex formation followed by a slower 
structural change,10,22 such as an allosteric effect being transmitted to the other binding site on the 
dimer. Component binding to one face of the hydroxylase could effect a structural change in the 
canyon region on the opposite half of the dimer, as noted previously in the PHH-PHM structure. In 
agreement with the stoichiometry mentioned above, a ratio of 2 MMOB:1 MMOH affords maximal 
activity for steady-state hydroxylation in the M. caps. system. Moreover, enzymatic inhibition occurs 
at higher ratios of MMOB, suggesting that MMOB saturates the binding sites on MMOH, inhibiting 
the association of MMOR with MMOH.  
 
ELECTRON TRANSFER TO THE OXIDIZED HYDROXYLASE 
An early study of ET from NADH to the diiron(III) centers in oxidized MMOH, premixed with 
MMOR and variable equivalents of MMOB, demonstrated that all of the ET events from the [2Fe-
2S] cluster of MMOR to diiron(III) active sites of MMOH are enhanced by MMOB.10 More recently, 
an investigation of the reaction of chemically reduced MMOR or MMOR-Fd with MMOH-MMOB 
mixtures showed the opposite effect, in which MMOB served to inhibit ET.23 These two apparently 
contradictory effects of MMOB on ET may be a consequence of a slow structural change associated 
with MMOB or MMOR binding to MMOH.23 The conclusion that hysteresis may control the activity 
of MMOH was similarly drawn from an analysis of the product distributions when various substrates 
were hydroxylated by MMO from M. trich.24 The interaction of MMOH with either MMOR or 
MMOB may depend on the presence or absence of the other component. The two may bind either 
concurrently, on opposing canyon regions of MMOH, or in rapid succession at the same canyon 
region on one side of the hydroxylase. 
These two scenarios for the interaction of the components during the catalytic cycle are 
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illustrated in Figure 1.7. In the half-sites reactivity mechanism, the reductase binds on one canyon 
surface for ET while the regulatory protein binds on the other canyon surface for dioxygen activation 
and substrate hydroxylation (Figure 1.7A). Hysteresis would reflect binding of the regulatory and the 
reductase components to the opposite faces of the hydroxylase, thereby predisposing each diiron 
center to traverse opposite segments of the catalytic cycle. RFQ Mössbauer experiments performed 
to investigate the reaction of reduced MMOH25 and ToMOH26-28 with dioxygen have recorded 
consistently a maximal conversion of ~ 50% of the initial diiron(II) protein to the oxygenated 
intermediates. This observation suggests that the oxidative phase of the catalytic cycle can occur only 
at one active site of the dimer, irrespective of whether both active sites are fully reduced. The 
reaction of reduced ToMOH with dioxygen studied by RFQ Mössbauer spectroscopy will be 
 
Figure 1.7. Possible scenarios for component interactions in the BMMs depicting a half-sites 
mechanism (A) and a non-interacting sites model (B). In (A), one active site is undergoing 
reduction while the second is activating dioxygen. In (B), a ternary complex may form but is 
not obligatory for catalysis and may have implications for ET and dioxygen activation. 
Adapted from reference 10. 
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presented in more detail in Chapters 2 and 3. Half-sites reactivity has also been proposed in other 
non-heme diiron proteins, in particular Δ9D29 and RNR-R2,30 and may be a conserved feature in these 
systems. A different scenario, depicted in Figure 1.7B, is that the regulatory protein binds loosely to 
the hydroxylase and is displaced partially or shifts in the presence of the reductase to form a ternary 
complex that is competent for ET and catalysis. The inhibitory effect of excess MMOB on steady-
state catalysis in MMO is best simulated by a model in which MMOB and MMOR bind to MMOH 
non-competitively and form a transient ternary complex.10 
 
FORMATION AND REACTIVITY OF ACTIVATED DIOXYGEN INTERMEDIATES 
Steady-state studies. The mechanism of hydrocarbon hydroxylation by the BMMs under steady-
state conditions has been examined with radical clock substrate (RCS) probes. These hydrocarbons 
often contain strained rings that open with a characteristic lifetime following the loss of a hydrogen 
atom or ion. Such alternative substrates have been used to probe the mechanism of steady-state 
catalysis for a variety of enzyme systems including the BMMs.1,31 Radical-derived ring-opened 
products will be observed only if their recombination rate is slower than ring expansion, in which 
case the lifetime of the radical can be estimated from ratios of the rearranged to unrearranged product 
alcohols. In general, only unrearranged products arising from rapid recombination of bound radical 
species are observed for most of the RCS probes tested in MMO, and their lifetime has been 
estimated as being less than 150 fs.1,31 In addition to ring expansion from H-atom abstraction from 
the substrate, some RCS probes can ring-open following hydride abstraction to yield products that 
differ from the radical-derived ones. Norcarane, methylcubane, and 1,1-dimethylcyclopropane are 
examples of such RCS probes and the major products formed in steady-state catalysis by ToMO32, 
T4MO33, and MMO1 with these substrates are the unrearranged alcohols. Little or no rearranged 
products, either radical- or carbocation-derived, are observed for these substrates in reactions with 
T4MO and MMO, in agreement with the other RCS experiments mentioned above. For the oxidation 
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of norcarane by MMO, ring-expansion products from both intermediates formed and the product 
ratios placed a lower limit of 20 ps on the radical lifetime, significantly greater than the value 
determined from any other probe. Oxidation of this RCS by T4MO afforded a radical-rearranged 
product (4.5% of the total), and no carbocation-derived product could be detected, contrary to the 
results from the oxidation of both 1,1-dimethyl- and 1,1-diethylcyclopropane.33 A recent 
reexamination of the norcarane reaction for MMO and ToMO revealed that desaturation of the 
substrate by BMMs can explain these discrepancies.34 Evidence for both a hydride and an H-atom 
transfer mechanism suggests that more than one reactive oxygenated intermediate may be involved.  
Transient kinetic studies. In the oxidative phase of the catalytic cycle (Figure 1.1), the regulatory 
protein is required for the formation of detectable intermediates35 and tunes the regioselectivity of 
substrate hydroxylation.36 Transient, pre-steady-state kinetic studies have been performed with 
chemically reduced mixtures of the hydroxylases and their regulatory proteins to study the reactivity 
of individual intermediates during the reaction of dioxygen with the reduced BMM hydroxylases. In 
particular, we have utilized single- and double-mixing stopped-flow methodologies whereby a 
solution of reduced hydroxylase with its regulatory protein is mixed rapidly with dioxygen, allowed 
to age for a time period that maximizes the formation of an intermediate of interest, and the aged 
solution is subsequently mixed with buffer containing a substrate. Loss of an optical absorption band 
characteristic of the intermediate,5 or of an infrared band of a substrate,37 is measured as a function of 
substrate concentration. Among the BMMs, this strategy has been the most effective for investigating 
the reactions of MMOH with dioxygen since both MMOHperoxo and Q have characteristic absorption 
bands. The effect of substrates on the decay rate of each intermediate can be readily monitored by 
recording a change in these optical features. Initial studies of MMO in which propylene, methane, 
and acetylene were used as substrates indicated that MMOHperoxo reacts only with propylene whereas 
Q reacts with all three substrates.5 Previous steady-state studies revealed that terminal alkenes are 
epoxidized by MMO with no C–H bond activation.38,39 Although Q oxidizes propylene faster than 
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MMOHperoxo, a judiciously chosen substrate might react more rapidly with MMOHperoxo than Q to 
confirm that MMOHperoxo is a reactive species. The oxidation of alternate substrates by these 
intermediates was therefore explored. Two such substrates, ethyl vinyl ether and diethyl ether, 
reacted more rapidly with MMOHperoxo than with Q.40 A comparison of the nucleophilicity of the 
substrates investigated, and a detailed study of the oxidation of these particular substrates, indicated 
that MMOHperoxo is a more electrophilic oxidant than Q, preferring to react by a two-electron, or a 
hydride abstraction, pathway, whereas one-electron oxidation processes are preferred by Q (Figure 
1.8). This difference in reactivity may explain the carbocation-derived products in the RCS probe 
experiments because attack of MMOHperoxo on these substrates is expected to form transient 
carbocations and Q would yield radical intermediates. 
 
In contrast to what we observe for MMOHperoxo, peroxodiiron(III) intermediates in ferritin,41 
RNR-R2,42-44 Δ9D,29 and synthetic model compounds have no observed reactivity toward 
hydrocarbons. These peroxo species have been characterized by rR spectroscopy, from which it 
 
Figure 1.8. Proposed mechanism for reaction of Q and MMOHperoxo with substrates. Q reacts by 
sequential one-electron oxidations (upper). Reaction of MMOHperoxo with ethyl vinyl ether 
proceeds by a two-electron mechanism, in which a transient carbocation is stabilized by the 
proximal oxygen atom (middle). Hydroxylation of diethyl ether by MMOHperoxo is also proposed 
to proceed by a two-electron process, in which hydride abstraction forms a transient carbocation 
that recombines with the coordinated hydroxide (lower). Adapted from reference 40. 
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appears that the peroxide moiety bridges the dimetallic center in a μ-1,2 fashion. Although a rR 
spectrum has not yet been obtained for MMOHperoxo, computational methods predict that a μ-η2:η2-
peroxo butterfly structure is more stable than the alternative μ-1,2 geometry of the bound 
peroxide.19,40,45 The occurrence of such a binding mode in MMOHperoxo may explain why it reacts 
with electron-rich hydrocarbons and why a Q-type species is only observed in MMO. The difference 
in reactivity between MMOHperoxo and Q parallels the known differences between (μ-η2:η2-
peroxo)dicopper(II) species and high-valent di(μ-oxo)dicopper(III) center in the dicopper 
complexes.7 The lower-valent complex reacts by two-electron processes compared to the higher-
valent counterpart, which prefers sequential one-electron oxidations. Theoretical studies on MMOH 
revealed that compression of the diiron cluster by the protein scaffold at the active site facilitates 
formation of a (μ-η2:η2-peroxo)diiron(III) structure and its subsequent conversion to Q.45 It will be 
interesting to learn whether such an effect may be absent in other BMM hydroxylases which have 
different spectral parameters for the peroxo species and for which a diiron(IV) species has not yet 
been observed. A key difference between MMOB and the other BMM regulatory proteins is that the 
former has an unstructured 35 amino acid N-terminal domain.18 Truncation of this domain leads to 
uncoupling of hydroxylation during steady-state turnover.46 The presence of the N-terminal tail also 
correlates with the unique ability of MMOH to form Q, and binding of this domain to MMOH might 
further serve to compress the diiron core. Despite the structural homology between the active site of 
MMOH and ToMOH, no intermediates were observed by stopped-flow optical spectroscopy in 
studies of the latter.26,27 
 
ORGANIZATION & SCOPE OF THESIS  
This thesis addresses the oxidative and reductive phases of the catalytic cycle in the ToMO 
system. Investigations of dioxygen activation in mutant and native forms of ToMOH are presented in 
Chapters 2 and 3, respectively. Studies of the steady-state oxidation of the RCS probe norcarane are 
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described in Chapter 4. Appendix A discusses attempts to photoreduce the oxidized hydroxylase in 
MMO by tris(bipyridyl)ruthenium(III) complexes tethered to MMOB, and Appendix B details 
electron transfer from reduced ToMOC to oxidized ToMOH. The work in these appendices is 
preliminary in nature. 
Until recently, no intermediates were reported during stopped-flow optical spectroscopic study 
of the reactions of reduced ToMOH or PHH, complexed with their respective regulatory proteins, 
with O2-saturated buffer. Comparison of the crystal structures of ToMOH and MMOH reveal that 
residue I100 in the former is analogous to a leucine in the latter that is proposed to gate substrate 
access to the diiron site during catalysis.47 As described in Chapter 2, mutations I100W/Y, L208F, 
and F205W were introduced in the α-subunit of ToMOH with the aim of retarding access at different 
points along the substrate access channel of any buffer components to the diiron site that might 
quench high-valent intermediates before they could accumulate to an observable level.14,47 The 
reactions of these reduced mutant hydroxylases in complex with ToMOD with dioxygen were 
studied by stopped-flow optical spectroscopy. This method revealed that, in the ToMOH I100W 
mutant, a transient species having a maximal absorption at 500 nm formed upon oxygenation. No 
optically active intermediates were observed for the native or any of the other mutant hydroxylases. 
The reaction of the I100W mutant with dioxygen was further interrogated by RFQ EPR, ENDOR, 
and Mössbauer spectroscopy. Two intermediates were observed: a mixed-valent diiron(III,IV) cluster 
coupled to a neutral tryptophanyl radical, the latter giving rise to the optical absorption at 500 nm, 
and a diiron(III) species, which has no distinct optical absorption features and forms prior to the 
mixed-valent diiron(III,IV).26 
Chapter 3 details our studies of dioxygen activation in the native system under steady-state and 
pre-steady-state conditions. First, we present the reaction of chemically reduced native ToMOH in 
complex with ToMOD by RFQ Mössbauer spectroscopy. A diiron(III) intermediate with isomer 
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shift, δ, and quadrupole splitting, ΔEQ, parameters similar to those for the I100W diiron(III) transient 
was discovered.27 This intermediate is longer-lived than that in the I100W mutant, presumably 
because it is no longer being quenched by a nearby redox-active residue. The effect of phenol, a 
substrate for this system, on the decay rate of this oxygenated intermediate was investigated by 
double-mixing RFQ Mössbauer spectroscopy. The decay is enhanced by more than thirty-fold in the 
presence of substrate, strongly suggesting that this species is the active oxidant in this system. 
Steady-state experiments are also described that complement the pre-steady-state investigations. The 
ToMO enzyme system appears to be incapable of accessing the peroxide shunt pathway for substrate 
hydroxylation in the absence of reducing equivalents from NADH, unlike MMO.24 Second, the 
system generates hydrogen peroxide if substrate is absent from the reaction mixture. Third, the 
steady-state activity for the hydroxylation of a series of para-substituted phenols provided some 
insight into the nature of the key intermediate in this system. Taken together, these results indicate 
that a peroxodiiron(III) intermediate is the active oxidant in this system. The peroxide moiety is 
predicted to have a binding geometry and/or protonation state different from those previously 
reported in similar carboxylate-bridged diiron systems.  
RCS probes have been extensively used to probe enzymatic oxidations under steady-state 
conditions. In most enzyme systems studied with these substrates, the calculated lifetimes of radical 
intermediates and the ratios of radical- and cation-derived products are consistent across a variety of 
different probes. Lifetime calculations from experiments employing norcarane as the RCS probe, 
however, are inconsistent in most enzyme systems studied thus far. The values obtained from product 
distributions for norcarane reactions are significantly greater that those from other substrates. A 
careful examination of the oxidation of norcarane by ToMO determined that more than twenty 
products form. Almost half of these products arise from oxidation of 2- and 3-norcarene, desaturation 
products of the parent compound. We therefore conclude that the lifetimes previously estimated in 
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the homologous T4MO, and for other CBDI enzymes such as MMO,48,49 greatly overestimated the 
amount of radical-derived product formed.32,34 By estimating the correct yields for the radical- and 
cation-derived products from our analysis, we determined lifetimes that agree with independent 
measurements carried out with different probes. Desaturation of substrates by this and other enzyme 
systems requires a judicious choice of RCS probe for which such reactivity is unfavorable. 
No intermediates prior to MMOHperoxo have been observed in any carboxylate-bridged diiron 
proteins to date. DFT methods19 predict that a short-lived superoxodiiron(II,III) species forms 
initially after dioxygen binding but that the calculated relative energies of MMOHred, MMOHsuperoxo, 
and MMOHperoxo preclude the accumulation and observation of such an intermediate. Appendix A 
describes studies utilizing tris(bipyridyl)ruthenium(II) complexes tethered to MMOB as a method of 
photoreducing the diiron cluster in MMOH in the presence of dioxygen to search for spectroscopic 
evidence for early events of dioxygen activation. 
Efficient ET from reduced ToMOC to the oxidized hydroxylase requires ToMOH and ToMOD 
to be mixed prior to the reduction event. Moreover, this reaction only yields ~ 50% of oxidized 
ToMOC as determined by the change in optical absorbance. Two- or three-exponential functions 
were required to model the kinetic traces obtained, suggesting that two or more processes are 
involved in the ET reaction. One possible explanation for this observation is that the electrons can be 
distributed statistically upon reacting with ToMOHox to yield mixtures of reduced, mixed-valent, and 
oxidized diiron sites. To address this question, the species formed after reaction of varying 
equivalents of ToMOCred with ToMOHox were determined by EPR spectroscopy. We observed 
formation of reduced diiron(II) centers at substoichiometric ratios of ToMOCred to ToMOHox, 
suggesting that reduction favors formation of a two-electron reduced active site as opposed to mixed-
valent centers. These results, together with our dioxygen activation studies, lead us to propose that a 
half-sites reactivity mechanism governs both the oxidative and reductive phases of the catalytic cycle 
in ToMO. 
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CONTEXT 
Accessibility of buffer components or bulk solvent to active sites of diiron proteins during 
dioxygen activation was proposed to quench reactive intermediates, hindering observation of such 
species. To investigate this hypothesis, several mutations were introduced into the α-subunit of 
ToMOH with the aim of constricting the channel. In the I100W variant, a transient species containing 
a diiron(III,IV) cluster weakly coupled to neutral tryptophan radical formed during reaction of 
reduced diiron(II) hydroxylase with dioxygen. This species is preceeded by a diiron(III) intermediate 
with spectroscopic parameters that differ from those reported for dioxygen-diiron(III) species in 
enzyme and model systems. The mechanistic implications that reaction of this variant hydroxylase 
with dioxygen has on the analogous process in the wild type system are discussed. 
 
INTRODUCTION 
Metal-activated dioxygen species are capable of oxidizing a broad range of substrates.1-4 In 
synthetic systems, these species are generated in a solvent that is inert to oxidation. The peptide 
matrix surrounding the active site protects reactive intermediates in protein systems. Enzyme are able 
to coordinate reduction of the active metal center and dioxygen activation to substrate binding, 
thereby assuring that reactive metal-oxygen units are generated only when substrate is available.5,6 
The active sites in non-heme carboxylate-bridged diiron (CBDI) proteins are buried within the 
protein framework as revealed by x-ray crystallography are buried within the protein framework.7-9 
Consequent, reactive intermediates such as Q, a di(μ-oxo)diiron(IV) center, in MMOH and X, a 
mixed-valent diiron(III,IV) cluster, in RNR-R2 can accumulate and be characterized by a number of 
spectroscopic methods. 
The primary coordination spheres of the diiron centers in the CBDI enzyme superfamily are 
remarkably similar, yet the high-valent intermediates Q and X are observed only in MMOH and 
RNR-R2, respectively.10 Although the capacity to form these iron(IV) species is reserved for these 
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two enzymes, proteins in this family activate dioxygen by analogous mechanisms. The reduced 
diiron(II) core reacts rapidly with O2 to generate a peroxo-bridged diiron(III) species as the first 
observable intermediate. No other oxygenated intermediates are observed in Ft and Δ9D, and the 
peroxodiiron(III) unit is detectable in Δ9D only when the substrate-carrier protein conjugate is bound 
to the desaturase. This behavior has been ascribed to stearoyl-ACP blocking access to the active site 
via a large substrate channel.11 To date, no oxygenated intermediates have been reported for the 
reactions of diiron(II) or diiron(III) forms of rubrerythrin with either dioxygen or hydrogen peroxide 
respectively. From the crystal structure, the active site of rubrerythrin is seen to be more accessible to 
solvent and buffer components than that of other enzymes in the family.12 The accumulation of 
reactive oxygenated iron(III) and iron(IV) intermediates thus appears to be correlated with 
accessibility of the diiron center to potential quenching moieties in the medium. 
At the outset of the present study, no transient species with UV-visible absorption bands had 
been detected kinetically for the reaction of reduced ToMOH with dioxygen. In the crystal structure 
of the native enzyme, a large channel for substrate access or product egress, extending from the 
protein surface to the active site pocket, was identified. As mentioned in Chapter 1, the product 
analogue 4-bromophenol binds within this channel, delineating its ability to serve as a pathway for 
substrate or product access to the diiron center.13 Site-directed mutagenesis studies of residues within 
the channel of ToMOH were therefore undertaken to examine the hypothesis that reactive 
intermediates would accumulate if solvent or buffer components were occluded from the active site 
in this system. Residues I100, F198, F205, and H96 form a hydrophobic entrance to that active site 
from the access channel in ToMOH (Figure 2.1). Of these residues, I100 is especially noteworthy. 
The analogous residue in MMOH, L110, is proposed to shift to gate substrate entry to and product 
egress from the active site during catalysis.7 Residue L98 in hemerythrin might perform a similar 
function, controlling solvent access to the diiron core.14 We therefore wondered whether mutation of 
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I100 would isolate the active site pocket from the channel sufficiently to shield the dimetallic center 
from buffer components or solvent, allowing accumulation of reactive intermediates to observable 
levels. Residue F205, which is on the opposite side of the channel from I100, and L208, which is 
farther from the active site pocket, were also selected as targets for mutagenesis (Figure 2.2). We 
substituted I100 with tyrosine and tryptophan, L208 with phenylalanine, and F205 with tryptophan. 
Modeling structures of these variant hydroxylases using the native crystal structure suggested that 
they would afford maximal closure of the channel without disrupting the protein fold of the 
surrounding matrix. A detailed examination of dioxygen activation in ToMOH I100W by RFQ EPR, 
Mössbauer, and ENDOR spectroscopy, as well as stopped-flow optical spectroscopy is presented 
here. The reactivity of other putative channel-blocking variants, I100Y, L208F, and F205W was 
investigated by pre-steady-state stopped-flow optical spectroscopy and steady-state methods.  
 
 
 
  
Figure 2.1. View of the active site pocket of ToMOH 
from the substrate access channel. The diiron atoms 
are depicted as orange spheres. The opening to the 
pocket is bordered by residues I100, T201, F205 and 
F196. I100 is analogous to the proposed leucine gate, 
L110, in MMOH. 
 
Figure 2.2. A substrate access channel (black) in 
ToMOH extends from the protein surface to the diiron 
active site. Residues H96, I100, and F205 form a 
hydrophobic region that joins the active site pocket to 
the channel. Residue L208 resides farther from the 
diiron active site, forming part of the channel wall. 
The iron atoms are depicted as orange spheres. 
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EXPERIMENTAL METHODS 
General Considerations. Plasmids containing the genes for the ToMO components were 
supplied by the laboratory of Professor Alberto Di Donato, Naples, Italy. Recombinant expression 
and preparation of the ToMO component proteins were carried out as described elsewhere.13 ToMOH 
variant proteins were prepared by the same protocol as used for the native enzyme. The iron content, 
measured by the ferrozine assay, ranged from 4.2 to 4.6 iron atoms per ToMOH dimer for all 
samples. Isotopically enriched ToMOH I100W protein for Mössbauer and ENDOR spectroscopy was 
obtained by expression in LeMaster’s media15 containing 57FeCl3 or tryptophan-d5, selectively 
labeled on the indole ring (Cambridge Isotope Labs, Andover, MA). The solution of 57FeCl3 was 
prepared by dissolving 57Fe powder (96.7% isotopic purity, Advanced Materials Technologies Ltd., 
Nes-Ziona, Israel) in concentrated hydrochloric acid. Deuterium oxide was purchased from 
Cambridge Isotope Labs and all other reagents were acquired from Aldrich Chemical Company. 
HPLC experiments were carried out with a Vydac protein & peptide C18 column connected to a 
Waters 600s controller and a Waters 2487 dual wavelength absorbance detector. Optical absorption 
spectra were recorded with an HP8452 diode-array spectrophotometer. 
Site Directed Mutagenesis of the ToMOH α-Subunit. The mutations were introduced by site 
directed mutagenesis on the parent pET-22b(+)/touBEA plasmid with an MJ Research MiniCycler 
using DNA polymerase pfU Turbo, dNTPs, and reaction buffer (Stratagene, La Jolla, CA) according 
to the manufacturer’s protocol. The sequences for oligonucleotides (Invitrogen, Carlsbad, CA) used 
as primers are given in Table 2.1. PCR products were transformed into E. coli XL-1 Blue 
supercompetent cells (Strategene, La Jolla, CA) by heat-shock as described by the manufacturer and 
grown overnight on LB-Agar plates containing ampicillin (300 µg/mL). Five colonies from each 
plate were picked and grown in 5 mL cultures (LB media, 300 µg ampicillin /mL) for 20 h. Cells 
were pelleted at 3500 rpm for 15 min and the plasmids were isolated with a Qiagen Mini-Prep kit. 
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Isolated plasmids were submitted for sequencing in the forward and reverse directions to the 
Biopolymers facility in the Center for Cancer Research (M.I.T.). 
 
Steady-State Activity Assays and Product Determinations for ToMOH Variants. A 
colorimetric assay was used to detect catechol that formed during steady-state hydroxylation of 
phenol by these variants.16 Catechol-2,3-dioxygenase cleaves catechol to form 2-hydroxymuconic 
semialdehyde, which can be monitored by measuring the absorption at 410 nm (ε = 1260 M-1cm-1). 
Assays were conducted at 25 ºC in 0.1 M Tris/HCl pH 7.5 in a final volume of 1 mL. Reaction 
mixtures contained 0.15 μM ToMOH, 10 μM ToMOD, 4 μM ToMOC, 30 nM ToMOF, and 
saturating amounts of catechol-2,3-dioxygenase. Steady-state hydroxylation of phenol (1 mM) was 
initiated with NADH to a final concentration of 1 mM. 
To determine if the regiospecificity of hydroxylation was altered by these mutations, products of 
steady-state turnover for phenol were identified by HPLC. The ToMO protein component 
concentrations were 0.3 μM ToMOH, 2 μM ToMOD, 4 μM ToMOC, and 30 nM ToMOF in 0.1 M 
Tris/HCl pH 7.5 (150 μL). Assay solutions contained 1 mM phenol, and were initiated with NADH 
to a final concentration of 2 mM. Reaction mixtures were incubated at 25 ºC for 15 min, quenched 
with 50 μL TFA, centrifuged for 10 min at 14000 x g, frozen in liquid nitrogen, and stored at  20 ºC. 
Table 2.1. Sequences for Mutagenic Primers for the α-Subunit of ToMOH 
MUTATION  PRIMER  SEQUENCE (5’ to 3’) 
I100W  sense  caacttcacttcggagcgTGGgcacttgaagaatacg 
  antisense  cgtattcttcaagtgcCCAcgctccgaagtgaagttg 
I100Y  sense  ggttagcactatgcaacttcacttcggagcgTATgcacttgaagaatacg 
  antisense  cgtattcttcaagtgcATAcgctccgaagtgaagttgcatagtgctaacc 
F205W  sense  ggcttcaccaatatgcagTGGctcggtttggccg 
  antisense  cggccaaaccgagCCActgcatattggtgaagcc 
L208F  sense  gcagtttctcggtTTCcgccgctgacgctgctgaggccg 
  antisense  cggcctcagcagcgtcagcggcGAAaccgagaaactgc 
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Samples were thawed and 100 μL of the supernatant was injected on to the Vydac column. HPLC 
conditions for separation of hydroxylated products from phenol were 0% buffer B for 7 min, 0% to 
40% B for 1 min (linear gradient), 40% to 100% for 7 min (linear gradient), and 100% B for 3 min 
(A: 1% acetonitrile, 98.8% ddH2O, 0.2% TFA; B: 49.9% acetonitrile, 49.9% ddH2O, 0.2% TFA). 
Absorption at 280 nm was monitored with time for all samples. Retention times for catechol, 
resorcinol, and hydroquinone were determined under these conditions. 
Stopped-Flow Optical Spectroscopy. A HiTech DX2 stopped flow instrument was made 
anaerobic by treatment with an anaerobic solution of sodium dithionite (> 4 mM). This solution was 
allowed to stand in the drive syringes and flow lines for at least 15 min to ensure complete 
scavenging of dioxygen. The instrument was then flushed with anaerobic 25 mM MOPS at the 
appropriate pH immediately prior to use. Solutions containing the hydroxylases and regulatory were 
made anaerobic by cycles of vacuum gas exchange with nitrogen and transferred to a Vacuum 
Atmospheres MO-20 anaerobic chamber, where they were reduced with excess sodium dithionite in 
the presence of methyl viologen. The reduced protein was dialyzed (8000 MWCO) twice against 
25 mM MOPS at specific pH values. Samples were then loaded either into tonometers or Hamilton 
gas-tight sample-lock syringes and loaded into the anaerobic stopped-flow instrument and mixed 
against O2-saturated 25 mM MOPS at a given pH. The software packages KinetAsyst 3.14 (HiTech 
Scientific, UK) or Kaleidagraph 3.5 (Synergy Software, Reading, PA) was used to fit the time 
dependence of the optical data. 
Reaction of ToMOH I100W/Y, F205W, and L208F with O2. Concentrations of the variant 
hydroxylases after mixing varied from 25 μM to 150 μM. Reaction mixtures contained three 
equivalents of ToMOD to one equivalent of ToMOH. The reduced hydroxylase pre-complexed with 
the regulatory protein was dialyzed against buffer, pH 7.0, and allowed to react with dioxygen-
saturated buffer of the same pH. The temperature of the stopped-flow instrument was maintained at 
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4.0 ± 0.1 °C. Multi-wavelength data were collected between 350 and 750 nm with a xenon arc lamp 
and a diode array detector. 
Temperature Dependence for Reaction of ToMOH I100W with O2–Saturated Buffer. The 
reaction of ToMOHred I100W:3ToMOD with dioxygen-saturated buffer was carried out in the 
stopped flow instrument over the range 4.0 to 36.0 °C. The pH of the dialysis and the O2-saturated 
buffer was 7.0. The concentration of ToMOH I100W:3ToMOD varied from 25 to 60 μM in the 
optical cell. The time-dependence of the optical signal at 500 nm was fit to an A B C model to 
determine the formation and decay rate constants. Eyring and Arrhenius plots were generated from 
the rate constants at different temperatures to determine ΔH‡ and ΔS‡ values for each processes. 
Solvent Kinetic Isotope Effect (SKIE) for Formation and Decay of the ToMOH I100W Transient. 
Solutions of ToMOH I100W and ToMOD were prepared as described in the temperature dependence 
experiments. After reduction, protein mixtures were dialyzed anaerobically against either 25 mM 
MOPS pD 6.61 in D2O or pH 7.0 in H2O and allowed to react with dioxygen. The reaction was 
carried out over the range 4.0 and 36.0 °C. Data were collected at 500 nm, and rate constants were 
determined using the model described above. 
Effect of pH on the Reaction of ToMOHred I100W with O2. In these experiments, the pH of the 
reaction mixture was adjusted either by using double-mixing mode to set the pH after dialysis and 
prior to oxygenation in the second push, or in single-mixing mode with dialysis carried out using 
buffers at specific pH values. For double-mixing experiments, the concentrations of the hydroxylase 
and regulatory protein after mixing were 94 μM and 282 μM, respectively. The reduced protein was 
dialyzed against buffer with a pH value of 6.6. In the first push, the solution of the hydroxylase and 
regulatory protein was mixed with anaerobic buffer, pH 6.6 or 8.0, and allowed to age for 1 min. In 
the second push, the aged protein solution was allowed to react with oxygenated buffer, pH 6.6 or 
7.2, and data were collected in multi- and single-wavelength modes. The instrument temperature was 
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maintained at 4.0 °C. For single-mixing experiments, the concentrations of the hydroxylase and 
regulatory protein in the optical cell were 18 μM and 45 μM respectively. After reduction, the first 
dialysis was carried out against 25 mM MOPS pH 7.0. The pH of the buffer was 6.5, 7.0, or 7.5 for 
the second dialysis. The reduced anaerobic samples were mixed at 4.0 °C with oxygenated 25 mM 
MOPS buffer at the appropriate pH values. Data were collected at 500 nm for 100 to 200 s 
Effect of Substrates on the Decay Rate of the ToMOH I100W Transient. This double-mixing 
experiment was carried out at 4.0 ºC monitoring the absorption 500 nm. The concentration of 
ToMOH I100W:3ToMOD after mixing was 25 μM. Reduced ToMOH I100W:3ToMOD was 
dialyzed against buffer at pH 7.0, and loaded into the anaerobic stopped-flow instrument. In the first 
push, the reduced hydroxylase was reacted with dioxygen-saturated buffer (pH 7.0) for 3.9 s. The 
aged solution was subsequently mixed with 25 mM MOPS pH 7.0 containing phenol, acetylene, or 
propylene. The concentration of phenol after mixing ranged from 25 μM to 5.2 mM. For acetylene 
and propylene, an aliquot (10 mL) of buffer was sparged with the gas for 1.5 h to obtain saturated 
solutions of these substrates (7.7 mM or 42.4 mM, respectively).17 Data were collected for 10 s to 
200 s at 500 nm and fit to either one or two exponential functions. 
RFQ Sample Preparation. Protein solutions of ToMOH I100W:3ToMOD were reduced and 
dialyzed against 25 mM MOPS pH 7.0 as described for stopped-flow experiments. Reduced mixtures 
were loaded into gas-tight syringes for an Update Instruments 1000 ram drive system connected to a 
model 705A computer controller. The RFQ instrumentation has been described in detail elsewhere.18 
Reduced protein was mixed with dioxygen buffer, allowed to age for reaction times between 34 ms 
and 600 s, and then quenched in isopentane at -140 ºC. The frozen protein solutions for this 
timecourse were packed into X-band EPR tubes and Mössbauer sample cups. Samples for ENDOR 
spectroscopy were quenched 4 s after mixing with dioxygen-saturated buffer, and packed into Q-
band EPR tubes. All RFQ samples were stored in liquid nitrogen until spectra were acquired. 
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Mössbauer Spectroscopy. ToMOH I100W isotopically enriched with 57Fe was used to generate 
RFQ samples for Mössbauer spectroscopy. The concentration of ToMOH I100W:3ToMOD after 
mixing was 290 μM. Mössbauer spectra were recorded at 4.2 K in an applied magnetic field of either 
50 mT or between 1 T and 8 T applied parallel to the γ-beam on instrumentation described 
elsewhere.18 The zero velocity refers to the centroid of a room temperature spectrum of an Fe foil.  
X-Band EPR Spectroscopy. Samples were generated with ToMOH I100W that contained 
either 56Fe or 57Fe. The concentration of ToMOH I100W:3ToMOD in the quenched reaction 
mixtures was 198 μM. EPR spectra at g = 2.00 were recorded at 30 K with the following parameters: 
power = 0.02 mW; frequency = 9.65 GHz; modulation frequency = 100 kHz; modulation amplitude 
= 5 G; gain = 6.3 × 104. EPR spectra at g = 16 were recorded at 8 K with the following parameters in 
parallel mode: power = 20 mW; frequency = 9.39 GHz; modulation frequency = 100 kHz; 
modulation amplitude = 10 G; gain = 6.3 × 104. 
ENDOR Spectroscopy. Samples were prepared either with 25 mM MOPS in D2O (pD 6.6) or 
H2O (pH 7.0), and the hydroxylase contained either natural abundance 56Fe or was isotopically 
enriched with 57Fe. For samples prepared with D2O-containing buffers, the reduced protein was 
dialyzed against deuterated buffers. The concentration of ToMOH I100W:3ToMOD in ENDOR 
samples ranged from 250 μM to 350 μM. 1H- and 2H-Mims ENDOR spectra were recorded on 
instrumentation described elsewhere.19 
Enzymatic Digestion and Mass Spectrometry of ToMOH I100W. Reduced ToMOH I100W 
was prepared as described above for the stopped-flow experiments. A 10-μL control aliquot of the 
ToMOH I100W:3ToMOD mixture was removed prior to making the protein anaerobic. The 
remainder of the protein was reduced with excess sodium dithionite and dialyzed under anaerobic 
conditions against 25 mM MOPS pH 7.0. The reduced protein was mixed with buffer oxygenated 
with either natural abundance 16O2 or enriched 18O2 (95%, Cambridge Isotope Labs, Andover, MA) 
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in the stopped-flow instrument. The polypeptide chains of reacted and unreacted oxidized protein 
solutions were separated on a 4-20% Tris/HCl SDS-PAGE gel run at 200 V for 45 min. The band 
corresponding to the α-subunit was excised and digested with trypsin according to the 
manufacturer’s protocol (New England Biolabs, Ipswich, MA). Positive ion MALDI-TOF mass 
spectrometry of digests was carried out with a Voyager DE-STR MALDI-TOF mass spectrometer 
(Applied Biosystems, Foster City, CA), installed in the Biopolymers Core Facility of the M.I.T. 
Center for Cancer Research. The instrument was operated in reflector mode with an accelerating 
potential of 20 kV and mass resolution of at least 1:10000. The MALDI matrix was α-cyano-4-
hydroxybenzoic acid. Protein digest samples were mixed with a 10 mg/mL matrix solution in a 1:1 
ratio and were deposited on the MALDI plate. Mass spectra were obtained using a nitrogen UV laser 
(337 nm). Each mass spectrum is the average of 50 laser shots. The mass spectrometer was calibrated 
as per the manufacturer's standard operating protocols, with a mixture of peptides of known mass that 
were spotted on the MALDI plate adjacent to the sample. Mass spectra were processed using the 
Applied Biosystems Data Explorer software. 
LC-MS analyses of the protein digests were carried out using a Tempo nano HPLC system 
(Applied Biosystems, Foster City, CA) coupled on-line to a QSTAR Elite quadrupole-time-of-flight 
tandem mass spectrometer (MDS Sciex/Applied Biosystems, Foster City, CA), installed in the 
Proteomics Core Facility of the M.I.T. Center for Cancer Research. The mass spectrometer was 
calibrated as per the manufacturer's standard operating protocols, with the fragment ions a peptide of 
known sequence. Separation of proteolytic peptides was carried out on a C18 capillary HPLC column 
(Michrom Bioresources, Auburn, CA) and a water-acetonitrile (with 0.1% formic acid) solvent 
gradient at a flow rate of 300 nL/min. Mass spectral data were acquired and processed with the 
Applied Biosystems Analyst QS software. Data acquisition was performed using the software 
"Information Dependent Acquisition" mode, with each MS scan, where peptide ion m/z values were 
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measured, followed by four MS/MS scans, where fragment ion spectra of the four most abundant 
precursor ions were acquired. A temporary exclusion list was generated by the software after each 
MS/MS data acquisition to minimize the generation of duplicate MS/MS spectra from the same 
precursor ion. 
 
RESULTS 
Steady-state Product Distribution and Activity of ToMOH Variants for Phenol. The steady-
state specific activities of the ToMOH variants for phenol were lower than that observed for wild-
type hydroxylase as determined by the coupled assay with catechol-2,3-dioxygenase. The I100W 
variant had a specific activity of 80 mU/mg compared to 1250 mU/mg for the wild-type protein. 
ToMOH I100Y, L208F, and F205W showed no activity under the conditions of this assay. Catechol, 
resorcinol, hydroquinone, and phenol are well separated by the method described in the Experimental 
Section, with retention times of 13, 11, 6.5, and 15 min, respectively. The peak corresponding to the 
enzymatic product had a retention time coincident with that of catechol (Figure 2.3). No peaks 
corresponding to resorcinol or hydroquinone were observed. Product analyses for the variant 
hydroxylases revealed catechol to be the only product formed. A trace amount of catechol was 
observed in assay mixtures for ToMOH I100Y, F205W, and L208F. 
Stopped-Flow Optical Study of the Reaction of ToMOH Variants with O2. No transient 
absorption bands between 350 and 750 nm were observed after mixing solutions of chemically 
reduced ToMOH variants I100Y, F205W, and L208F and ToMOD with dioxygen-saturated buffer. 
Reaction of reduced ToMOH I100W with dioxygen afforded an optically-active transient with an 
absorption maximum, λmax, at 500 nm (Figure 2.4). Single-wavelength data collected at λmax were fit 
best to a three-component sequential reaction model. Rate constants for the formation and decay rate 
constants and the molar extinction coefficient of this transient of the 500 nm band are kf = 0.804 ± 
0.001 s-1, kd = 0.054 ± 0.002 s-1, and ε = (1.5 ± 0.2) x 103 M-1cm-1, respectively. The values for λmax 
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Figure 2.3. HPLC traces at 280 nm of steady-state reaction mixtures for wild-type and F205W variant of 
ToMOH. Catechol (black arrow) is the only observed product in reactions. The peak corresponding to phenol 
(blue arrow), the substrate used in these assays, was of a lower intensity in the reaction containing the F205W 
mutant, consistent with the reduced steady-state activity of this hydroxylase. The compound eluting at 6 min 
does not arise from hydroquinone, as determined by HPLC traces for samples doped with this compound. A 
background peak at ~ 12.5 min (red arrow) appears in all traces with equal intensity. 
 
Figure 2.4. Stopped-flow UV/visible spectra for the reaction of I100Wred:3ToMOD with O2-saturated 
buffer. Multi-wavelength data reveal the formation and decay of a transient species with an absorbance 
maximum at 500 nm. No other absorbance bands are observed during the reaction. The single wavelength 
data at 500 nm (inset) were fit to a three component sequential kinetic model and the calculated rate 
constants and the molar extinction coefficient for the intermediate are 0.804 ± 0.001 s-1 (formation), 0.054 ± 
0.002 s-1 (decay), and 1.5 ± 0.2 x 103 M-1cm-1 respectively. 
53
and ε are similar to those reported for deprotonated tryptophanyl radicals in small peptides and 
proteins.20,21 The regulatory protein was required in the reaction mixture for formation of the 
transient species. The requirement for the regulatory protein to facilitate dioxygen activation in the 
hydroxylase has been previously reported for MMO. 
Time-Dependent Mössbauer Spectra for the Reaction of ToMOHred I100W with O2. The 
Mössbauer spectrum of the reduced protein contains only diiron(II) clusters, which are modeled as 
two distinct diiron(II) sites (Figure 2.5A). After mixing with dioxygen-saturated buffer, 
approximately 40% of the diiron(II) sites reacted rapidly to form a diiron(III) intermediate (Figure 
2.5B, C). This intermediate was simulated as a single quadrupole doublet with values for the isomer 
shift, δ, and quadrupole splitting, ΔEQ, of 0.54 and 0.67 mm/s, respectively (red line). These 
parameters differ from those of other non-heme diiron(III) intermediates characterized because δ < 
0.6 mm/s and ΔEQ < 1.0 mm/s. This transient species subsequently evolves to form a mixed-valent 
diiron(III,IV) cluster, a process that maximizes at ~ 4 s (Figure 2.5D). A paramagnetic spectral 
component with features (arrows) similar to those of intermediate X was observed (Figure 2.6A).22,23 
The signals corresponding to unreacted diiron(II) and oxygenated diiron(III) precursors are omitted 
from this spectrum for clarity. Analysis of the spectrum indicates that this paramagnetic component 
accounts for 15 ± 2% of the total Fe absorption. The spectrum of this sample recorded with a strong 
applied field of 8 T (Figure 2.6B) showed a two-fold increase in the intensity of the paramagnetic 
component to 30 ± 3% of total Fe absorption. This field-dependent increase of the paramagnetic 
absorption indicates that the S = ½ diiron(III,IV) cluster is weakly spin-coupled to a nearby S = ½ 
paramagnet. For a weakly coupled system (J < 1 cm-1) in a weak applied field of 50 mT, the energy 
separations of the four electronic levels are small, whereas in a strong applied field of 8 T, the 
Zeeman interaction increases the energy separations between these levels. At 4.2 K and 50 mT, all 
four levels are nearly equally populated, and the spectrum contains two equal-intensity components: 
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a paramagnetic component (two MS = ±1 sublevels of the triplet state) superposed on a diamagnetic 
component (the singlet state and the MS = 0 sublevel of the triplet state). In contrast, at 4.2 K and 8 T, 
only the lowest MS = -1 sublevel is populated and the diamagnetic component disappears, doubling 
the intensity of the paramagnetic component. We compared a simulated spectrum of the X-Y● 
 
Figure 2.5. Mössbauer spectra of freeze-quenched samples from the reaction of ToMOHred I100W:3ToMOD with 
O2. The samples were frozen before mixing (A) and 0.07 s (B), 0.44 s (C), 3.5 s (D), 37 s (E) and 900 s (F) after 
mixing. The spectra (vertical bars) are collected at 4.2 K in a 50 mT field applied parallel to the γ-beam. The 
diiron(II) spectrum (A) was simulated as a superposition of two unresolved quadrupole doublets (green lines in A) 
with an intensity ratio of 1.6:1 for doublet 1:doublet 2. The parameters are δ = 1.32 mm/s, ΔEQ = 3.11 mm/s, and 
line width = 0.65 mm/s for doublet 1, and δ = 1.31 mm/s, ΔEQ = 2.32 mm/s, and line width = 0.65 mm/s for 
doublet 2. In B-F, the red, blue, orange and cyan lines are simulated spectra of the diiron(III) transient, 
diiron(III,IV)-W● intermediate, major diion(III) and minor diiron(III) products, respectively. The spectrum of the 
major diiron(III) product (─) is modeled with a single quadrupole doublet with δ = 0.51 mm/s, ΔEQ = 0.84 mm/s, 
and line width = 0.35 mm/s. The spectrum of the minor diiron(III) product (─) is simulated with δ = 0.56 mm/s, 
ΔEQ = 1.77 mm/s, and line width = 0.33 mm/s. For clarity, the diiron(II) spectral component is not shown 
specifically in B-F. The simulated spectra are plotted at the following absorption intensity: red, 29% and 27% in B 
and C, respectively; blue, 16% and 34% in C and D, respectively; orange, 14%, 60% and 65% in D, E, and F, 
respectively; cyan, 3%, 8% and 8% in D, E, and F, respectively. The black lines overlaid with the experimental 
spectra are composite spectra including the diiron(II) and all other species mentioned above. 
55
species in RNR-R2 W48F23 to the spectrum of the 3.5 s sample, and the agreement was remarkable 
and consistent with a weakly-coupled diiron(III,IV)–W• pair (Figure 2.6B). Values for δ and ΔEQ 
(FeIII/FeIV) for this species are 0.47/0.22 and 0.70/0.64 mm/s, respectively.  
Percentages of Fe-absorption corresponding to species generated at different time points, 
including others not depicted here, were thereby obtained. On the basis of the Fe/protein ratio 
determined for the freeze-quenched samples, 3.88 Fe atoms/ToMOH dimer, these relative 
percentages were converted to accumulation amounts of diiron cluster/protomer for the diiron species 
at various time points. The results (diamonds) are presented in Figure 2.7, which shows clearly the 
formation and decay of the various diiron species. Before mixing with O2, the reduced protein sample 
contains mainly diiron(II) clusters, 0.96 diiron clusters/ToMOH protomer, the spectrum of which can 
be modeled as two unresolved quadrupole doublets (Figure 2.5A, green lines) with parameters given 
 
 
Figure 2.6. Mössbauer spectra of the sample quenched after 
3.5 s recorded with an applied field of 50 mT (A) and 8 T 
(B) show intensity changes expected for a weakly spin-
coupled system. The diiron(II) contributions (50% of the 
total Fe absorption) were removed from the raw data for 
clarity. Spectra are simulated with parameters used for X-Y• 
from RNR-R2 W48F (blue lines). 
 
 
 
Figure 2.7. Speciation plot for the reaction of 
ToMOHred I100W:3ToMOD with dioxygen. The 
diiron(II) starting material (♦) rapidly converts 
to a diiron(III) intermediate (♦) at ~ 18 s-1. The 
diiron(III) transient evolves to the mixed-valent 
species (♦) at ~ 1 s-1. The formation and decay 
rates of the g = 2.0 signal () from RFQ EPR 
experiments are within error of the rates for 
mixed-valent species determined by Mössbauer. 
The diiron(III) resting state (♦) is reformed as 
the mixed-valent species decays at ~ 0.08 s-1.  
The diiron(II) starting material (−), the diiron(III) 
intermediate (−), mixed-valent diiron(III,IV) 
transient (−), g = 2.0 EPR signal (−), and the 
diiron(III) product (−) were fit to two-
exponential functions.
A 
 
 
 
 
B 
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in the figure caption. After mixing with O2-saturated buffer, approximately 40% of the diiron(II) sites 
react rapidly to form the diiron(III) intermediate (Figure 2.5, red lines) with a rate constant of 
~ 18 s-1. Accumulation of the diiron(III) intermediate reaches a maximum of 0.32 clusters/protomer 
at 0.14 s and then decays at a rate of ~ 1.1 s-1 (Figure 2.7, red line and diamonds). The decay of the 
diiron(III) intermediate parallels the formation of the diiron(III,IV)–W● species (Figure 2.7, blue line 
and diamonds), while the unreacted diiron(II) sites stay relatively stable (Figure 2.7, olive green line 
and diamonds) during this decay phase of the diiron(III) intermediate. This result establishes 
unambiguously that the diiron(III) transient is a true precursor to diiron(III,IV)–W●. The data also 
reveal that the diiron(III,IV)–W● species reaches a maximum accumulation of 0.33 clusters/protomer 
at 3.5 s and decays with a rate constant of ~ 0.08 s-1 to generate the diiron(III) product (Figure 2.7, 
orange line). The formation and decay rates of the optically silent diiron(III,IV) cluster are linked to 
that of the optically active W●, because the rates of the former, determined from Mössbauer 
spectroscopy, agree with those of the latter, determined from optical studies (17, also, see Table 2.2). 
Slow oxidation (~ 0.01 s-1) of residual unreacted diiron(II) species accompanies the second phase 
formation of the diiron(III) product and the generation of other minor, unidentified ferric species. A 
previously unreported, minor oxidation product (Figure 2.5, cyan lines) can detected as forming 
around 1 to 2 s after mixing with O2, after 5 s its accumulation reaches a constant value of ~ 8% of 
the total iron in the samples. Its Mössbauer parameters (δ = 0.56 mm/s and ΔEQ = 1.77 mm/s) and 
diamagnetism, revealed by high-field Mössbauer measurements, indicate a diiron(III) cluster. Its 
kinetic profile suggests that it is a final product. A definitive identification cannot be made, however, 
due to the small amount of material that accumulates. 
Time-Dependent EPR Spectra for the Reaction of ToMOHred I100W with O2. The intensity 
of two EPR signals changed during the reaction of the reduced variant hydroxylase with dioxygen. A 
signal at g = 16, which corresponds to diiron(II) centers, decays in a biphasic manner. The first phase 
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Figure 2.9. EPR spectra of the mixed-valent diiron(III,IV)–W• transient generated during reaction 
of reduced ToMOH I100W with dioxygen. The reaction was quenched after either 4 s for natural 
abundant diiron(II) protein (blue) or at 3.5 s for 57Fe-enriched protein (red). Line broadening from 
hyperfine interactions with 57Fe nuclei is evident, confirming that EPR-active species is at or near 
the dimetallic cluster. 
 
Table 2.2. Formation and Decay Rate Constants of the Mixed-Valent 
Diiron(III,IV)-W• Species Measured by Optical, Mössbauer, and EPR Spectroscopy 
 
Rate Constant Optical Mössbauer EPR 
kf (s-1) 0.804(1) 1.1 0.77 
kd (s-1) 0.054(2) 0.08 0.15 
 
 
Figure 2.8. Time-dependent EPR spectra for the transient formed during the 
reaction of ToMOHred I100W:3ToMOD with O2. The intensity of the signal at g = 
2.0 maximizes 4 s (─) after mixing reduced protein with dioxygen-saturated buffer. 
Spectra for samples that were allowed to react for 520 ms (─), 10 s (─), and 100 s 
(─) are also shown. 
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is rapid and could not be simulated accurately with the data collected. This initial decay is complete 
by ~ 0.17 s, which is consistent with the decay kinetics of the rapidly interacting diiron(II) sites 
observed in the Mössbauer measurements (vide supra). The second phase was slower and incomplete 
by 150 s. Figure 2.8 displays EPR spectra of selected freeze-quenched samples in the g = 2.0 region, 
showing the rise and fall of the transient EPR signal. Line broadening of this signal was observed for 
samples prepared with 57Fe-enriched ToMOH I100W, confirming that the unpaired electron interacts 
with the diiron center (Figure 2.9). This signal and the observed hyperfine interaction with the iron 
nuclei are similar to that reported for X–W•+ and X–Y• in RNR-R2.22-24 The intensity of this transient 
signal appeared and decayed with rate constants of 0.77 s-1 and 0.15 s-1, maximizing at approximately 
4 s (Figure 2.7,  and −). The rate constants for formation and decay agree with those reported from 
the stopped-flow optical and Mössbauer experiments, confirming that this EPR active species 
corresponds to the spin coupled mixed-valent diiron(III,IV)–W● intermediate (Table 2.2). The time-
dependent EPR data indicate that the fast-reacting diiron(II) protein and the mixed-valent species are 
not kinetically linked because the rate of decay of the former is much faster than the rate of formation 
of the latter. This result indicates the presence of an intervening EPR-silent species, namely, the 
diiron(III) intermediate observed in the Mössbauer spectra of RFQ samples quenched between 0.03 s 
and 4 s, described above. 
Prior to 1H and 2H-Mims ENDOR measurements, X-band EPR spectra were recorded on samples 
quenched 4 s after mixing solutions of ToMOHred I100W:3ToMOD with dioxygen-saturated buffer. 
The g = 2.0 signal has two contributions as previously mentioned, one from the diiron(III,IV) cluster 
and the other from the tryptophan radical. The radical signal is visible at temperatures up to ~ 77 K, 
whereas the diiron signal is visible only below ~ 40 K (Figure 2.10). The peak width of the mixed-
valent diiron(III,IV)–W● transient is smaller than that reported elsewhere for tryptophan cation and 
neutral radicals.25 
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 Kinetic Activation Parameters and Kinetic Isotope Effects for Formation and Decay of the 
Diiron(III,IV)–W• Species.  The rate constants kf and kd vary with temperature to give linear Eyring 
plots (Figure 2.11). The values of ΔH‡ and ΔS‡ for formation of this species are similar to those 
reported for decay of Q to MMOHox (Table 2.3).26 Both kf and kd were sensitive to the hydrogen 
isotope concentration with normal isotope effects, kH > kD, observed over the examined temperature 
range (Table 2.4). The ratio of kH/kD decreased with increasing temperature from 2.51 to 1.97 for kf 
and 3.2 to 1.72 for kd. From Arrhenius plots, the formation activation energy is greater in deuterated 
 
Figure 2.11. Eyring Plots for formation and decay of the tryptophanyl radical generated during 
reaction of reduced ToMOH I100W with oxygenated buffer. Values for ΔH‡ and ΔS‡ were determined 
from linear fits to data for kf (•) and kd (■) and are reported in Table 2.2. 
 
Figure 2.10. X-band EPR spectra of the diiron(III,IV)–W• at (A) 20 K and (B) 65 K. (A) The 
spectrum at 20 K contains the anisotropic features associated with the diiron center with the 
radical signal saturated. (B) Spectrum at 65 K of the intermediate is predominantly from the W 
radical. The diiron center is not saturated below 60 K 
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 Figure 2.12. SKIE for kf and kd of the ToMOH I100W transient. Stopped-flow optical data acquired at 500 nm 
and 4.0 °C show the formation and decay of the mixed-valent diiron(III,IV)–W• are slower in deuterated than in 
protic buffers (left). The difference in activation energy for both phases in protic versus deuterated buffers is 
non-zero as determined from the Arrhenius plots (right). The temperature dependence of kH/kD is therefore non-
zero for both processes with the decay exhibiting a stronger dependence than formation. This data imply that 
hydrogen atom transfer or tunneling from W100 to the diiron(III) intermediate does not occur during formation. 
 
Table 2.4. Formation and Decay Rate Constants for I100W Transient in H2O and D2O Buffers 
Temp  H2O  D2O  Formation  Decay 
(± 0.1 °C)  kf (s-1)  kd (s-1)  kf (s-1)  kd (s-1)  kH / kD  kH / kD 
4.0  0.90 ±  0.01 0.093 ± 0.009 0.358 ± 0.002 0.029 ± 0.001 2.51 ± 0.04  3.2 ± 0.3 
10.0  1.39 ± 0.02 0.143 ± 0.002 0.567 ± 0.003 0.060 ± 0.001 2.46 ± 0.03  2.36 ± 0.05 
15.0  2.09 ± 0.03 0.218 ± 0.002 0.93 ± 0.04 0.111 ± 0.001 2.24 ± 0.08  1.97 ± 0.02 
20.0  3.25 ± 0.05 0.359 ± 0.008 1.50 ± 0.06 0.195 ± 0.001 2.17 ± 0.09  1.84 ± 0.04 
25.0  4.9 ± 0.1 0.59 ± 0.01 2.50 ± 0.07 0.342 ± 0.001 1.97 ± 0.07  1.72 ± 0.02 
 
Table 2.3. Activation Parameters for Formation and Decay of Species Observed in 
the Reaction of ToMOH I100W:3ToMOD and MMOH:2MMOB with Dioxygen 
  Rate Constants ΔH‡ (kcal/mol) ΔS‡ (cal/mol•K) 
ToMOH I100W  kf  12.7 ± 0.5  -13 ± 2 
  kd  17.0 ± 0.4  -3 ± 2 
MMOH (M. caps)*  k1 (Hred → Hperoxo)  27.9 ± 0.1  43 ± 2 
  k2 (Hperoxo → Q)  28.7 ± 0.3  43.9 ± 0.5 
  k3 (Q → Hox)  13.7 ± 0.7  -18 ± 2 
* Reference 26 
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solvent, 15.6 ± 0.5 kcal/mol, than in protic, 13.5 ± 0.1 kcal/mol, as expected from the ratio of kH/kD  
(Figure 2.12). The solvent kinetic isotope effect (SKIE) for the formation process is weakly 
dependent on temperature and contrasts with the stronger, non-linear dependence for the decay 
process. The magnitude and sensitivity to temperature of the SKIEs indicate that hydrogen atom 
transfer or tunneling does not occur in the transition state during the reaction of the diiron(III) 
intermediate with W100, or for subsequent decay of the mixed-valent diiron(III,IV)–W• species.  
Effect of pH on the Reaction of ToMOH I100W with O2-Saturated Buffer. As the pH 
increased from 6.5 and 7.5, the rates of oxidation of W100 by the diiron(III) intermediate and decay 
of the diiron(III,IV)–W• species increased (Table 2.5). From data collected in diode array mode, the 
absorption maximum of the tryptophanyl radical was unchanged over the examined pH range. To 
explain the pH dependence, we propose a model in which a rate-limiting deprotonation precedes a 
fast oxidation reaction. The pH dependence data agree reasonably well with this model to give a 
calculated proton-independent electron transfer rate of 1.22 s-1 (Figure 2.13). The decay rate of the 
transient is also sensitive to pH, following a similar trend as observed for the formation rate. Values 
Table 2.5. Formation and Decay Rate 
Constants at Varying pH Values 
pH  kf (s-1)  kd (s-1) 
6.5  0.66 ± 0.01  0.0417 ± 0.0006 
6.6  0.71 ± 0.01  0.052 ± 0.005 
7.0  0.86 ± 0.04  0.070 ± 0.003 
7.2  1.05 ± 0.02  0.095 ± 0.001 
7.5  1.13 ± 0.02  0.091 ± 0.001 
 
 
 
Figure 2.13. Effect of proton concentration on formation 
and decay of the diiron(III,IV)–W• species . Increasing 
pH increases kf and kd of the ToMOH I100W transient. 
The rate constants both increase with decreasing [H+], 
with kf (■) and kd (●) increasing ~ 2-fold between pH 6.5 
and 7.5. The y-axis scales differ above and below the 
break. 
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of kd increase almost two-fold with an order of magnitude decrease in proton concentration. The data 
were adequately fit with the model applied to the formation rate, rate-limiting deprotonation followed 
by oxidation, yielding a rate constant of 0.12 s-1 for the rapid second step of the reaction (Figure 
2.13).   
Effect of Substrates on the Decay Rate of the ToMOH I100W Transient. The presence of 
phenol increased the decay rate constant of the tryptophanyl radical from 0.054 s-1 to 13.7 ± 0.4 s-1. 
The concentration dependence of kd was modeled with a saturation binding model applied to the 
reaction of oxygenated intermediates in MMOH with alternative substrates, where a substrate-
enzyme complex forms prior to reaction (eq 2.1).27 From this analysis, the rate constant for reaction 
with phenol, krxn, and the substrate-enzyme dissociation constant, Kd, are 20 ± 2 s-1 and 2.3 ± 0.5 mM, 
respectively (Figure 2.14). In double-mixing experiments employing phenol, the absorbance over all 
wavelengths increased after decay of the transient. This growth in absorption was modeled as an 
independent exponential function in all data for which phenol was the substrate. 
 
   
Figure 2.14. Effect of substrates on the decay rate of the tryptophanyl radical. The decay rate increases the in 
presence of phenol, a substrate for the native enzyme system (left). The dependence of the observed rate on 
phenol concentration is well modeled by saturation kinetics. The determined reaction rate of the intermediate, 
krxn, with phenol and the substrate binding constant, Kd, are 20 ± 2 s-1 and 2.3 ± 0.5 mM respectively. 
Propylene, a substrate for MMOHperoxo, also accelerates kd by more than 50-fold to 2.8 s-1 whereas acetylene 
has only a minor effect (right). 
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The decay rate of W● is also accelerated in the presence of propylene. The observed decay rate 
constants are 0.239 ± 0.003 s-1 and 2.8 ± 0.1 s-1 for propylene concentrations of 19 μM and 3.8 mM, 
respectively. Addition of acetylene to the tryptophanyl radical had little influence on the decay 
process, increasing the rate constant from 0.079 ± 0.002 s-1 to 0.114 ± 0.006 s-1 (Figure 2.14). 
1H- and 2H-ENDOR Spectra of the Mixed Valent Diiron(III,IV)–W• Couple. To confirm 
that the protein-based radical resides on a tryptophan residue, 1,2H-ENDOR spectra were recorded of 
this transient in H2O/D2O buffers using enzymes that contained either natural abundance tryptophan 
or the tryptophan selectively deuterated on the indole ring. Although the radical EPR signal overlaps 
that of the diiron center, the spectrum of the latter is substantially broader. Signals from the two can 
therefore be distinguished by their field dependence as well as by their different relaxation properties. 
The 1H–CW ENDOR spectra collected at fields associated with the radical for samples containing 
natural abundance tryptophan residues are dominated by signals from the Cβ protons of the residue, 
with strong hyperfine couplings of ~ 20 MHz, and by those from the indole ring, with smaller 
couplings (Figure 2.15). Additional features near νH have been assigned to protein matrix protons in 
 
Figure 2.15. 1H-Mims ENDOR spectra of the tryptophan radical in buffers 
containing H2O (black) and D2O (blue). The two spectra are superimposable 
indicating that there are no exchangeable protons on the radical. The spectra, as 
for the 2H-Mims spectra, are dominated by signals from the indole protons. 
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other systems.28 To determine that the radical is centered at tryptophan, we collected 2H-Mims 
ENDOR spectra from natural-abundance and selectively deuterated, tryptophan(d5-indole), 
hydroxylase. 
The sample prepared with isotopically enriched tryptophan shows 2H-Mims ENDOR signals with 
hyperfine couplings corresponding to AH > 10 MHz when the field of observation is where the radical 
signal is strongest (Figure 2.16). These signals arise from the aromatic protons of the indole ring 
because they are absent at fields outside the EPR envelope of the radical signal in the natural-
abundance sample. The signals unequivocally confirm that the protein-based radical resides on a 
tryptophan residue. 
 
1H–CW ENDOR spectra collected at the field corresponding to the maximum intensity of the 
radical are similar for the diiron(III,IV)–W● transient generated with unlabelled protein in deuterated 
and protic buffers, but such comparisons are difficult because of strong signals from non-
exchangeable protons (Figure 2.15). As a result, the presence of potentially exchangeable protons 
was investigated by 2H Mims ENDOR measurements. 2H-Mims ENDOR signals corresponding to 1H 
coupling of AH ~ 4-8 MHz were observed in samples generated in deuterated buffer (Figure 2.17). 
 
Figure 2.16. 2H-Mims ENDOR spectra of the tryptophanyl radical. Protein in this sample 
was expressed in media containing isotopically enriched tryptophan(d5-indole). Saturation 
of the transition corresponding to the radical signal at g ~ 2.00 (middle) yields 2H signals 
from the labeled indole ring. These peaks disappear upon saturation at higher (top) or lower 
(bottom) g-values. Magnetic fields scanned are reported as g-values in the figure. 
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Because these signals are observed at fields across the EPR envelope of the diiron center, and outside 
that of the tryptophanyl radical, they can be assigned to the diiron center (compare Figures 2.16 and 
2.17). By analogy to the diiron centers of intermediate X and MMOHmv, for which ENDOR signals 
from terminal water molecules on the iron(III) ion correspond to species with AH ~ 7-9 MHz, the 
signals observed in the diiron(III,IV)–W● transient can be assigned to a terminal water molecule or 
hydroxide ion on the ferric ion.28,29  
If the tryptophanyl radical were protonated at the indole nitrogen atom, one would expect an 
additional 2H signal, with AH > 10 MHz, at fields associated with this radical.30-34 No such 2H signals 
are observed, however (Figure 2.17). The absence of an exchangeable proton associated with the 
 
Figure 2.17. 2H-Mims ENDOR spectra of the diiron(III,IV)–W• species generated in 
deuterated buffers. Signals arising from protonated species are observed over the swept 
magnetic fields. The signal shows minor changes upon saturation at g = 1.9875 to 2.0 and 
does not correlate with the tryptophan radical. The corresponding proton scale is shown for 
comparison. 
66
protein radical is consistent with our interpretation of the stopped-flow optical data, where a band 
with λmax of 500 nm indicated a deprotonated tryptophanyl radical. 
Tryptic Digestion and Mass Spectrometry Analyses of ToMOH I100W and its Oxidation 
Product. The most ion intense peaks in the MALDI-TOF(+) spectra are between 700 and 2500 m/z 
for the in-gel tryptic digested α-subunit of as-isolated and O2-reacted ToMOHred I100W. The 
expected tryptic peptide containing W100, 85ADPGWVSTMQLHFGAWALEEYAASTAEAR113, 
has a predicted monoisotopic mass of 3165.5 Da for the [M+H]+ parent ion. The ion envelope at m/z 
= 3166 in the protein sample as-isolated after expression is well separated from other ions in the 
spectrum. This fragment is assigned as the 29mer peptide containing W100. Two additional 
envelopes of lower intensity are present at m/z values of 3182 and 3198 (Figure 2.18). The relative 
 
Figure 2.18. MALDI-TOF spectra of tryptic peptides for the α-subunit of O2-reacted (top) 
and as-isolated (bottom) ToMOH I100W.  The mass of the [M+H]+ ion at 3166 m/z agrees 
with the predicted mass for the 29mer peptide. Two additional envelopes of 16 and 32 Da 
higher mass are also present. The relative intensity of these three envelopes changes in the 
reacted sample, with [M+H]+ less abundant than [M+H]++16. 
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intensities of these latter two envelopes in the reacted sample increase markedly, with that at 
m/z = 3182 becoming the most intense. The envelopes at m/z = 3182 and 3198 were unchanged in 
MALDI-TOF spectra of digestion products of reduced ToMOH I100W reacted with 18O2-saturated 
buffer.  
The tryptic peptide of interest also contains other residues sensitive to oxidation, such as 
methionine and histidine. To determine the decay pathway chemistry for the W• species, we 
attempted to identify the specific residue that is oxidized. Fragmention of the tryptic peptide was 
carried out by ESI(+)-MS/MS. Ions resulting from the [M+H]3+ ion were assigned to respective b and 
y peptides35 by considering the fragment ion mass and the peak-to-peak separation within the ion 
envelope. We could not identify the ions corresponding to every possible fragment because the peak 
intensities were below our detection threshold. From the ions that were isolated, the b ions limit the 
site of modification to lie between S91 and E104, a region that includes two other possible sites of 
oxidation, M93 and H96. The y fragment ions further narrowed the possible region of oxidation, 
excluding M93. Probable sites of oxidation are therefore limited to H96 and W100 (Figure 2.19).  
 
DISCUSSION 
Mixed-Valent Diiron(III,IV)–W● Species as an Entry to Identifying ToMOH 
Intermediates. Dioxygen reacts rapidly, kobs ~ 18 s-1, with reduced diiron(II) ToMOH I100W 
preincubated with ToMOD to yield a diiron(III) intermediate that was only disclosed because it 
generated the tryptophan radical. One-electron reduction of this diiron(III) transient gives rise to a 
mixed-valent diiron(III,IV) center. The peroxodiiron(III) species in RNR-R2 reacts in a similar 
manner. Oxidation of W48 and protonation of one of the oxygen atoms in the peroxo-adduct of 
RNR-R2 facilitates O–O bond cleavage to form X.23,24 The proposed mechanism for dioxygen 
activation in cytochrome P450 enzymes requires protonation of the distal oxygen atoms in the 
peroxoiron(III) intermediate by a conserved threonine-aspartic acid pair.6,19 Residue T201 in the 
68
active site cavity of ToMOH, which is strongly conserved among the BMMs, could function in a 
proton shuttle pathway to the diiron core. In MMOH, this threonine is proposed either to deliver 
protons to the peroxodiiron(III) species directly,36 or more plausibly, by strategically holding a 
hydronium ion for proton transfer during reduction of the oxidized diiron(III) center.37 Conversion of 
the diiron(III) intermediate in ToMOH to the mixed-valent center could proceed by an analogous 
pathway as that in the heme systems and RNR-R2. In the I100W variant, T201 could help to provide 
a crucial proton to facilitate cleavage of the O–O bond to form the mixed-valent transient. Protons 
 
Ion Mass (m/z) Charge   Ion Mass (m/z) Charge 
b4 341.2 +1   y1 175.1 +1 
b5 527.2 +1   y2 246.2 +1 
b6 626.3 +1   y3 375.2 +1 
b6 313.2 +2   y4 446.3 +1 
b7 713.3 +1   y5 547.3 +1 
b20 1122.5 +2   y6 634.3 +1 
b22 1239.6 +2   y7 705.4 +1 
     y8 776.4 +1 
     y9 939.5 +1 
     y12 1320.6 +1 
     y19 1055.8 +2 
     y23 1278.6 +2 
     y27 1328.2 +2 
     y27 999.1 +3 
 
Figure 2.19. ESI-MS/MS fragment ions arising from the tryptic peptide containing 
W100. The fragment peptide ions of the tryptic peptide of interest are labeled using 
the b and y ion nomenclature (top). W100 is in red font. The [M+H]3+ parent ion 
was fragmented. The fragment peptide ions were assigned based on mass and 
isotopic spacing of the individual envelopes. The fragment ions containing the 
modified residue are shown in italics. This analysis revealed that the 16 Da 
increase observed for the reacted sample results from modification of a residue 
situated between H96 and E104. 
69
would be consumed during the oxidative phase of the ToMOH catalytic cycle, which would contrast 
MMOH where protons are proposed to be required during reduction of the oxidized diiron(III) core. 
In the native system, T201 may be important for steady-state catalysis if substrate radical generation 
is a pathway for arene hydroxylation. Pre-steady-state studies of a series of variants at this position 
would be valuable in discerning its possible role in the mechanism of substrate oxidation. 
An investigation of T201 variants of T4MOH demonstrated that this residue does not affect 
steady-state catalysis.38 For an observable effect under steady-state conditions however, T201 must 
be involved in the rate-determining step. Product release is believed to be rate-limiting for 
hydroxylation by MMOH.39 The products catechol and phenol can bind to the diiron center in 
ToMOHox, isolated after purification or following single-turnover experiments (Chapter 3). Lack of 
knowledge of the rate-determining step under steady-state catalysis prevents us from making a 
meaningful comparison between the earlier steady-state and current pre-steady-state analyses. 
Values of δ and ΔEQ for the mixed-valent diiron(III,IV) transient in ToMOH I100W are 
comparable those of the Fe(III)Fe(IV) centers of intermediate X and QX.23,40 In addition, the 2H-
Mims ENDOR spectra of the ToMOH diiron(III,IV) species prepared in deuterated buffer suggest 
that an exchangeable proton-containing species is coordinated to the iron(III) ion. The observed 
hyperfine couplings for this protonated ligand are within the range of those reported for terminal 
water molecules on the ferric centers in MMOHmv and intermediate X.24,29 This terminal hydroxide 
ion or water molecule may arise by a mechanism similar to that proposed for RNR-R2.24 
Protonation-aided cleavage of the O–O bond in the diiron(III) species would yield a water molecule 
that coordinates to the ferric ion. Despite the differences between the diiron(III) intermediate in 
ToMOH and those of other CBDI enzymes, the ability to form high-valent transients with similar 
spectroscopic parameters might arise from the homologous primary coordination spheres that these 
enzymes share.  
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Our preliminary assignment of the protein-based radical as W• was based on stopped-flow 
optical experiments. In these studies, a λmax was measured to be 500 nm, within the previously 
reported range for tryptophanyl radicals.20,21,41  Since the species (λmax 500 nm) was observed only in 
the tryptophan variant, this specific residue seemed to be critical for transient formation. 1H- and 2H-
Mims ENDOR spectra of this species containing unlabeled and selectively deuterated tryptophan 
residues firmly establish the presence of a tryptophanyl radical. Samples made in protic and 
deuterated buffers had similar 1H-Mims ENDOR spectra, providing evidence that the tryptophanyl 
radical was deprotonated, confirming unequivocally our initial assignment that the optically active 
intermedate observed in stopped-flow studies was a neutral tryptophanyl radical. 
The redox potentials of the aromatic side chains of tyrosine and tryptophan are pH dependent 
with lower proton concentrations favoring oxidation.20,41 In the present study, we observed the 
deprotonated form of the radical, the λmax value of which was invariant across the examined pH range 
of 6.5 to 7.5. We were unable to access pH values near the reported pKa values for the indole ring42 
and the cationic indolyl radical41 because of protein instability. Nonetheless, deprotonation of the 
indole nitrogen is tightly coupled to electron abstraction as the tryptophan cation radical is not 
observed. We exclude mechanisms such as hydrogen atom transfer from W100 to the diiron center or 
a proton tunneling event during the rate-determing step for formation and decay of the diiron(III,IV)–
W• transient because of the magnitude and temperature dependence of the kinetic isotope effects. In 
enzymes where hydrogen-atom transfer or proton tunneling are proposed to occur, the isotope effect 
ranges from 3 to in excess of 100 and are temperature independent.43,44 The isotope effects observed 
here are less than 3.2 for either rate constant and were temperature dependent, both of which are 
atypical of hydrogen-atom transfer or tunneling. 
Disruption of electron transfer pathways from W48 and Y122 to oxygenated diiron 
intermediates in RNR-R2 results in the oxidation of phenylalanine and tyrosine residues near the 
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dimetallic center.45-47 Models of the I100Y mutation estimate the distance between the diiron center 
and this tyrosine at 7 to 10 Å, positioning this residue for possible oxidation.48 Absorption bands 
corresponding to tyrosyl radicals or iron-catecholate species were not observed during or after the 
reaction of ToMOHred I100Y with dioxygen. Absence of these bands suggests that, if oxidation of the 
tyrosine residue occurs, a stable radical species is not formed and the L-dopa product is unable to 
coordinate to the diiron center. Alternatively, the diiron(III) intermediate may not be a strong enough 
oxidant to abstract an electron from Y100. This limitation may arise from the redox potential of 
tyrosine or from other parameters that affect the ET, such as the distance.  
As mentioned in the Results Section, a model whereby a slow reversible equilibrium precedes 
the fast oxidation provides the most satisfacory fit to the pH dependence data. Deprotonation of the 
tryptophan residue, of the diiron(III) intermediate, or of an amino acid sidechain required to accept 
the proton from the tryptophan residue could limit the oxidation rate. The tryptophan cation radical is 
not observed in our optical studies, implying that proton loss must occur either before or after 
oxidation of this residue. Deprotonation of the indole nitrogen before electron abstraction by the 
diiron(III) intermediate is expected to be unfavorable because the pKa of this proton is estimated to 
be 17.42 Oxidation of W100 prior to proton loss would yield a transient tryptophan cation radical, the 
pKa of which is 3.7.41 Deprotonation of the radical cation is therefore predicted to be facile and rapid 
within the examined pH range. Proton loss from the indole ring could limit the oxidation rate if it is 
required to occur prior to this reaction. Alternatively, if loss occurs after oxidation, the rate limiting 
deprotonation event might involve either the diiron(III) intermediate or other amino acid residues 
involved in this oxidation event. 
Implications for Catalysis in Native ToMOH. The mechanism for arene hydroxylation by the 
native hydroxylase could proceed by either one- or two-electron oxidation pathways. If this reaction 
occurs by initial electron abstraction from substrate, the hydroxylation mechanism could involve 
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generation of a species similar to mixed-valent diiron(III,IV)–W• center in ToMOH I100W. 
However, oxidation of the aromatic substrate by an electrophilic attack on the π-system would be 
comparable to the reactions of MMOHperoxo with electron-rich substrates26 and bypass stable radical 
intermediates. 
Both radical- and cation-derived products were observed for oxidation of RCS probes by T4MO, 
implying that one- and two-electron oxidation mechanisms might occur in this system.49 Formation 
of both of these products could reflect two competing mechanisms for substrate oxidation arising 
from ease of approach of these unnatural substrates to the diiron site. If substrate is bound close to 
the reactive intermediate, then oxidation proceeds by hydride abstraction to generate a substrate 
cation. Ring-opening of the substrate gives rise to the observed cation-derived product. On the other 
hand, if the hydrocarbon is not in close proximity to the oxidizing intermediate, electron abstraction 
may predominate to generate substrate-radical intermediates. If the diiron(III) species is the only 
iron-based transient formed during dioxygen activation in the native hydrooxylase, the preference for 
electron-rich substrates, such as the indole ring of W100 or aromatic compounds, by this transient in 
ToMOH is similar to the observed reactivity of MMOHperoxo and the peroxodiiron(III) species in 
RNR-R2. The formation of both radical- and cation-derived RCS products could arise from two 
distinct intermediates that react with these substrates. In MMOH, Q is proposed to carry out one-
electron oxidations whereas MMOHperoxo reacts by hydride abstraction and epoxidation 
mechanisms.26 The diiron(III) intermediate observed in ToMOH I100W is the only observed 
precursor to the mixed-valent diiron(III,IV) center, yet we cannot exclude formation of a short-lived 
di(μ-oxo)diiron(IV) intermediate. Formation of a Q-type intermediate would facilitate electron 
abstraction pathways and the diiron(III) intermediate would allow for two-electron oxidation 
mechanisms. Investigation of the diiron(III) transient in the wild type hydroxylase is important for 
probing further whether one- or two-electron oxidation pathways and high-valent diiron 
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intermediates can form during dioxygen activation and substrate hydroxylation and is discussed in 
greater detail in Chapter 3.  
The Mössbauer parameters and lack of optical absorption features in the near-IR region for the 
diiron(III) transient species are unique among intermediates at this oxidation level in the CBDI 
enzyme family.4 Specifically, values for λmax near 700 nm, δ > 0.6 mm/s, and ΔEQ > 1 mm/s  are 
characteristic parameters of μ-1,2-peroxodiiron(III) clusters in synthetic and enzyme systems.10 This 
intermediate is EPR–silent like other peroxo-bridged diiron(III) clusters. We tentatively assign this 
intermediate as a peroxodiiron(III) species based on the similarities of the proposed reactivity to 
other peroxo-intermediates and by analogy to the mechanism of dioxygen activation at synthetic and 
enzymatic CBDI centers. 
The differences between the Mössbauer parameters for this intermediate and those of other 
peroxodiiron(III) species might arise from an alternate binding geometry of the peroxide moiety to 
the diiron core. Binding modes, such as μ-η1:η2- and μ-1,1-, of peroxide fragments at diiron(III) 
centers are proposed to occur during formation of MMOHperoxo50 and X.51,52 The peroxide fragment 
here might adopt such a conformation. The protonation state of the peroxide bridge may also differ. 
Hydroperoxoiron(III) intermediates reported in heme systems are proposed to be electrophilic 
oxidants,6,53 similar to the observed reactivity of peroxodiiron(III) centers. Detailed structural 
investigations of this intermediate in the native system by ENDOR and XAS would provide insight 
into the structure of this species.  
The redox potential of the diiron(III) intermediate can be estimated by Marcus Theory (eq 2.2). 
The variable kET is the electron transfer rate, k0 is the characteristic frequency of the nuclei, usually 
assigned a value of 1013, R is the gas constant, and T is the temperature in K.54 The term β, fixed at 
1.1 Å-1, is related to the nature of the intervening medium between the redox partners. The distance 
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between the tryptophan residue and the diiron center, r, was determined from the crystal structure to 
be 6.5 Å,48 and r0 is the contact distance, which is generally set to 3 Å. Reorganization energies, λ, of 
1 and 0.1V were used to calculate a range for the reduction potential of the diiron(III) intermediate. 
The driving force, ΔG, is the sum of the reduction potentials for the forward reaction. Since we did 
not observe a transient tyrosyl radical in the I100Y variant, the reduction potential of the diiron(III) 
intermediate might lie between that of Y and W. Depending on whether deprotonation of the indole 
ring occurs before or after electron abstraction, the potential may be further limited to between those 
of the W•/W- and the W•+/W half reactions. To obtain a conservative estimate of the oxidizing power 
of the diiron(III) intermediate, we assumed that proton loss must occur prior to electron transfer as 
the energetic cost is less for oxidation of the deprotonated versus neutral indole ring. The foregoing 
analysis was used to estimate the potential for the Fe2III/Fe2III,IV half reaction, assuming that the 
W●/W- couple was 0.73 V which corresponds to deprotonation of 50% of the tryptophan residues.41 
To negate the inhibitory effect of protons on the oxidation rate, the calculated proton-independent 
oxidation rate of 1.22 s-1 determined from the variable pH data was used for kET. With these 
assumptions, we estimate the reduction potential of the intermediate is between 1.1 and 1.3 V versus 
NHE. This range is close to the reduction potentials of oxidants such as hydrogen peroxide (0.878 
V), manganese dioxide (1.224 V), and chromate (1.35 V). The latter two oxidants, MnO2 and CrO4-, 
are commonly employed for the conversion of hydroxyl groups to either carbonyl or carboxylate 
functionalities. The peroxodiiron(III) intermediate in MMOH is proposed to carry out similar 
oxidation reactions albeit via hydride abstraction.26 
Mechanism of Dioxygen Activation and W100 Oxidation. Scheme 2.1 depicts our proposed 
mechanism of formation for the mixed-valent diiron(III,IV)–W● transient. Dioxygen binding to the 
reduced diiron(II) enzyme would yield a peroxodiiron(III) intermediate, two possible geometries for 
which are depicted. Electron abstraction from W100 by the diiron(III) center is accompanied by 
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protonation-aided cleavage of the O–O bond to form the mixed-valent diiron(III,IV)–W• transient. 
The structure of the mixed-valent diiron core is similar to that proposed for intermediate X, where the 
oxygen atoms derived from dioxygen (filled circles in Scheme 2.1) become an oxo-bridge and a 
terminal hydroxide or water molecule. 
 
The diiron(III,IV) cluster and W● radical decay at the same rate as measured by Mössbauer, 
EPR, and optical spectroscopy. The two S = ½ centers are therefore likely to share a common 
mechanism to restore the oxidized diiron(III) cluster and quench the protein radical. In reacted 
ToMOH I100W, the installed tryptophan appears to be oxidized, as evidence by the 16 Da increase 
in mass of the tryptic peptide containing W100 and the fragmentation peptides thereof. In the crystal 
structure of ToMOH I100W, the indole ring adopts conformations in which the C4–C7 vector is 
oriented either away from or toward the active site.48 We predict that C5 or C6 is the site of 
oxidation, based on the distances between these two carbon atoms and the diiron core in the oxidized 
crystal structure. Oxidation of W● arising from attack by dioxygen is unlikely, as the mass of the 
predicted products would be 32 Da greater than the parent [M+H]+ ion of the unmodified peptide, 
disagreeing with experimental results.55 The peak at m/z = 3198 in the MALDI-TOF spectra (Figure 
2.19) is of weak intensity and is attributed to further oxidation of the W100 from multiple turnovers 
of the hydroxylase, instead of oxidation of the indolyl radical by O2. In addition, such a pathway 
Scheme 2.1. Proposed Mechanism for Formation of the Diiron(III,IV)–W• Transient. 
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would not explain the simultaneous decay of the mixed-valent diiron(III,IV) center. Instead, we 
propose a radical recombination mechanism, where an oxygen atom species on the diiron(III,IV) 
cluster is transferred to the indolyl radical (Scheme 2.2). 
 
The terminal hydroxide or water molecule must be exchangeable to explain the insensitivity of 
the mass of the tryptic peptide and its fragments containing W100 to the isotopic content of the 
dioxygen source. 2H-ENDOR spectra of the transient in deuterated buffers identified an 
exchangeable species with hyperfine coupling constants similar to those reported for terminal water 
ligands on the ferric ion in X and MMOHmv.28,29 The exchange rate of this labile species must be 
significantly faster than that of the decay of the transient species to prevent incorporation of 18O-
atoms into the tryptic peptide. Rapid exchange of oxygen atom ligands at high-valent iron centers has 
been reported for bridging and terminal ligands in intermediate X24 and terminal oxo-groups at 
mononuclear iron centers.56,57 Hydroxyl radical transfer from the diiron center to W• followed by 
rearomatization of the indole ring gives rise to an oxo-bridged diiron(III) cluster and a hydroxyindole 
side chain at W100. Addition of water to the diiron core reforms the di(μ-hydroxo)diiron(III) resting 
state. 
The decay reaction is sensitive to proton concentration. The active site of ToMOH is charge 
neutral, and depending on the ligand type and binding geometries in the intermediate, the terminal 
Scheme 2.2. Proposed Mechanism for Decay of the Diiron(III,IV)–W• Transient. 
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ligand could be either a bound water or hydroxide. If the terminal species is a bound water molecule, 
deprotonation might be required prior to hydroxyl radical transfer. Alternatively, the protonation 
state of residues within the active site cavity or channel near W100 may be important for stabilizing 
the diiron(III,IV) or W•. Deprotonation of these residues could favor decay of these transient species. 
More detailed structural information on the transient species formed during dioxygen activation in 
the native and I100W variant of the hydroxylase will be required to determine the source of this 
proton dependence. 
Potential substrates for BMMs, such as propylene and phenol, accelerate decay of the tryptophanyl 
radical in stopped-flow optical studies. In the steady state, the activity of ToMOH I100W is more 
than an order of magnitude lower than that of the wild type enzyme, possibly due to retardation of 
substrate access or product egress in the variant hydroxylase. The ability of phenol and propylene to 
accelerate the decay rate is interesting. Phenol could quench the tryptophanyl radical by hydrogen 
atom transfer from the O–H group to form a phenoxyl radical. Similar reactivity is observed in small 
molecule chemistry where analogues of phenol are used as radical scavengers. Neutral and cationic 
tryptophanyl radicals reportedly abstract hydrogen atoms from the hydroxyl group of p-
methoxyphenol at rates exceeding 105 s-1.58 No absorption bands were observed at 410 nm during our 
double-mixing optical experiments, which indicates that any phenoxyl radical formed by hydrogen-
atom abstraction must be short-lived. To explain the sensitivity of the decay rate on propylene and 
acetylene, we consider the bond dissociation energies of the weakest C–H bonds in these molecules. 
The BDE of the phenolic O–H bond is similar to that of the methyl sp3 C–H bond in propylene, ~ 87 
kcal/mol.59,60 Acetylene, by comparison, has a C–H BDE almost 50 kcal/mol greater than that of 
phenol or propylene. The tryptophanyl radical is capable of abstracting a hydrogen atom from the 
weak O–H bond in phenol and C–H bond in propylene, accelerating the decay of this transient. 
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Because the same reaction with acetylene requires more energy, the decay rate is not appreciably 
perturbed upon mixing the radical with this substrate. 
The reaction of phenol with the neutral tryptophan radical is a pathway distinct from hydroxylation 
of to yield catechol under steady state conditions where the diiron centers are distributed into 
populations of reduced, diiron(III) intermediate, diiron(III,IV)–W● transient, and diiron(III) product 
species. The presence of W100 effectively out-competes the phenolic substrate for the diiron(III) 
intermediate, if substrate binding occurs after dioxygen activation. Substrate could conceivably bind 
to the active site in either the reduced state, prior to dioxygen binding and activation, or in the 
oxidized state after oxidation of W100 or phenol. The reduced capacity of the I100W hydroxylase to 
oxidize phenol reflects the retarded access of substrate into the active site pocket afforded by the 
mutation. Considering the location of residue 100 in the ToMOH α-subunit, separating the active site 
pocket from the rest of the channel and cavity 2, it is reasonable to propose that it may serve to gate 
substrate entry, product egress, or solvent access to the diiron center as proposed for L110 in MMOH 
and L98 in hemerythrin 14,61. Evidence supporting this proposal is illustrated by the two 
conformations of the indole side chain in the crystal structure of I100W, which allow different levels 
of access to the diiron center of ToMOH. 
 
CONCLUSIONS 
The reaction of diiron(II) ToMOH I100W with dioxygen yields a diiron(III) intermediate, which 
subsequently abstracts an electron from W100 to form a chromophoric mixed-valent diiron(III,IV)–
W• species. This coupled species could decay by transfer of an O-atom from the diiron core to the 
protein-based radical. The one-electron redox chemistry afforded by the diiron(III) intermediate 
resembles that of the peroxodiiron(III) intermediate in RNR-R2. No other high-valent diiron species 
were observed, suggesting that oxidation of hydrocarbons in this system occurs at the diiron(III) 
level. This diiron(III) intermediate is spectroscopically different to μ-1,2-peroxodiiron(III) clusters in 
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CBDI enzymes and model compounds. These differences suggest that this intermediate in ToMOH 
may have an alternate binding geometry or protonation state of the dioxygen-derived fragment. The 
oxidation of W100 to form deprotonated tryptophanyl radical has allowed for an estimation of the 
reduction potential of the diiron(III) intermediate at 1.1 – 1.3 V. The mixed-valent diiron(III,IV) 
center has spectroscopic parameters similar to those of intermediates X and QX, although the 
diiron(III) precursors differ spectroscopically. 
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CHAPTER 3 
CHARACTERIZATION OF THE ARENE-OXIDIZING 
INTERMEDIATE IN ToMOH AS A DIIRON(III) SPECIES 
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 CONTEXT 
The observation of a diiron(III) intermediate during oxygenation of ToMOHred I100W with 
optical and Mössbauer parameters that differ from transients with the same oxidation state in other 
CBDI systems led to a reinvestigation of the wild-type hydroxylase. This same diiron(III) 
intermediate was observed in RFQ Mössbauer samples generated during reaction of the wild-type 
diiron(II) hydroxylase and ToMOD with dioxygen-saturated buffer. The decay rate of this species 
was slower than observed in ToMOH I100W and sensitive to phenol, reacting quantitatively with 
this substrate to produce catechol. Under steady-state conditions, hydrogen peroxide is generated if 
substrate is not present, and consumed in the absence of reducing equivalents. The Hammett 
relationship determined from the specific activities for hydroxylation of a variety of p-substituted 
phenols yielded values of ρ < 0, indicative of an electrophile attacking the substrate. The oxidation 
state and reactivity of the intermediate, and the evolution of hydrogen peroxide suggest that this 
species is a peroxo-bridged diiron(III) center where the binding geometry or protonation state of the 
{O22-} fragment differs from those previously characterized. 
 
INTRODUCTION 
Dioxygen activation at structurally homologous active sites in metalloproteins often leads to 
transient species having similar spectroscopic properties. For example, heme prosthetic groups bind 
dioxygen in their ferrous forms to generate η1-peroxoiron(III) intermediates.1,2 Protonation of the 
distal oxygen atom in this transient species facilitates O–O bond cleavage and formation of an 
(oxo)iron(IV)–porphyrin cation radical (Scheme 3.1). The reactivity of the heme iron unit is 
modulated by the proximal ligand trans to the O2-binding site on the metal center and by the 
surrounding protein matrix, dictating dioxygen binding or activation depending on the requisite 
enzyme function. Similar phenomena occur for the non-heme carboxylate-bridged diiron (CBDI) 
protein superfamily, in which a reduced, diiron(II), form reacts with dioxygen (Scheme 3.1).3,4 The 
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 choice of non-bridging ligands at the dimetallic center, histidine versus aspartate or glutamate, and 
the availability of an open coordination site determine whether O2 will bind reversibly or be activated 
for substrate oxidation. For dioxygen activation, the diiron(II) form of the protein typically reacts 
with dioxygen to form a peroxodiiron(III) center. In the hydroxylase component of methane 
monooxygenase, either homolytic5 or heterolytic6 cleavage of the O–O bond in this species occurs to 
yield a high-valent di(μ-oxo)diiron(IV) core, designated Q. In the R2 subunit of ribonucleotide 
reductase, the peroxo intermediate carries out a one-electron oxidation of W48 to form a mixed-
valent diiron(III,IV) species, designated X.7 The peroxodiiron(III) units in  MMOH and RNR-R2 are 
the only ones in the CBDI enzyme superfamily that evolve to form iron(IV) intermediates. 
 
As noted in Chapters 1 and 2, the primary coordination spheres of stearyol-ACP Δ9D 
desaturase,8 rubrerythrin,9 and ToMOH10,11 bear a strong resemblance to those of MMOH and RNR-
R2. No intermediates have previously been reported for reaction of the reduced forms of these 
enzymes with dioxygen. Addition of the substrate-carrier protein conjugate to reduced Δ9D prior to 
reaction with dioxygen allowed such an intermediate to be generated, however, the Mössbauer, rR, 
and optical spectroscopic parameters of which are indicative of a μ-1,2-peroxodiiron(III) species.12,13 
Scheme 3.1. Dioxygen Activation at Iron-Heme and CBDI Centers 
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 In Chapter 2, we described how the access of solvent or buffer components to the diiron center 
in ToMOH during dioxygen activation might be modified by occluding the substrate access channel 
in various variants. Reaction of ToMOHred I100W with O2 led to formation of a transient mixed-
valent diiron(III,IV)–W• chromophore in this system that was characterized by various spectroscopic 
methods. Of particular interest was a diiron(III) intermediate, formed prior to the diiron(III,IV)–W• 
species, having Mössbauer parameters and optical absorption features different from those of other 
peroxodiiron(III) transients.4,14 Its isomer shift lies within the range of known peroxide-bridged 
synthetic diiron(III) complexes, but the quadrupole splitting differs by more than 0.3 mm/s.14-16 No 
transient optical absorption band, other than that of the deprotonated tryptophanyl radical signal at 
500 nm, were apparent during reaction of reduced ToMOH I100W and ToMOD with dioxygen. 
We describe in the present chapter the results of experiments, including single- and double-
mixing rapid-freeze quench Mössbauer studies, to determine whether this same diiron(III) species 
forms in native ToMOH. As will be demonstrated, such an intermediate does indeed accumulate over 
a relatively long time scale of 1 to 2 s, and reacts with substrate as examined by double-mixing 
methods in which the oxygenated species was first generated and then exposed to buffer containing 
phenol. To gain further insight into the nature of this intermediate, steady-state experiments were 
conducted to determine (i) whether hydrogen peroxide evolves during catalytic turnover; (ii) whether 
a peroxide shunt pathway to this species is accessible in this system; and (iii) the reactivity profile of 
the diiron(III) center in comparison to those of other CBDI enzymes and synthetic complexes. The 
results suggest that this intermediate contains a {O22-} fragment bound to a diiron(III) center, but 
with a previously unknown coordination geometry and/or protonation state. 
 
EXPERIMENTAL METHODS 
General Considerations. Plasmids containing the genes for the Pseudomonas sp. OX1 ToMO 
component proteins were kindly supplied by the laboratory of Professor Alberto Di Donato, Naples, 
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 Italy. Expression and preparation of ToMOH and ToMOD were carried out as described elsewhere10 
with the following changes. For 57Fe enrichment, ToMOH was expressed in media (10 g tryptone, 10 
g NaCl, and 2 g Cassamino acids per liter of ddH2O) supplemented with 40 μM 57FeCl3. The solution 
of 57FeCl3 was prepared by dissolving enriched metal powder (96.7% isotopic purity, Advanced 
Materials Technologies Ltd., Nes-Ziona, Israel) in concentrated hydrochloric acid. Ion exchange 
buffers contained 57FeCl3 (150 μM) instead of Mohr’s salt. Specific activities for phenol for the 
isolated components were greater than 1200 mU/mg. The iron content of the hydroxylase was 4.2 ± 
0.3 Fe:H dimer as measured by the ferrozine assay.17 HPLC experiments were performed with a 
Vydac protein & peptide C18 column connected to an Agilent 1200 series instrument equipped with 
a multi-wavelength detector. Instrumentation for optical and Mössbauer spectroscopy are as reported 
elsewhere.18,19 All other reagents were purchased from Aldrich Chemical Company and used as 
received. 
Rapid-Freeze Quench Sample Preparation for Mössbauer Spectroscopy. Samples of 57Fe-
enriched ToMOH and ToMOD were reduced and dialyzed as described in Chapter 2 and 
elsewhere.18 For single-mixing rapid-freeze quench (RFQ) experiments, a solution of 
ToMOH:2ToMOD (690 μM) in 25 mM MOPS buffer, pH 7.0, was rapidly combined with an equal 
volume of O2-saturated buffer at 4.0 °C. The oxygenated protein was allowed to react for a specific 
period of time, ranging from 34 ms to 15 min, after which the protein mixtures were quenched in 
isopentane at –140 °C. Samples were packed into Mössbauer sample cups and stored in liquid 
nitrogen. For double-mixing experiments, oxygenated buffer and the reduced protein solution (510 
μM ToMOH, 1.02 mM ToMOD) were first mixed with an equal volume of O2 saturated buffer and 
allowed to react for ~ 170 ms. This oxygenated protein solution was then mixed with a half volume 
of buffer containing phenol (4.6 mM in 25 mM MOPS buffer, pH 7.0), aged for times varying from 
25 ms to 30 min, and quenched in isopentane at -140 °C. A sample of the 0.17-s aged oxygenated 
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 protein without phenol was collected as a reference. The dilution factors for single- and double-
mixing samples were two and three, respectively. The product of phenol oxidation was determined 
and quantified in double-mixing RFQ Mössbauer samples, for which the oxygenated protein was 
allowed to react with substrate for at least 5 s in the following manner. Ascorbic acid (20 μL, 22 mM 
in ddH2O) was added to an aliquot (50 μL) of a thawed Mössbauer sample. This mixture was 
allowed to stand for 5 min, after which TFA (30 μL, 50% in ddH2O) was added. Samples were 
centrifuged and the supernatant was loaded onto a Vydac column. HPLC conditions for separation of 
hydroxylated products from phenol were 0% buffer B for 7 min, 0% to 40% B for 1 min (linear 
gradient), 40% to 100% for 7 min (linear gradient), and 100% B for 3 min (A: 1% acetonitrile, 98.8% 
ddH2O, 0.2% TFA; B: 49.9% acetonitrile, 49.9% ddH2O, 0.2% TFA). Absorption at 280 nm was 
monitored with time for all samples. Retention times for catechol, resorcinol, and hydroquinone were 
determined under these conditions. Mössbauer measurements were carried out at 4.2 K with an 
applied magnetic field parallel to the γ-irradiation using spectrometers described previously.19 
Analysis of the Mössbauer spectra were performed with the program WMOSS (WEB Research). The 
zero velocity refers to the centroid of a room-temperature spectrum of a metallic Fe foil. 
Assay for Hydrogen Peroxide Release in the Steady-State. A colorimetric assay employing 
potassium thiocyanate and ferrous ammonium sulfate was used to detect hydrogen peroxide.20 Each 
reaction solution contained 1 μM ToMOH, 2 μM ToMOC, 4 μM ToMOD, 0.1 μM ToMOF, and 1 
mM NADH in 500 μL of Tris/HCl buffer, pH 7.5, at 25 °C. In samples containing phenol as a 
substrate, the concentration was 4 mM. Reactions were initiated by addition of NADH, quenched 
after a specified reaction time with 100 μL of 0.4 M trichloroacetic acid, and centrifuged at 13,500 × 
g for 5 min. After centrifugation, aliquots of solutions of potassium thiocyanate (100 μL, 2.5 M) and 
ferrous ammonium sulfate (200 μL, 10 mM) in ddH2O were added to the supernatant (500 μL). The 
mixture was shaken vigorously and allowed to stand for 5 min before the absorbance at 480 nm was 
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 measured. Solutions of hydrogen peroxide were standardized by measuring the absorbance at 
240 nm.21 These solutions were treated as described for the enzyme reaction mixtures to generate a 
standard curve. The consumption of NADH to liberate hydrogen peroxide was determined by 
monitoring the absorbance decrease at 340 nm, which corresponds to the depletion of NADH (ε340 = 
6220 M-1cm-1), for 5 min, quenching the reaction, and measuring the concentration of hydrogen 
peroxide present. To monitor the absorbance change at 340 nm, the initial NADH concentration in 
the assay solution was reduced from 1 mM to 0.2 mM. 
An Attempt to Initiate Catalysis by a Peroxide Shunt Pathway. HPLC analysis of reaction 
mixtures was conducted following steady-state experiments as above in which NADH and ToMOF 
were omitted and hydrogen peroxide was added as a reduced dioxygen source. Assay mixtures (0.5 
mL) contained 15 μM ToMOH, 30 μM ToMOC, 40 μM ToMOD, 20 mM hydrogen peroxide, and 2 
mM phenol in 0.1 M Tris/HCl buffer, pH 7.5. ToMOH was the last component added to each 
mixture. These solutions were stirred and allowed to react at 25 °C for specified times ranging from 
30 s to 12 min. Samples were quenched with 100 μL of 0.4 M trichloroacetic acid, centrifuged, and 
loaded onto the HPLC column as described above. A series of experiments was also performed in 
which the concentrations of hydrogen peroxide produced were assayed as outlined above except that, 
prior to measuring the absorbance, the sample was diluted 15-fold with ddH2O. Solutions of 
hydrogen peroxide, which were standardized by measuring the absorbance at 240 nm, were used to 
calibrate HPLC peak integrals. Dioxygen release from reaction mixtures containing ToMOH and 
ToMOD was assayed by the alkaline pyrogallol method.22 Anaerobic assay mixtures for O2 
generation contained 100 μM ToMOH and 400 μM ToMOD in 200 μL of 25 mM MOPS, pH 7.5, to 
which hydrogen peroxide (0.6 mL, 30% solution) was added. Control samples were also prepared in 
which the protein solution or hydrogen peroxide was substituted with buffer. 
Hammett Studies. The steady-state activity of ToMOH using as substrates the following para-
substituted phenols, cresol, phenol, fluorophenol, chlorophenol, and nitrophenol, were determined by 
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 directly quantifying the catechol products by the HPLC protocol described above. Assay mixtures 
comprising 0.3 μM ToMOH, 15 μM ToMOD, 2 μM ToMOC, 40 nM ToMOF, and 1 mM substrate 
in 0.1 M Tris/HCl, pH 7.5, were incubated at 25 °C. Steady-state turnover was initiated by addition 
of NADH to a final concentration of 1 mM. Aliquots (100 μL) were removed at 10-s intervals, 
quenched with TFA (10 μL), vortexed for 5 s, and centrifuged at 5000 rpm for 5 min to pellet the 
denatured protein. Each aliquot was then frozen in liquid nitrogen and stored at -78 °C. For p-chloro 
and p-nitrophenol, samples were taken at 30-s instead of 10-s intervals. The supernatant was 
analyzed by HPLC as mentioned previously. The absorbance was monitored at 280 nm for all 
substrates except for nitrophenol, the samples of which were monitored at 465 nm. Standard curves 
were generated for catechol products with the appropriate substituent in the 4-position. 4-
Fluorocatechol was synthesized according to a literature procedure23 and characterized by 1H-NMR 
spectroscopy. The solid catechols were vacuum-sublimed and stored in the dark prior to use. 
 
RESULTS 
Formation of a Diiron(III) Intermediate by Oxygenation of ToMOHred. Because the 
diiron(III) intermediate identified in the ToMOH I100W variant is diamagnetic and exhibits no 
apparent optical absorption bands (Chapter 2), Mössbauer spectroscopy was used to seek 
spectroscopic evidence for the possible accumulation of this same diiron(III) intermediate in the 
reaction of reduced wild-type ToMOH with dioxygen. The reaction was freeze-quenched at various 
reaction times (0.07 s, 0.14 s, 0.44 s, 2 s, and 32 s) by the RFQ method (Experimental Methods) and 
the resulting samples were characterized by Mössbauer spectroscopy. Figure 3.1 displays the 4.2-K 
Mössbauer spectrum of the diiron(II) ToMOH before reaction with O2 (A). Also presented are 
spectra of several freeze-quenched samples (B-D) that clearly reveal the sequence of events that 
occur during the reaction. By comparison with the spectrum of the reduced ToMOH reactant (A), the 
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 spectrum of a sample freeze-quenched at 0.14 s reaction time (B) shows ~ 45% reduction in intensity 
of the quadrupole doublet arising from the reduced, diiron(II) ToMOH and the appearance of a sharp 
quadrupole doublet (red line in B) with parameters (δ = 0.55 ± 0.02 mm/s, ΔEQ = 0.67 ± 0.03 mm/s, 
and line width = 0.27 mm/s) that are identical to those of the diiron(III) intermediate observed in 
ToMOH I100W. A high-field experiment confirms that this doublet arises from a diamagnetic 
system (Figure 3.2). These observations establish that the diiron(II) sites in wild-type ToMOH 
indeed react rapidly with O2 to generate a diiron(III) intermediate that reported in Chapter 2. 
 
Figure 3.1. Mössbauer spectra of freeze-quenched samples from the reaction of reduced ToMOH:2ToMOD 
mixtures with O2. The samples were frozen before mixing (A) and 0.14 s (B), 2 s (C), and 32 s (D) after mixing. 
The spectra (vertical bars) are collected at 4.2 K in a 50 mT field applied parallel to the γ-ray beam. The red and 
orange lines are simulated spectra of the diiron(III) intermediate and diiron(III) product, respectively. The 
spectrum of the diiron(III) intermediate (red) was modeled with a single quadrupole doublet with δ = 0.55 mm/s, 
ΔEQ = 0.67 mm/s and line width = 0.27 mm/s. The spectrum of the diiron(III) product (orange) was simulated as 
a superposition of two equal intensity quadrupole doublets with parameters δ = 0.52 mm/s, ΔEQ = 0.73 mm/s 
and line width = 0.32 for doublet 1 and δ = 0.52 mm/s, ΔEQ = 0.97 mm/s and line width = 0.28 mm/s for doublet 
2. They are plotted at the following absorption intensities: red, 44%, 41% and 13% in B, C, and D; orange, 41% 
in D. Unreacted diiron(II) protein accounts for ~ 56% of total Fe absorption at maximal accumulation of the 
intermediate (B). These parameters and intensities are the results of a global analysis of the entire set of the 
Mössbauer spectra including those that are not depicted here. 
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 Accumulation of this intermediate reaches a maximum corresponding to 44% of the total Fe 
absorption and remains unchanged for several seconds (compare spectra B and C) before decaying 
directly to the diiron(III) product (orange line in D). No other intermediates were detected.  
Kinetics of the Reaction of ToMOHred with O2. To obtain a quantitative estimate of the time 
evolution of Fe species generated during the oxidation of reduced ToMOH, it is necessary to 
deconvolute the Mössbauer spectra into various spectral components corresponding to the different 
Fe species. Although δ values for the diiron(III) intermediate (0.55 mm/s) and product (0.52 mm/s) 
are similar, different ΔEQ values for the intermediate (0.67 mm/s) and product (0.85 mm/s) allow the 
spectra of these two species to be readily deconvoluted (Figure 3.3). A global analysis of the entire 
set of the Mössbauer spectra, including those for time points not depicted, yields the characteristic 
 
Figure 3.2 High-field Mössbauer spectrum (vertical bars in A) of a freeze-
quench sample from the reaction of reduced ToMOH:2ToMOD with O2 
frozen at 0.14 s after mixing the reduced protein with O2. The spectrum was 
collected at 4.2 K in an applied field of 8 T parallel to the -beam. The green 
line in A is the spectrum of the diiron(II) protein before mixing recorded 
under the same experimental conditions, and is plotted at 56% of the total Fe 
absorption of the freeze-quenched sample. Removal of the diiron(II) 
contribution from spectrum A yields spectrum B (vertical bars). The red line 
in B is a theoretical spectrum of the diiron(III) intermediate simulated with 
parameters determined at low field (see caption of Figure 1) and assuming 
diamagnetism. The excellent agreement between theory and experiment 
indicate the ground state of the diiron(III) intermediate is diamagnetic, 
revealing antiferromagnetic coupling between the two ferric ions. 
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 parameters reported above as well as percentages of Fe absorption for the species detected in the 
freeze-quenched samples. On the bases of the Fe and protein contents determined for the freeze-
quenched samples, 3.5 Fe atoms/ToMOH dimer, these percentages can be converted into amounts of 
diiron clusters per ToMOH monomer. The results are presented in Figure 3.4 (diamonds). Analysis 
of these data indicate that the diiron(III) intermediate (red diamonds) forms rapidly with a rate 
constant of ~ 26 s-1 and accumulates to a maximum of 0.4 clusters/ToMOH monomer (or 0.8 
clusters/dimer). It decays slowly at a rate of 0.045 s-1 to generate the diiron(III) product (orange 
diamonds). Data for the reduced ToMOH (green diamonds) reveal two populations for the diiron(II) 
sites that are differentiable by their rates of reaction with dioxygen. One population (0.4 
clusters/ToMOH monomer) reacts rapidly (26 s-1) to form the diiron(III) intermediate, while the 
remaining diiron(II) sites react slowly at a rate of ~ 0.02 s-1.  
 
Figure 3.3. Overlay of Mössbauer spectra of the 
diiron(III) intermediate (red) and product (orange). 
The spectrum for the intermediate (red vertical bars) 
was prepared by removing the 56% diiron(II) 
contribution from the raw spectrum of the 0.14 s 
freeze-quenched sample (Figure 3.1B), and the product 
spectrum (orange vertical bars) was the spectrum of as-
purified oxidized ToMOH. For comparison the two 
spectra are scaled to matching intensities. The solid 
lines are theoretical spectra simulated with parameters 
of the Fe species reported in the caption of Figure 3.1. 
 
Figure 3.4. Speciation plot for reaction of diiron(II) 
ToMOH:2ToMOD with dioxygen. Reduced diiron(II) 
protein (♦) reacts with dioxygen at ~ 26 s-1 to form a 
diiron(III) transient species (♦). Only ~45% of 
diiron(II) clusters give rise to this intermediate. The 
diiron(III) transient subsequently decays to the 
oxidized resting state (♦) at ~ 0.045 s-1. The unreacted 
diiron(II) centers decay slowly at 0.02 s-1. Solid lines 
are one- or two-exponential fits to the data. 
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 Effect of Phenol on Decay of the Diiron(III) Intermediate. The reactivity of the diiron(III) 
intermediate with phenol as a substrate was probed by using the double-mixing RFQ technique and 
Mössbauer spectroscopy. Reduced ToMOH was allowed to react with O2 for 0.17 s to afford a 
maximum accumulation of the diiron(III) intermediate prior to the introduction of the substrate 
phenol. The oxygenated protein mixture was then mixed with a buffer solution containing phenol. 
The reaction was allowed to proceed for various times and then quenched at -140 °C (Experimental 
Methods). Samples were collected for Mössbauer investigations. The resulting Mössbauer spectra for 
a few of these time points are presented in Figure 3.5. As in the single-mixing experiments, the 
spectrum of the 0.17-s aged oxygenated protein shows that ~ 40% of the diiron(II) sites evolve to the 
diiron(III) intermediate (Figure 3.5, spectrum A, red line). After mixing with phenol, the quadrupole 
doublet corresponding to this species decreases its intensity almost immediately and becomes nearly 
undetectable at 5 s (Figure 3.5, B-D, red lines). This behavior is in stark contrast to the relatively 
stable accumulation of this species observed in the absence of phenol. In addition, the diiron(III) 
product is detected almost immediately after mixing with phenol and grows into a dominant species 
at 5 s  (Figure 3.5, B-D, orange lines). The unreacted diiron(II) protein, however, remains relatively 
stable (compare the absorption peak at 3 mm/s in spectra A to D) and starts to decay several seconds 
after mixing with phenol, behavior similar to that observed in the absence of phenol. As in the single 
mixing study, a global analysis to deconvolute the entire set of spectra into spectral components was 
performed and kinetic data for the Fe species generated after mixing with phenol were thereby 
obtained. The data are depicted in Figure 3.6 (diamonds) together with results of kinetic modeling of 
the formation and decay of the diiron species (color lines). The decay rate of the diiron(III) 
intermediate increases by more than 40-fold, from 0.045 s-1 to 2.0 s-1, in the presence of phenol. 
Because the amount of unreacted diiron(II) sites remains constant during the decay phase of this 
transient, the decay of the diiron(III) intermediate (Figure 3.6, red line) parallels the early formation 
of the diiron(III) product (Figure 3.6, orange line), both in rate constant (2.0 s-1) and in the extent of 
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 accumulation (0.4 clusters/ToMOH monomer). Decay of the unreacted diiron(II) species, with a rate 
constant of ~0.01 s-1, accounts for the second phase of production of the diiron(III) product. No other 
intermediate was detected. Mössbauer parameters of the diiron(III) intermediate differ in the 
 
Figure 3.5.  Mössbauer spectra of double-mixing RFQ samples for reaction of the diiron(III) intermediate with 
buffer containing phenol. Reduced protein was allowed to react with O2 for 0.17 s to generate the intermediate 
before mixing with phenol (A). After mixing with phenol, the reaction mixture was freeze-quenched at 0.14 s 
(B), 0.67 s (C), 5 s (D) and 100 s (E). The spectra (vertical bars) are collected at 4.2 K in a 50 mT applied field 
parallel to the γ-ray beam. The green, red and orange lines are simulated spectra, respectively, of the unreacted 
diiron(II) protein, diiron(III) intermediate and diiron(III) product. The spectra of the diiron(III) intermediate in 
the absence of phenol (red in A) and diiron(III) product (orange) were simulated using the parameters reported 
in the caption of Figure 3.1. The spectrum of the diiron(III) intermediate was perturbed slightly by the presence 
of phenol (see the following Figure 3.6) and was simulated with the altered parameters reported in text (red lines 
in B-E). The spectrum of the unreacted diiron(II) was modeled as a superposition of two quadrupole doublets 
with an intensity ratio of 10 to 1, and the following parameters: δ = 1.32 mm/s, ΔEQ = 3.06 mm/s for the intense 
doublet, and δ = 1.39 mm/s and ΔEQ = 2.13 mm/s for the minor doublet. The simulated spectra are plotted at the 
following absorption intensities: green, 61%, 60%, 58%, 57% and 29%; red, 39%, 30%, 14%, 0% and 0%; 
orange, 0%, 12%, 28%, 43% and 71% in A, B, C, D and E, respectively. The black lines overlaid with the 
spectra are composite spectra including all the Fe species mentioned above. 
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 presence and absence of phenol (Figure 3.7); in the presence of phenol, this species was modeled by 
a quadrupole doublet with parameters (δ = 0.52 ± 0.02 mm/s and ΔEQ = 0.62 ± 0.03 mm/s) that are 
slightly different from those (δ = 0.55 mm/s and ΔEQ = 0.67 mm/s) observed in the absence of this 
substrate. Also, the absorption lines of this doublet are broader by 0.03 mm/s and 0.06 mm/s for the 
low-energy and high-energy line, respectively, in samples containing phenol (Figure 3.7). These 
differences, although minor, suggest that phenol perturbs the diiron center of the intermediate prior to 
reacting with it. 
The acceleration of the decay rate of the diiron(III) transient by phenol provides strong evidence 
that this species is responsible for the substrate oxidation. Indeed, catechol was detected and 
determined by HPLC analyses to be the only observed aromatic product in the double-mixing 
samples at reaction times equal to and longer than 5 s. The concentration of this hydroxylation 
product in the samples was 145 ± 1 μM, in good agreement with the estimated intermediate 
 
Figure 3.6. Speciation plot for reaction of the 
diiron(III) intermediate with phenol. The intermediate 
(♦) decays at 2 s-1 to give rise to the early formation 
phase of diiron(III) product (♦). Diiron(II) clusters (♦) 
that do not traverse the intermediate oxidize more 
slowly, with a rate constant of ~ 0.01 s-1 to product. 
Solid lines represent one- or two-exponential fits to the 
data. 
 
 
Figure 3.7. Overlay of Mössbauer spectra of the 
diiron(III) intermediate in the absence (red) and 
presence (black) of phenol. These spectra were 
prepared by removing the unreacted diiron(II) 
contributions from the spectrum shown in Figure 3.5A 
and spectrum of a sample freeze-quenched at 70 ms 
after mixing with phenol. Addition of phenol results in 
smaller values for δ and ΔEQ as compared to the 
intermediate generated in the absence of substrate (see 
text for parameters). Absorption lines also broaden in 
the presence of phenol by 0.03 and 0.06 mm/s, for 
low- and high-energy lines, respectively. 
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 concentration, ~ 135 μM, accumulated before mixing with phenol. The intermediate concentration 
was estimated from the result of the Mössbauer analysis (40% Fe absorption for the intermediate 
before mixing with phenol) and protein and Fe contents determined for the double mixing samples 
(170 μM protein and 3.92 Fe/ToMOH dimer). A broad optical absorption band centered at 580 nm, 
consistent with that of an iron-catecholate charge transfer transition, was observed in optical spectra 
of samples prepared by double-mixing (Figure 3.8). Coordination of catechol to the diiron center, 
however, appears to cause only minor perturbations to the diiron site, since the Mössbauer spectrum 
of the final product, the oxidized protein (Figure 3.5E, orange line), could be simulated with 
quadrupole doublets identical to those used to model the Mössbauer absorption of the as-purified 
diiron(III) ToMOH (Figure 3.3, orange spectrum). 
Release of Hydrogen Peroxide by ToMO under Steady-State Conditions. Under steady-state 
conditions, hydrogen peroxide was evolved in the absence of phenol (Figure 3.9). Its rate of 
formation could be modeled with a hyperbolic function, suggesting that the enzyme system may be 
inactivated in the presence of hydrogen peroxide, as reported for phenol hydroxylase from 
Pseudomonas sp. CF600.24 The efficiency of the NADH oxidase reaction, defined as the ratio of the 
decrease in NADH concentration to the increase in hydrogen peroxide concentration, was 51(4)%. 
 
Figure 3.8. Optical spectrum of a sample following an RFQ 
double-mixing Mössbauer experiment. The broad absorption band 
is centered at ~ 580 nm. 
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 Addition of substrate to the reaction mixture retarded peroxide formation, implying that phenol reacts 
either with a peroxodiiron(III) center or a precursor of such a transient. 
Peroxide Shunt Pathway and Catalase Activity of ToMOHox. Hydroxylation products were 
not detected in samples containing hydrogen peroxide, ToMOHox, ToMOD, and ToMOC. Inclusion 
of ToMOC in the reaction mixtures was to assure that protein component interactions would not 
affect our inability to access a peroxide shunt pathway. We noticed during the course of the 
experiments that hydrogen peroxide was rapidly consumed. Its concentration was monitored in acid-
quenched samples by integrating the peak eluting at ~ 3.3 min in HPLC traces recorded at 240 nm 
(Figure 3.10) and by the colorimetric method used to assay for hydrogen peroxide release. Samples 
in which the hydroxylase was omitted showed no appreciable decrease in H2O2 concentration.  
 
Experiments utilizing only ToMOHox and ToMOD revealed that dioxygen was rapidly evolved 
upon addition of aliquots of hydrogen peroxide. The evolved gas from these reaction mixtures 
oxidized the pale pink solution of alkaline pyrogallol to a brown color. Addition of hydrogen 
peroxide to vials containing buffer, or addition of buffer to protein solutions, did not result in 
 
Figure 3.9. Concentration of hydrogen peroxide 
evolved under steady-state conditions with (□) and 
without (•) phenol. Hydrogen peroxide is formed 
slowly as NADH is consumed by the enzyme system. 
The addition of substrate inhibits peroxide formation. 
Data were fit with hyperbolic functions. 
 
 
Figure 3.10. Change in the concentration of hydrogen 
peroxide with time after mixing with ToMOH–
ToMOD mixtures. Hydrogen peroxide is rapidly 
consumed and evolved dioxygen in a manner 
independent of the presence of substrate. A peroxide 
shunt pathway was not accessed because catechol was 
not observed in assay solutions that contained phenol. 
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 oxidation of pyrogallol.  
Hammett Relationship for Substrate Oxidation by ToMO. Initial reaction rates were used to 
generate Hammett plots for the oxidation of phenolic substrates by ToMO (Figure 3.11). Plots of the 
substituent constants σm and σp+ against the logarithm of the ratio of the initial rates for the 
substituted phenols and phenol were fit with a linear equation. Reaction constants, ρ, of -1.3 and -1.7 
for σm and σp+ were determined for this system, consistent with electrophilic attack on the aromatic 
substrate. The rate data were plotted against two substituent constants because of the hydroxylation 
mechanism proposed for the homologous T4MO system. In that system, NIH shift experiments 
suggested that the substrate is attacked either at the site of oxidation (σm), to yield a substrate cation, 
Scheme 3.2. Proposed Pathways for Substrate Hydroxylation 
 
 
Figure 3.11. Hammett plots for oxidation of p-substituted phenols by 
ToMO. The values of ρ were -1.3 and -1.7 for σm (■) and σ + (•) 
respectively. A negative reaction constant is indicative of 
electrophilic reactions. The goodness of fit as measured by R2 for 
either σ value is 0.81.  
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 or at the para and meta positions (σp+), to form a transient arene epoxide (Scheme 3.2). There is 
appreciable scatter in the plots, however, with R2 ~ 0.81 in both cases. Scaling the initial reaction 
velocities to account for the percentage of deprotonated substrate does not significantly improve the 
quality of the fit. 
 
DISCUSSION 
Mechanism of Dioxygen Activation by ToMOH. The reduced diiron(II) forms of the CBDI 
enzymes are reactive toward dioxygen, activating the molecule to yield intermediates with Fe–O 
bonds that react with substrates.3,12,25-28 The first intermediate observed spectroscopically in the 
systems characterized thus far is a peroxodiiron(III) adduct, with well-defined spectroscopic 
parameters, including a near-IR optical absorption band.4 Despite the structural homology of the 
active sites of ToMOH and MMOH,10 the first intermediate observed upon oxygenation of 
ToMOHred is a diiron(III) transient for which no such absorption feature could be detected. The 
Mössbauer spectroscopic parameters, δ and ΔEQ, for this intermediate are 0.55 and 0.67 mm/s, 
respectively, which are both lower than those of peroxodiiron(III) centers in related enzymes and 
model complexes. Despite the spectroscopic differences, we tentatively assign the diiron(III) 
transient formed after oxygenation of reduced ToMOH as a peroxodiiron(III) center. This assignment 
is based on the following observations: (i) the reactivity of the transient is similar to that reported for 
peroxodiiron(III) intermediates in other systems and requires that the regulatory protein ToMOD be 
present in order to form; (ii) hydrogen peroxide is liberated during steady-state turnover in the 
absence of substrate; and (iii) by analogy to dioxygen activation in other CBDI systems, in which the 
diiron(III) intermediates are all peroxo species. The observed spectroscopic differences from peroxo 
intermediates in other systems may arise from a weak or red-shifted absorption band in the optical 
spectrum, photodecomposition, additional ligands coordinated to the diiron center, or an alternative 
geometry or protonation state of the peroxide moiety. 
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 The {O22-} fragments in the peroxodiiron(III) intermediates in RNR-R2,29,30 Δ9D,12 and Ft31,32 
are proposed to bind in a cis-μ-1,2- fashion and that in MMOH has alternatively been given the same 
assignment33-35 or that of a μ−η2,η2 side-on peroxide.5,27,36 In the former geometry, the out-of-plane 
and in-plane π* dioxygen orbitals interact with dyz and dz2 orbitals, respectively, on the iron atoms. 
The out-of-plane orbitals form π–bonds and the in-plane orbital gives rise to σ–bonds between 
peroxide and the dimetallic unit. In the case of iron(III), π-bonding dominates the interaction because 
the metal orbitals are half-filled.37 The characteristic low energy absorption feature centered at ~700 
nm in μ-1,2-peroxodiiron(III) species arises from ππ* to dyz transitions, according to one formalism.37 
The strength of this π–bonding interaction dictates therefore the energy and intensity of this 
transition as well as the O–O bond strength. In systems where high-valent oxygenated diiron species 
are observed, π–bonding is proposed to dominate the interaction between the {O22-} fragment and the 
diiron center because cleavage of the consequent weaker O–O is more facile. The extinction 
coefficients for the peroxodiiron(III) intermediate in MMOH, RNR-R2, Δ9D, and Ft follow the 
expected trend therefore, with those reported for this transient in RNR-R2 and MMOH being greater 
than those for the same species in Δ9D and Ft. If π-bonding in the ToMOH intermediate is weak, the 
energy and intensity of this charge transfer are predicted to decrease. The absorption maximum will 
therefore be red-shifted, with a smaller extinction coefficient than that of similar diiron(III) species. 
Weaker π-bonding would favor peroxide release, disfavor formation of high-valent intermediates, 
and reduce the electron density on the iron atoms. The Mössbauer parameters are indicators of the 
symmetry of the electric field gradient around (ΔEQ), and effective charge or oxidation state (δ) of, 
the iron atoms. Reducing the electron density therefore should lower δ relative to systems with 
stronger π-bonds. Longer Fe–O bonds may increase the symmetry, translating into a smaller ΔEQ 
values. The Fe–O–O bond angle, which determines in part the Fe–Fe distance, strongly influences 
the π-bonding contribution from the peroxide fragment, with smaller angles favoring σ-only 
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 bonding. If the absorption band is therefore weak and low in energy in ToMOHperoxo, we predict that 
the Fe–Fe distance in this intermediate will be shorter than that observed in peroxo-adducts of other 
CBDI systems.  
Another possibility is that the peroxodiiron(III) species might decompose upon irradiation, as 
reported previously for a cis-μ-1,2-peroxodiiron(III) complex37 and for the superoxodiiron(III) 
intermediate in myo-inositol oxygenase.25 Reaction of reduced ToMOH I100W and ToMOD with 
dioxygen quantitatively converts the diiron(III) intermediate to the mixed-valent diiron(III,IV)–W• 
couple (Chapter 2). The calculated extinction coefficient at 500 nm of the radical agrees with the 
accumulation of ToMOHperoxo, judging by Mössbauer spectroscopy. The photodecomposition rate of 
the diiron(III) transient, therefore, must slower than ~ 1 s-1 to permit quantitative formation of the 
diiron(III,IV)–W•  species. Given an estimated formation rate constant of 25 s-1 for this intermediate 
from Mössbauer studies, we predict that this transient should accumulate to adequate levels to permit 
detection of any optical features. We can therefore exclude photodecomposition as an explanation for 
the lack of an optical absorption band. 
The nature, number, and protonation state of the bridging ligands in dioxygen adducts of CBDI 
model complexes influence the spectroscopic features of the characterized cis-μ-1,2-
peroxodiiron(III) intermediates. Model compounds with oxo,38,39 hydroxo,39 or alkoxo15,16,40,41 
bridges opposite the bound peroxide have absorption maxima, extinction coefficients, and Mössbauer 
parameters that cover a broad range of values (Table 1).14-16,39,42 A number of these compounds have 
values for δ within range of the present 0.52 mm/s value, although all the ΔEQ parameters are ~ 1.0 
mm/s. Amino acid side chains in the active site pocket of ToMOH, such as E243, which shifts 
between the Mn(II)-reconstituted and diiron(III) forms,10,11 could be incorporated as additional 
oxygen atom bridges, thereby modulating the absorption and Mössbauer spectra of ToMOHperoxo. 
Any absorption band arising from this intermediate would either have to be obscured by end 
absorption from the protein optical band at 280 nm or lie in the near-IR region, beyond the range of 
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 our diode array instrument detector.  
 
Finally, the geometry or protonation state of the peroxide fragment in ToMOHperoxo may differ 
from those of other μ-1,2-peroxodiiron(III) intermediates. Diiron(III) centers containing 1,1-peroxo-, 
1,1-hydroperoxo-, or η1:η2-peroxo bridges have all been proposed for transition states linking the 
reduced diiron(II) forms to diiron(III) and high-valent intermediates in MMOH and RNR-R2.5,36,37,43 
If the intermediate is protonated, such proton transfers could not be rate-determining within the limits 
of RFQ methods because we find no solvent kinetic isotope effect for either its formation or decay in 
single-mixing Mössbauer studies.44 Hydroperoxy intermediates in cytochromes P450 and heme iron 
synthetic complexes are proposed to be electrophilic oxidants, reacting with electron-rich 
substrates.45 MMOHperoxo and the peroxo intermediate in RNR-R2 are also capable of oxidizing 
electron-rich substrates, such as aromatic side chain residues,26,46 alkenes,28 and ethers.27 The 
reactivity profile of the intermediate reported here is similar to those of hydroperoxoiron(III) species 
in heme systems, MMOHperoxo, and the peroxo intermediate in RNR-R2. ToMOH can epoxidize or 
hydroxylate halogenated alkenes and a number of aromatic compounds, preferring electron-rich 
substrates over poorer ones.47,48 A preliminary cryoreduction study of the ToMOH intermediate gives 
Table 3.1. Mössbauer and Optical Spectroscopic Parameters for μ-1,2-Peroxodiiron(III) Complexes 
Donor Set Bridging Ligands 
λmax 
[nm] 
ε 
[M-1cm-1] 
δ 
[mm/s] 
ΔEQ 
[mm/s] Ref. 
N3O3 hydroxo 644 3000 0.50 1.31 39 
N3O3 oxo 577 1500 0.50 1.46 39 
N3O3a 
alkoxo 
carboxylato 665 2300 0.57 1.44 15 
N3O3 a 
alkoxo 
carboxylato 710 1500 0.58 1.17 15 
N3O3 
alkoxo 
carboxylato 500 – 800 1700 
0.65 
0.58 
1.70 
0.70 14 
N3O3 dicarboxylato 694 2650 0.66 1.40 16 
N4O2* oxo 494, 648, 846 1100, 1200, 230 0.54 1.68 42 
aThese compounds were characterized by Mössbauer and optical spectroscopy only. 
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 rise to an EPR-active species, which will allow us to probe its structure by 17O-ENDOR spectroscopy 
in future work.49 
ToMOH is unique among BMMs studied to date because it can serve as a catalase in the 
absence of reducing equivalents and as an NADH oxidase in conjunction with the other components 
of the enzyme system. The catalase activity of ToMOHox suggests that dioxygen activation by 
ToMOHred may be reversible, if protons are lost prior to ET. Dioxygen binds reversibly to diiron(II) 
clusters in respiratory proteins, such as hemerythrin, but has not been reported for CBDI enzymes 
that catalyze substrate oxidation. RFQ Mössbauer spectra of samples from reaction of dioxygen with 
ToMOHred and ToMOD demonstrate that ToMOHperoxo decays to form only the oxidized diiron(III) 
center. The catalase reaction was conducted with more than a 20-fold excess of hydrogen peroxide, 
which could drive the reaction in the reverse direction. Hydrogen peroxide could react with 
ToMOHox, liberating two water molecules and generating ToMOHperoxo (Scheme 3.3). Oxidation of 
the peroxide fragment by the diiron(III) center evolves dioxygen with formation of ToMOHred. 
Binding of a second molecule of hydrogen peroxide, possibly in a μ-1,1 fashion, to the diiron(II) 
center would allow for protonation of the distal oxygen atom followed by cleavage of the O–O bond. 
This binding mode for a peroxide fragment to a diiron(II) center has been previously proposed during 
reaction of synthetic peroxodiiron(III) complexes with the diiron(II) starting compound.41 The oxo-
bridged diiron(III) center formed after O–O bond cleavage can react with water to form ToMOHox or 
with hydrogen peroxide to generate ToMOHperoxo.  
The ToMO enzyme system catalyses the two-electron reduction of dioxygen to hydrogen 
Scheme 3.3. Reaction of ToMOHox with Hydrogen Peroxide 
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 peroxide with an efficiency of 51%. Reductive quenching of the diiron(III) intermediate in the 
absence of substrate could explain this poor efficiency. Electron transfer from reduced ToMOC to 
ToMOHperoxo prior to dissociation of peroxide may allow for complete reduction of dioxygen to 
water, as occurs in MMOH.17 The combined rate for dissociation of ToMOD, and binding and ET 
from reduced ToMOC to ToMOHperoxo, would have to exceed the decay rate of the transient, for 
which the rate constant is 0.05 s-1. The catalytic rate of phenol hydroxylation is 20-fold greater than 
the decay rate of ToMOHperoxo.50 The rate of protein complex formation and ET is faster therefore 
than that of ToMOHperoxo decay, suggesting that reductive quenching of ToMOHperoxo is kinetically 
feasible. The reduction of ToMOHperoxo could give rise to a peroxodiiron(II) species, similar to that 
proposed in Scheme 3.3. 
Substrate Hydroxylation by ToMOH. The rate constant for decay of the ToMOH diiron(III) 
intermediate is sensitive to phenol, increasing by more than thirty-fold, from 0.05 s-1 to 2 s-1, in its 
excess. The reaction is quantitative and forms catechol. The Mössbauer spectrum of ToMOHperoxo 
differs with phenol present, in contrast to that of the diiron(III) end product in double-mixing 
samples, which can be modeled with parameters identical to those in the absence of catechol (Figures 
2 and 4). Presumably, phenol accesses the CBDI active site via the channel and binds to the diiron 
center before undergoing oxidation. Coordination of phenol to a CBDI center in this manner would 
direct hydroxylation at the ortho position. The high regioselectivity of phenol hydroxylation by 
ToMO parallels that of model complexes in which the substrates are tethered to ligands bound to iron 
and where oxidation occurs regiospecifically at the closest accessible position.16,51,52 
Substrate coordination might potentiate reaction pathways that are otherwise unavailable in its 
absence. The choice of phenol as substrate for our experiments was determined because of the weak 
regioselectivity exhibited by the enzyme system for toluene. ToMO oxidizes phenol exclusively to 
catechol, but oxidation of toluene yields a mixture of cresols.50 To ensure that the Mössbauer 
spectrum of the diiron(III) product could be readily distinguished from that of the diiron(III) 
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 intermediate, phenol was therefore chosen as substrate.  
A possible detailed mechanism for phenol hydroxylation is shown in Scheme 3.4. Dioxygen 
activation involves formation a peroxodiiron(III) intermediate, which we arbitrarily depict with a μ-
1,2- geometry. Phenol next coordinates to one iron(III) center atom, after which there is an 
electrophilic attack of the {O22-} fragment on the arene π-system. The resulting arene epoxide ring 
opens, and rearomatization leads to oxidized diiron(III) center with bound product. In the absence of 
substrate, the intermediate slowly liberates hydrogen peroxide to return the resting diiron(III) state, 
ToMOHox. For reaction with toluene, a similar mechanism is expected but with substrate orientation 
being affected by residues within the active site pocket rather than by coordination to the diiron 
center. No EPR active species were observed in samples from the double-mixing studies. We 
previously reported the reaction of the diiron(III) intermediate to produce a neutral tryptophanyl 
radical centered at the mutagenic site (I100W, Chapter 2). Oxidation of phenol to catechol did not 
produce a similar substrate-based radical with an appreciable lifetime. Substrate proximity to the 
diiron center may direct the reaction through radical pathways at longer distances and two-electron 
processes at shorter distances.  
Linear free energy relationships for steady-state hydroxylation of substrate by ToMO have 
negative slopes (Figure 11), indicative of electrophilic attack on the aryl ring with substrate oxidation 
being at least partially rate-limiting. Activation of an aromatic substrate by donation from a hydroxyl 
group predisposes the system to electrophilic attack. As such, hydroxylation could proceed by a 
Scheme 3.4. Substrate Hydroxylation and Dioxygen Activation by ToMOH 
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 mechanism different from that that used for less activated arenes, such as toluene and benzene. 
Hammett studies of the homologous T4MO enzyme system employing substituted benzenes as 
substrates, however, are consistent with an electrophilic attack on the π-ring.53 The results of NIH 
shift experiments using T4MO suggested that hydroxylation involves formation of a transient arene 
epoxide that opens reversibly, or attack at a specific carbon atom, to yield a substrate carbocation.54 
The intermediate in ToMOH is therefore electrophilic, demonstrating a preference for two-electron 
oxidation of electron-rich substrates, such as alkenes and arenes, or one-electron abstraction from a 
nearby redox active residue, as occurred in the I100W variant. 
Slow binding of substrate in the active site pocket will retard the steady-state hydroxylation rate 
and bring about deviations from a linear Hammett relationship. Mutation of two glutamate residues, 
E214 and E284, on the protein surface near the channel opening and far from the active site enhance 
the rate of steady-state hydroxylation of 4-nitrophenol.48 More than 60% of this substrate is 
deprotonated at pH 7.5. Removal of negative charge at the opening of the substrate access channel 
could eliminate repulsion with deprotonated carboxylate side chains of E214 and E284, increasing 
the ease of substrate access to the active site. Correcting the observed hydroxylation rate of substrates 
in the Hammett study for the fraction of substrate that is protonated at pH 7.5 did not improve the 
quality of the fit. Other factors, such as the energy cost in bringing a charged species into a buried, 
neutral active site pocket in ToMOH, may also hinder access and affect the oxidation of these 
electron-poor aromatic compounds. 
A portion of the product remains bound to the diiron center, as evidenced by the appearance of a 
broad absorption band at 580 nm. Phenol, the substrate used here, is also a reaction product of 
benzene hydroxylation by ToMOH. Phenol, like catechol, can also bind to the diiron center and does 
so, as evidenced by the growth of an absorption band centered at 495 nm during titration of 
ToMOHox with phenol (data not shown). A similar absorption band was reported in a mutant of 
RNR-R2 in which F208 is hydroxylated and binds to the diiron center.26 Product release in this pre-
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 steady-state system may be slow because the installed hydroxyl group allows coordination to the 
diiron center. Dissociation and egress of products is proposed to be the rate-determining step in 
steady-state hydroxylation by MMOH.55 Coordination of products to the diiron center after 
hydroxylation, and the effects of these events on the reaction rate, are probably common to the 
hydroxylation mechanisms of BMMs. In ToMOH, a linear Hammett relationship provides strong 
evidence that substrate hydroxylation limits the reaction rate, implying that product dissociation is at 
least partially rate-limiting.  
Quantitation of catechol formed in double-mixing samples was possible only after treatment of 
the diiron(III) protein with ascorbic acid. Under steady-state conditions, reduction of product-bound 
ToMOHox facilitates its release to restart a catalytic cycle. Reduction-facilitated product release has 
been proposed previously for MMOH.17,56 Such a mechanism, whereby product release is enhanced 
by reduction of the diiron center would require that diffusion of product out of the active site occur 
more rapidly than subsequent steps involving dioxygen activation, hydrocarbon diffusion into the 
active site, and hydroxylation. Previously steady-state oxidation of benzene by ToMO results in the 
initial accumulation of phenol, and phenol is only hydroxylated to catechol at low benzene 
concentrations.50 The accumulation of phenol is therefore evidence that the rate of product 
dissociation exceeds that of reduction of the oxidized hydroxylase and subsequent dioxygen 
activation. 
ToMOD enhanced binding of phenol to the diiron center by a factor of two, as measured by 
optical titration of the oxidized hydroxylase with phenol.44 This result suggests that hydroxylase-
regulatory protein interactions perturb the diiron center, possibly by reorienting residues to increase 
the active site volume and allow substrate access. The flexibility of the active site to facilitate 
changes in the volume of the substrate-binding cavity was reported previously for other BMMs. For 
example, the volume is increased by partial unwinding of helix E in MMOHox upon binding of 6-
bromohexanol.57 Analogous helical rearrangements were also noted in the crystal structure of the 
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 PHH–PHM complex.58 The regulatory protein in these systems may therefore effect structural 
changes to allow for dioxygen activation and substrate access to, and/or product egress from, the 
diiron center. 
Implications for the CBDI Protein Family. Half-sites reactivity, whereby two equivalent 
active sites alternate in traversing opposite halves of the catalytic cycle, has been proposed in RNR-
R2,59 Δ9D,12 and MMOH.17 The maximum observed accumulation of the peroxodiiron(III) 
intermediate in ToMOH is consistently recorded to be ~ 45%, with the remaining protein present as 
unreactive diiron(II) starting material. Such reproducible yields of the intermediate generated upon 
oxygenation of reduced wild-type and mutant I100W18 hydroxylases suggests that dioxygen 
activation in this system only occurs at one active site per dimer. This conserved feature of CBDI 
family members may reflect allosteric changes transmitted through the protein framework as amino 
acid side chains shift with the transition from the reduced enzyme to intermediate and oxidized 
forms. The protein framework can modulate the mechanism of dioxygen activation and the reactivity 
of those intermediates, as evidenced by the ability of MMOH and RNR-R2 to form high-valent 
species, of Δ9D and Ft to form only peroxo-bridged intermediates, and of ToMOH to form a putative 
peroxodiiron(III) transient with different spectroscopic characteristics. DFT methods have proposed 
that compression of the Fe–Fe vector by the protein matrix aids in the formation of Q.5 Subtle 
changes afforded by the orientation of subunits or complex formation with other components may be 
responsible for tuning the different reactivities of BMMs. 
 
CONCLUSIONS 
The reactive intermediate in ToMOH that hydroxylates arenes is a diiron(III) species, which we 
tentatively assign as a peroxo adduct. This intermediate is an electrophile, similar to μ-1,2-
peroxodiiron(III) transients in RNR-R2 and MMOH. ToMOH is distinct, however, because it 
generates hydrogen peroxide during steady-state turnover in the absence of substrate and acts as a 
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 catalase, consuming hydrogen peroxide to liberate dioxygen. Our results suggest that the dioxygen 
activation step(s) may be reversible in this system, which has not been previously reported for any 
BMM. The Mössbauer parameters and optical characteristics of ToMOHperoxo differentiate it from 
other μ-1,2-peroxodiiron(III) centers in biology. Further characterization of this intermediate by 
ENDOR, XAS, and X-ray crystallography will provide invaluable insight into factors that govern 
dioxygen activation at CBDI centers in biology. 
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CONTEXT 
In Chapters 2 and 3, we examined the diiron intermediates formed during the reaction of 
reduced hydroxylase with dioxygen. In Chapter 4, we present the steady-state hydroxylation for 
norcarane, a radical clock substrate that can distinguish between one- and two-electron oxidation 
pathways. For this substrate, opening of the cyclopropane ring after H-atom or hydride abstraction 
gives rise to diagnostic products. We carefully examined the enzymatic oxidation of norcarane by 
ToMO, paying close attention to minor products formed during the reaction. The ToMO enzyme 
system readily desaturates norcarane under steady-state conditions to yield a mixture of 2- and 3-
norcarene. These unsaturated compounds are better substrates than the parent norcarane, giving rise 
to a number of secondary oxidation products. We identified 17 oxidation products in the enzyme 
oxidation reactions, half of which arise from norcarene oxidation. These products have similar 
elution times and fragmentation patterns in GC/MS analyses, preventing accurate quantification of 
the diagnostic radical and cationic products. We estimate the lifetime of any substrate radical 
intermediate formed during oxidation by ToMO to be short-lived with a lifetime no greater than 
25 ps. Lifetimes calculated by using norcarane as an RCS probe are typically greater than those 
reported from the oxidation of a number of other probes, probably because the desaturation chemistry 
observed here was not considered. 
 
INTRODUCTION 
Radical clock substrate probes have been used extensively to investigate enzymatic oxidation 
reactions. These small organic compounds contain strained ring systems that rearrange upon radical 
formation to yield a diagnostic product. Recombination of the substrate radical and the enzyme 
intermediate to form hydroxylated products competes with substrate radical rearrangement for these 
probes. Armed with the known rate of rearrangement for a particular RCS probe, the lifetime of the 
enzyme radical species can be estimated from the ratio of radical-rearranged and unrearranged 
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products. A handful of RCS probes, such as norcarane (1), can also distinguish between one- and 
two-electron oxidation pathways. Upon hydride abstraction from this probe, the substrate cation ring 
opens to yield a product distinct from the radical-derived one. For norcarane, formation of a radical 
or a cation at C2 gives product alcohol 21 or 22, respectively, as shown in Scheme 4.1. The two 
oxidation pathways can thus be distinguished with one probe. No information regarding transient 
species is directly obtained, however, as the experiment monitors only product distributions at the 
end of the reaction. To take advantage of the mechanistic insight offered by these substrates, accurate 
quantification and identification of all oxidation products are required. 
Norcarane (1) has been applied as a probe in studies of many enzyme-catalyzed oxidation 
reactions.1-7 Radical and cation-rearranged products were detected in low yield, suggesting that one- 
and two-electron oxidation pathways were accessible to these enzymes. The evidence for radical-
derived products in norcarane studies and the consequent conclusion that radical intermediates exist 
disagreed, in most instances, with experimental results conducted with other RCS probes.8,9 
Moreover, results from "hypersensitive" radical probes,10 including those that can differentiate 
between radical and cation pathways, indicated that no radicals with significant lifetimes were 
formed during oxidation reactions. Most studies employing norcarane reported yields of radical and 
cation rearranged products that were similar to those of a number of unidentified oxidation products 
of norcarane. Eight oxidation products from norcarane have been reported, but the reaction mixtures 
appeared to contain many more products with similar molecular weights and GC retention properties.  
In this work, we studied oxidation reactions of norcarane by the ToMO system with careful 
Scheme 4.1. Ring-Expansion Products Arising from Norcarane Oxidation  
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attention to the identities of minor products.  Norcarane was desaturated to 2- and 3-norcarene in 
addition to forming primary oxidation products such as 17. These unsaturated compounds were better 
substrates for this system than the parent norcarane, undergoing oxidation to yield secondary 
oxidation products. To understand the extent to which these secondary oxidation products might 
complicate product identification and quantification, enzymatic reactions were carried out employing 
both norcarenes as substrates. The number of characterized potential products arising from norcarane 
oxidation was determined to be twenty, with almost half resulting from norcarene oxidation. These 
compounds have similar retention times and mass spectra on GC/MS instruments equipped with a 
low polarity column. In particular, we found that the radical- and cation-derived rearrangement 
products from norcarane co-elute with norcarene oxidation products.  We conclude that the already 
small yields attributed to these rearranged products were overestimated in earlier studies by an order 
of magnitude or more. 
 
EXPERIMENTAL METHODS 
General Considerations. Syntheses of norcarane (1), 2-norcarene (2), 3-norcarene (3), and 
oxygenated products 4-22 were carried out as described elsewhere (Scheme 4.2).3,11-18 Norcarane (ca. 
99% pure) was treated with mCPBA to oxidize trace olefinic materials and purified by preparative 
GC (¼ inch × 8 ft column, 10% SE-52 on 60/80 Chromosorb W). The isolated sample was shown to 
be > 99.96% homogeneous by analytical GC. The unsaturated derivatives, 2- and 3-norcarene, were 
purified by preparative GC (10% SE-52 on 60/80 Chromosorb W, 1/4 in × 8 ft column) at 100 oC 
(isothermal). Sample purities were determined by GC (DB-5, 40 °C) using flame ionization detection  
(FID). NMR spectra were recorded in CDCl3 at 300 or 500 MHz. Proton correlation was resolved 
with bidimensional COSY experiments, and stereochemistry was determined by monodimensional 
NOE difference experiments. All yields and purities of other authentic samples were determined by 
GC (DB-5) using flame ionization detection and GC-MS (HP-5MS 5% phenylmethyl siloxane 
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column) with electron impact (EI) ionization. Mass spectra of purified samples are reported 
elsewhere.11  
Enzymatic Oxidations by ToMO. Purified ToMOF and plasmids containing the genes for 
ToMOH, ToMOD, and ToMOC were kindly supplied by Professor Alberto Di Donato, Naples, Italy. 
The proteins were expressed in E. coli and purified as described elsewhere.19,20 The specific activity 
on phenol was 1.2(1) × 103 mU/mg of hydroxylase, and the iron content for ToMOH was 4.3 ± 0.2 as 
determined by previously reported methods.19,20 In a typical reaction, a mixture of 1 nmol of 
ToMOH, 66.57 nmol of ToMOD, 20 nmol of ToMOC, and 0.1 nmol of ToMOF was diluted to a 
volume of 2 mL with 20 mM potassium phosphate buffer (pH = 7.4). The mixture was allowed to 
Scheme 4.2. Products of Norcarane Oxidation 
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stand in an ice bath for 10 min. Either 2-, 3-norcarene (10 μL, 2 mg norcarene/100 μL methanol), or 
norcarane (1.5 mmol, neat) was added as substrate. The mixture was incubated at 26 °C for 10 min 
while shaking. The enzymatic hydroxylation was initiated by addition of buffer solution containing 
NADH to give a sample concentration of 1 mM NADH. The mixture was gently shaken at 26 ºC for 
30 min and then extracted with CH2Cl2 (3 × 2 mL). The combined organic phase was dried (MgSO4) 
and filtered. An internal standard of 1-phenyl-1-propanol was added, and the mixture was 
concentrated under a stream of nitrogen. The concentrated sample was analyzed by GC/FID (0.32 
mm × 30 m capillary column, 5% phenyl silicone bonded phase) and GC-MS (0.25 mm × 30 m, 
capillary column, 5% phenyl silicone bonded phase). 
 
RESULTS & DISCUSSION 
Desaturase Reactions of Norcarane. Small amounts of impurities including norcarenes can be 
detected in distilled samples of norcarane. To avoid complications from the use of slightly 
contaminated substrate, distilled norcarane was treated with mCPBA to oxidize traces of olefins and 
isolated by preparative GC. Analysis of the purified sample by analytical GC indicated that norcarane 
was at least 99.96% homogeneous, and no impurities of 2-norcarene or 3-norcarene could be 
detected to the limit of instrumental sensitivity.  
Both 2- and 3-norcarene were observed in the product mixture for enzyme-catalyzed oxidation 
of norcarane by ToMO prior to concentrating sample and were formed in ~ 5% yield (Figure 4.1). 
The yield of norcarenes was 0.1% relative to initial substrate loading but was greater than that of all 
oxidation products of norcarane except the norcaranols. The yields of alcohols 21 and 22, the radical- 
and cation-derived products respectively, were approximately six-fold lower than those of the 
norcarenes. 
Non-heme diiron enzymes have been previously reported to perform desaturase reactions. For 
example, Δ9D converts stearoyl-ACP to oleoyl-ACP, and MMO from M. trich. desaturates 
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ethylbenzene to styrene and cyclohexadienes to benzene in 9 and 40% yield, respectively.21 Previous 
studies, however, did not realize that norcarane was susceptible to similar desaturation. As steady 
state assays proceed, the relative affinity of ToMO for norcarane and norcarenes can impact the 
number of oxidation products in the reaction mixture and the final ratio of norcarenes to norcarane. 
ToMOH oxidizes 3-norcarene more efficiently than norcarane (vide infra). An examination of 
product distributions arising from norcarane oxidation requires consideration of the enzymatic 
hydroxylation products of norcarene. Conditions were therefore surveyed to develop GC methods to 
separate products from norcarane and norcarene oxidation. 
Analytical Protocol for Oxidation Products. Identification and quantification of these 
compounds by GC/MS with selective ion monitoring and GC/FID, respectively, is challenging 
because the molecular weights, fragmentation patterns, and elution times are similar for oxidation 
products of norcarane and norcarenes. The radical- (21) and cation-derived (22) products are of 
particular concern because the utility of radical clock substrates requires accurate quantification of 
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Figure 4.1.  Portions of GC traces (40 °C, DB-5 column) of norcarane before (top) and after (bottom) 
reaction with ToMO. The expansions are 100× the amplitude of the lower traces. Under the GC 
conditions used for these analyses, 3-norcarene and 2-norcarene elute with retention times of 10.1 and 
10.3 min, respectively. 
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these products and unrearranged alcohols 17 - 20. Product 21 presents further complications because 
the fragmentation pattern contains two large molecular weight ions that are found in most other mass 
spectra (Figure 4.2). Furthermore, its retention time on a low polarity column is similar to those of 
10, 13, 16, and A, all of which arise from norcarene oxidation. This observation supports our 
conclusion that the enzymatic decomposition of norcarenes must be characterized in studies 
employing norcarane as a diagnostic probe. 
Authentic samples and a mixture containing radical-derived product 3-
hydroxymethylcyclohexene (21), cyclohepta-3,5-dienol (16), and syn-2-norcaranol (17) in an 
approximate 1:1:50 ratio illustrate the similar elution times and difficulty separating these 
compounds (Table 4.1). On a low polarity 5% phenyl silicone column (DB-5), 21 and 16 eluted at 
coincidental times at oven temperatures of 70 °C or greater, whereas peaks corresponding to 21 and 
17 overlapped at 50 °C or 60 °C. The major product formed was 17 in enzyme-catalyzed oxidations 
of norcarane and would obscure detection of the small amount of 21. Compound 16 arises from 
oxidation of norcarenes and could result in an overestimation of the yield of 21 if higher column 
temperatures were used. A similar phenomenon was observed for other alcohol products, such as 10, 
where the temperature effect on the retention of each alcohol product differed. As such, 
quantification of 21 independent of other products was not possible under any of the examined 
conditions. To obtain accurate yields of 21, the combined yield of all products eluting at that 
retention time must be determined along with the percentage of 21 present. Overall yields were 
determined by GC/FID, and the identity and percentage composition were determined by GC/MS.  
Product Yields from Norcarane Oxidations. GC/FID traces contained a number of 
overlapping peaks incompletely resolved, as expected from our discussion above, but 17 oxidation 
products could be identified by comparison to standards (Table 4.2). The structure of one product, A, 
could not be determined. The major oxygenated products are 2-norcaranols 17 and 18, as reported for 
similar diiron enzymes.3,5,6 Activation of this C–H bond is more facile because of the lower bond 
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dissociation relative to that at C3.22 The high yield of 2- and 3-norcarene is surprising as these 
products were not reported previously for norcarane oxidation by any BMM.3,5,6 Peaks corresponding 
to norcarene oxidation products were observed in previous studies with norcarane, but these products 
were not identified.  
m/z
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Figure 4.2. SIM mode GC spectra obtained by monitoring 12 ion channels. Spectra of 21, 16, and 
A at the same GC elution time have similar fragmentation patterns except for differences in the 
ratio of intensity of m/z = 95 to 94 and 81 to 79. In each spectrum, the m/z = 95 signal is marked 
with an arrow for calibration. 
Table 4.1. Observed Retention Times for GC Elutions 
as a Function of Column Temperaturea 
T (°C) 21 16 17 
100 7.0 7.0 7.1 
90 8.4 8.4 8.6 
80 10.7 10.7 10.9 
70 14.4 14.4 14.6 
60 20.7 20.5 20.8 
50 31.6 30.8 31.3 
aReported in min on a DB-5 column. Compounds 16, 17, 
and 21 are shown in Scheme 4.1 
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Although the detection of products 21 and 22 provides evidence for radical or cationic substrate-
based intermediates, accurate quantification is required to estimate the lifetime of such species as 
well as the partitioning of the reaction between one- and two-electron processes. Yields cannot be 
determined as accurately as desired because of limitations in our capacity to separate these 
compounds from other oxidation products. From mass spectra, compound 21 is not the major 
component of the mixture 21 + 16 + A, as evidenced by the ratio of peaks with m/z = 95 to 94 and 81 
to 79. If the yield of 21 is 50% of the co-eluting species, the calculated lifetime of a putative radical 
intermediate is at most 25 ps. This lifetime is in disagreement with that of 263 ps reported from 
norcarane oxidation by T4MO.5 In that experiment, cation-rearranged products were not observed for 
norcarane oxidation, but cation-derived products were formed in four-fold greater yield than that of 
the radical-derived products for reaction mixtures using 1,1-diethyl- and 1,1-dimethylcyclopropane. 
The results reported here for ToMO agree with those of the latter from oxidation of cyclopropane 
probes by T4MO, for which radical-derived products were formed in low yield. 
Enzyme-Catalyzed Oxidations of Norcarenes.  For enzyme systems where unnatural 
substrates are not efficiently oxidized, products arising from the reaction of minor impurities with the 
enzyme intermediate(s) can accumulate and complicate data analysis. As for norcarane, preparative 
GC was used to ensure that the norcarene substrates were of the highest possible purity. Substrates 2 
and 3 used in our experiments contained no detectable impurities by NMR spectroscopy and were 
99.7% and 99.3% pure, respectively, by analytical GC. The distribution of ToMO oxidation products 
of the norcarenes is listed in Table 4.3. 
Product yields were almost 15-fold higher in ToMO oxidations when 3-norcarene was the 
substrate instead of 2-norcarene. Two other BMMs, MMO and PH, and cytochrome P450 2B1 
showed a similar preference for 3-norcarene over 2-norcarene. Compounds 16 and A, previously 
mentioned because of the similarity of their retention times to that of 21, are observed in product 
mixtures of 3-norcarene oxidation by ToMO. These products were not exclusive to 3-norcarene 
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because 2-norcarene was also oxidized to 16 and A by MMO, PH, and cytochrome P450 2B1. 
Furthermore, these products are also observed in norcarane oxidation reactions because norcarenes 
are generated by desaturation of norcarane (vide supra). Whereas the yield of 16 is 1.3% of all 3-
norcarene products for ToMO, that of 16 relative to that of 21 in norcarane reactions is of greater 
consequence. The poor turnover for norcarane compared to norcarenes by ToMO and the short 
lifetime of any radical species in ToMO ensure that 16 and A are formed in a high enough yield to 
hamper an accurate estimation of lifetimes.  
 
The oxidation product varied depending on the position of the double bond; for 2-norcarene, the 
major product was ketone 5, whereas 3-norcarene reactions contained predominantly epoxide 9 
8 9 10 11 12
FI
D
 s
ig
na
l
retention time (min)
8 9 10 11 12
FI
D
 s
ig
na
l
A
B
ToMO
sMMO
CYP2B1
ToMO
sMMO
CYP2B1
5
10+1376
8
9+B
12
16+A
10+13
 
Figure 4.3.  Portions of GC traces of products from oxidation of 2-norcarene (A) and 3-norcarene (B) 
with toluene monooxygenase from P. sporium OX1 (ToMO), soluble methane monooxygenase from M. 
capsulatus (Bath) (sMMO), and cytochrome P450 2B1 (CYP2B1).  The identities of some of the products 
are indicated with the compound numbers. 
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(Figure 4.3). Oxidation of 3-norcarene by MMO or cytochrome P450 2B1 yields primarily the 
alcohol products rather than the epoxide. An unidentified product B eluted at the same retention time 
as 9, but was a minor product based on a comparison of mass spectra for the peak to that of an 
authentic sample of 9.  
Desaturation Effects on Radical Clock Probe Oxidations. In systems where product yields 
are low because of inefficient enzymatic oxidation of norcarane, the contamination level with 
norcarenes must be as minimal as possible. Treatment of distilled samples of norcarane with mCPBA 
followed by preparative GC scavenged trace 2-norcarene. Even using this material, it was not 
possible to measure precisely the yield of 21. Studies employing norcarane as an RCS probe must 
consider oxidation products of norcarane and norcarenes. The extent to which product distributions 
in earlier studies using norcarane were influenced by trace norcarenes cannot be evaluated because 
substrate purities were not reported.  Any future study using norcarane as a probe should demonstrate 
by high performance GC that the norcarane sample is not contaminated with norcarenes. An 
alternative strategy that will circumvent complications arising from norcarene oxidation products is 
to conduct assays under single turnover rather than steady-state conditions. To accumulate norcarene 
oxidation products requires multiple turnovers of the enzyme system, which cannot occur in single 
turnover experiments. Unfortunately, many enzymes do not efficiently oxidize norcarane, and this 
strategy will be prohibitive in most cases because the required enzyme concentration will be high. 
The efficiency of desaturation of norcarane is surprising, and one should expect that any 
mechanistic probe with a reactive CH functionality adjacent to the readily oxidized position would 
undergo desaturation. Any probe that meets this criterion is predicted to yield relatively large 
amounts of secondary oxidation products that complicate mechanistic studies. Included are most 
conceivable probes, of course, except the subset containing a methyl group adjacent to a cyclopropyl 
ring. Oxidation of the methyl group is not expected to result in desaturation because of the large 
increase in strain energy that would result from an sp2-hybridized carbon atom in a cyclopropyl ring. 
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When the probe is capable of reacting in a desaturase reaction, care should be taken to identify as 
many products as possible, including secondary oxidation products from the dehydrogenated probe, 
to avoid the pitfalls outlined for norcarane.  
Implications for Catalysis in ToMO. In Chapters 2 and 3, we proposed that the active oxidant 
is electrophilic in character, resembling the established reactivity of other peroxodiiron(III) 
intermediates. Prior to the radical clock studies discussed here, ToMO had not been observed to carry 
out hydroxylation of aliphatic compounds. The same observation was made with T4MO, where 
radical clock substrates, such as norcarane and 1,2-diethylcyclopropane, were the first reported 
saturated hydrocarbons to be oxidized by this system.5 Only a small amount of product 21 was 
observed for oxidation of norcarane by ToMOH, contrasted by the greater yields of the norcaranols 
and norcarenes. Oxygen-atom insertion into the C–H bond of norcarane to give norcaranols may 
occur by a mechanism similar to that proposed for methane hydroxylation by Q or diethyl ether 
hydroxylation by MMOHperoxo.23,24 The intermediate observed in ToMOH can carry out one- and 
two-electron oxidation reactions, as evidenced by the ToMOH I100W results discussed in Chapter 2, 
and by the studies of the wild type hydroxylase in Chapter 3. Proximity and positioning of these 
substrates relative to the diiron center in the active site pocket could determine the reaction pathway. 
In systems where more than one reactive intermediate is present, distinct reactivity profiles such 
as insertion across C–H bonds and epoxidation could be attributed to different species.9 Only one 
intermediate is observed in ToMOH, however, requiring a mechanism that bifurcates to yield two 
products. Initial hydride abstraction from the substrate would form a transient carbocation. For 
desaturation, an amino acid side chain, such as the hydroxyl group of Thr201, could abstract a proton 
from the carbon atom adjacent to the positively-charged center to yield norcarenes. For substrate 
hydroxylation, recombination of the substrate cation with the oxygen atom on the iron center that 
accepted the hydride would yield the norcaranol products (Scheme 4.3). Two conditions must be 
satisfied for this mechanism to be valid. First, the rearrangement rate of the substrate cation must be 
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slower than that of either recombination or proton abstraction. Second, the rate of recombination 
must be greater than the rate of proton abstraction, as the yield of norcaranols is 8-fold greater than 
the norcarene yield.  
 
An alternate mechanism for desaturation might involve substrate hydroxylation followed by 
elimination of water. Similar reactivity has been reported for Δ9D, where O-atom transfer from the 
diiron center to the sulfur atom in thioether substrates was observed.25 For addition across a C–H 
bond, a two-electron three-centered transition state would allow for formation of the norcaranols. 
This mechanism is analogous to that proposed for alkene epoxidation and diethyl ether oxidation by 
MMOHperoxo.  
Changes in oxidation products as well as the preference of 3-norcarene most likely arise from 
binding of substrate within the active site. Toluene and norcarene are of comparable shape and size5 
and are therefore likely to bind in a similar manner. The enzymatic product distribution for toluene 
hydroxylation is biased towards the para position.19 The methylene bridge of norcarene could mimic 
the tolyl methyl group. The double bond in 3-norcarene is therefore placed favorably to undergo 
epoxidation whereas the double bond in 2-norcarene is less accessible to the oxidizing intermediate. 
Oxidation of C3 in 2-norcarene followed by rearrangement would yield 3-norcarenol (Scheme 4.4). 
Subsequent dissociation and tautomerization of this product would yield 5. 
Scheme 4.3. Hydride Abstraction Mechanism for ToMO Oxidation of Norcarane 
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CONCLUSIONS 
Radical clock substrate probes have been widely used to provide mechanistic insight into 
enzyme catalyzed oxidations. Desaturation of these substrates was not been considered previously. 
For norcarane, desaturation is a significant pathway during oxidation of this probe by ToMO. Of 
greater concern, the oxidation of the norcarenes is favored over that of norcarane, leading to an 
accumulation of over 20 products. By considering the rich uncharacterized chemistry of these probes 
upon reaction with ToMO, we have ascertained that a radical pathway does not predominate the 
hydroxylation of this substrate, contrary to previous reports on T4MO. The desaturase activity 
afforded by this enzyme also mirrors similar desaturation chemistry proposed by other 
peroxodiiron(III) intermediates, adding further support to our tentative assignment of the diiron(III) 
transient as such a species. 
 
ACKNOWLEDGEMENTS 
Most of the credit for the work reported in this chapter goes to the Newcomb lab at the 
University of Illinois at Chicago. Data analysis, method development, and substrate synthesis were 
carried out there. Duplicate experiments were performed at M.I.T. and confirmed qualitatively that 
desaturation of norcarane occurred to an appreciable level during oxidation reactions with ToMO, 
MMO, and PH. 
Scheme 4.4. Oxidation Pathways of 2- and 3-Norcarene by ToMO 
132
REFERENCES 
 
1. Austin, R. N.; Chang, H.-K.; Zylstra, G. J.; Groves, J. T., J. Am. Chem. Soc. 2000, 122 (47), 
11747-11748. 
2. Auclair, K.; Hu, Z.; Little, D. M.; Ortiz de Montellano, P. R.; Groves, J. T., J. Am. Chem. Soc. 
2002, 124 (21), 6020-6027. 
3. Newcomb, M.; Shen, R.; Lu, Y.; Coon, M. J.; Hollenberg, P. F.; Kopp, D. A.; Lippard, S. J., J. 
Am. Chem. Soc. 2002, 124 (24), 6879-6996. 
4. Newcomb, M.; Shen, R.; Lu, Y.; Coon, M. J.; Hollenberg, P. F.; Kopp, D. A.; Lippard, S. J., J. 
Am. Chem. Soc. 2006, 128 (4), 1394. 
5. Moe, L. A.; Hu, Z.; Deng, D.; Austin, R. N.; Groves, J. T.; Fox, B. G., Biochemistry 2004, 43 
(50), 15688-15701. 
6. Brazeau, B. J.; Austin, R. N.; Tarr, C.; Groves, J. T.; Lipscomb, J. D., J. Am. Chem. Soc. 2001, 
123 (48), 11831-11837. 
7. Groves, J. T., J. Inorg. Biochem. 2006, 100 (4), 434-447. 
8. Merkx, M.; Kopp, D. A.; Sazinsky, M. H.; Blazyk, J. L.; Müller, J.; Lippard, S. J., Angew. 
Chem., Int. Ed. 2001, 40 (15), 2782-2807. 
9. Baik, M.-H.; Newcomb, M.; Friesner, R. A.; Lippard, S. J., Chem. Rev. 2003, 103 (6), 2385-
2419. 
10. Newcomb, M.; Toy, P. H., Acc. Chem. Res. 2000, 33 (7), 449-455. 
11. Newcomb, M.; Lansakara-P., D. S. P.; Kim, H.-Y.; Chandrasena, R. E. P.; Lippard, S. J.; 
Beauvais, L. G.; Murray, L. J.; Izzo, V.; Hollenberg, P. F.; Coon, M. J., J. Org. Chem. 2007, 72 
(4), 1128-1133. 
12. Kawabata, N.; Naka, M.; Yamashita, S., J. Am. Chem. Soc. 1976, 98 (9), 2676-2677. 
13. Chan, J. H. H.; Rickborn, B., J. Am. Chem. Soc. 1968, 90 (23), 6406-6411. 
14. Chini, M.; Crotti, P.; Flippin, L. A.; Gardelli, C.; Macchia, F., J. Org. Chem. 1992, 57 (6), 1713-
1718. 
15. Denmark, S. E.; Edwards, J. P., J. Org. Chem. 1991, 56 (25), 6974-6981. 
16. Dauben, W. G.; Berezin, G. H., J. Am. Chem. Soc. 1963, 85 (4), 468-472. 
133
17. Friedrich, E. C.; Holmstead, R. L., J. Org. Chem. 1972, 37 (16), 2550-2554. 
18. Charette, A. B.; Francoeur, S.; Martel, J.; Wilb, N., Angew. Chem., Int. Ed. 2000, 39 (24), 4539-
4542. 
19. Cafaro, V.; Scognamiglio, R.; Viggiani, A.; Izzo, V.; Passaro, I.; Notomista, E.; Dal Piaz, F.; 
Amoresano, A.; Casbarra, A.; Pucci, P.; DiDonato, A., Eur. J. Biochem. 2002, 269 (22), 5689-
5699. 
20. Sazinsky, M. H.; Bard, J.; DiDonato, A.; Lippard, S. J., J. Biol. Chem. 2004, 279 (29), 30600-
30610. 
21. Jin, Y.; Lipscomb, J. D., J. Biol. Inorg. Chem. 2001, 6 (7), 717-725. 
22. Halgren, T. A.; Roberts, J. D.; Horner, J. H.; Martinez, F. N.; Tronche, C.; Newcomb, M., J. Am. 
Chem. Soc. 2000, 122 (13), 2988-2994. 
23. Baik, M.-H.; Gherman, B. F.; Friesner, R. A.; Lippard, S. J., J. Am. Chem. Soc. 2002, 124 (49), 
14608-14615. 
24. Beauvais, L. G.; Lippard, S. J., J. Am. Chem. Soc. 2005, 127 (20), 7370-7378. 
25. Fox, B. G.; Lyle, K. S.; Rogge, C. E., Acc. Chem. Res. 2004, 37 (7), 421-429. 
 
 
 
 
 
134
  
 
 
 
 
 
 
APPENDIX A 
PRELIMINARY STUDIES OF PHOTOINDUCED ELECTRON 
TRANSFER TO OXIDIZED MMOH 
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INTRODUCTION 
Dioxygen activation at non-heme carboxylate-bridged diiron(III) centers is incompletely 
understood. For example, the peroxide moiety in the conserved peroxo-bridged diiron(III) cluster is 
proposed to bind in either a μ-1,2 or μ-η2:η2 fashion.1-4 The high-valent species Q in MMOH has 
been assigned as both a symmetric and asymmetric di(μ-oxo)diiron(IV) cluster.5,6 The conversion of 
MMOHperoxo to Q is proposed to proceed by either homolytic3,4 or heterolytic7 O–O bond cleavage, 
the latter facilitated by protonation of the peroxide moeity. A detailed, complete mechanistic 
understanding of dioxygen activation in MMOH, and by extension other non-heme diiron enzymes, 
is therefore lacking. No intermediates are observed prior to the peroxodiiron(III) transient and after 
reacting the reduced diiron(II) protein with dioxygen-saturated buffer. Only oxygen isotope effects8 
and kinetic models9 have been experimentally applied to infer information about these early steps. 
In the MMO system, computational methods predict that a short-lived mixed-valent 
superoxodiiron(II,III) transient forms prior to MMOHperoxo.4 In agreement with this prediction, the 
rate constants obtained from RFQ EPR, Mössbauer, and stopped-flow optical experiments suggest 
the presence of such an intermediate because the rate of decay of the diiron(II) signal at g = 16 is 
faster than the rate of formation of the peroxodiiron(III) species.10,11 Thus far, the techniques 
employed to probe the dioxygen activation in these systems rely on rapid mixing of two solutions. 
Photochemical methods, such as photoreduction of the active site of metalloproteins12-15 or rapid 
photodissociation of dioxygen16 from small inorganic complexes, however, are limited by the rate of 
the photochemical process rather than the mixing time (~ 1 ms). Such a strategy might allow us to 
interrogate the diiron center prior to the formation of MMOHperoxo. We therefore attempted to use a 
tris(bipyridyl)ruthenium(II) complex tethered to MMOB to photoreduce the diiron active site in 
MMOH. The shortcomings of this strategy and possible future directions are described. 
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EXPERIMENTAL METHODS 
General Considerations. MMO component proteins were expressed either in E. coli (MMOB 
and MMOR) or in M. caps. (MMOH) and isolated as described elsewhere.17,18 Plasmids for 
recombinant expression of mutant forms of MMOB were supplied by Matthew Sazinsky. For all 
batches of MMOH isolated, the iron content determined by the ferrozine assay ranged from 3.8 to 4.2 
Fe atoms per MMOH dimer. The specific activities determined by monitoring NADH consumption 
and with propylene as substrate ranged from 300 to 400 mU/mg of hyrdoxylase, similar to those 
reported elsewhere.19 LC/MS ESI(+) analyses for proteins were carried out at the Biopolymers 
facility at M.I.T. as described in Chapter 2. Instrumentation for GC analyses and optical spectroscopy 
have been reported previously.17 Reagents and materials were purchased from Sigma Aldrich 
Chemical Company. 
Synthesis of Labeled MMOB.  The MMOB mutants, N101C, C89A/H35C, and C89A/D22C, 
were modified according to the following procedure. The reagent (4-bromomethyl-4′-methyl-2,2′-
bipyridyl)(bisbipyridyl)ruthenium(II) hexafluorophosphate, [Ru(bpy)3′](PF6) was prepared according 
to literature procedures20 and characterized by ESI(+)-MS. An aliquot of the MMOB mutant protein 
(300 μL of 1mM) was exchanged into 50 mM Tris/HCl pH 8.0 buffer by serial dilution and 
concentration steps. The buffer-exchanged protein (300 μL) was mixed with an aliquot (800 μL) of 
5 mM [Ru(bpy)3′](PF6) in distilled water and stirred in the dark. The reaction mixture was allowed to 
stand at room temperature for 4 h, after which it was loaded onto a BioGel PD10 desalting column 
(BioRad Labs, CA), equilibrated with 25mM MOPS pH 7.0. Fractions were eluted with the 
equilibration buffer, and those that eluted prior to the retention volume (8 mL) were collected, 
pooled, and loaded on a DEAE Sepharose CL-6B ion exchange column. The Ru(bpy)3′-MMOB 
conjugate was eluted with a linear gradient of NaCl from 0 to 250 mM over 200 mL in 25 mM 
MOPS pH 7.0. SDS-PAGE and optical absorption spectral analysis of the fractions were recorded. 
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Fractions that absorbed at 452 nm and contained MMOB were pooled, concentrated to 100 μL, and 
drop-frozen in liquid nitrogen.  All purified Ru(bpy)3′–MMOB constructs, RuMMOB, were 
submitted to the Biopolymers Lab (M.I.T.) for LC/MS ESI(+). The steady-state activity and product 
composition for propylene as substrate were determined for the MMOB constructs. 
Effect of MMOHox on Fluorescence of RuMMOB. Degassed solutions of RuMMOB (2.5 μM) 
with or without MMOH (1.4 μM) were transferred to a fluorescence cuvette.  The fluorescence at 
600nm was recorded at 25.0 ± 0.2 °C for excitation at 337nm or 450nm using a Hitachi F-3010 
Fluorescence Spectrophotometer.  
EPR Sample Preparation. Solutions of MMOH, MMOB, and RuMMOB N101C were made 
anaerobic by repeated cycles of vacuum degassing and purging with nitrogen.  The protein solutions 
and aniline were transferred to a Vacuum Atmospheres MO-20 anaerobic chamber.  A standardized 
solution of sodium dithionite was used to reduce a portion of MMOHox to MMOHmv as described 
previously21 using methyl viologen as the mediator. All samples were made in duplicate and 
contained either oxidized or mixed valent MMOH (250 μM). MMOB (0.5 mM), RuMMOB N101C 
(0.5 mM), and aniline (1 mM) were either individually added or omitted. One of each pair of 
identical samples was exposed to a flash from a SunPak auto 433AF flash lamp. All samples were 
frozen and stored in liquid nitrogen.  The EPR spectra were recorded at 5 K, 0.201mW, and 
9.376GHz on a Bruker EMX (X-Band) spectrometer with ER 4102ST cavity. Spectra were modeled 
to obtain g-values using the software package Simfonia (Bruker). 
 
RESULTS 
Characterization of RuMMOB Constructs. The experimentally determined molecular weights 
for the RuMMOB constructs are given in Table 1. Only one product peak was observed in the LC 
trace for RuMMOB N101C, and deconvolution of the ion envelope indicated it to be the 1:1 
conjugate of MMOB N101C with [Ru(bpy)3′]2+ (Figure A.1). Three major peaks were observed in 
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the LC trace of the purified RuMMOB C89A/D22C. Bands corresponding to proteins with a lower 
molecular weight than MMOB were observed on the SDS-PAGE gel for fractions from the DEAE 
 
Figure A.1. LC trace and deconvoluted MS data for RuMMOB N101C. Only one major product is 
observed in the LC trace (top panel) with a retention time at 29.7 min. The LC trace is given as ion counts 
per second as opposed to an optical signal. The ion envelope for the species corresponding to the major 
product (middle panel) agrees with the LC trace with only one contributor to the envelope. The 
experimentally determined mass of RuMMOB, deconvoluted from the ion envelope (bottom), is 16439 
Da, which agrees with the expected value of 16435 Da. 
Table A.1. Simulated g-values and Intensities of EPR Signals in MMOH Samples. 
MMOH MMOB Aniline Flash g values Intensity Limits 
ox WT Y N 1.88, 1.77, 1.62 1237, -1304 
ox WT Y Y 1.92, 1.77, 1.62 1923, -1527 
ox Ru Y Y 1.91, 1.77, 1.62 2461, -2086 
mv WT N N 1.88, 1.76, 1.62 15088, -10643 
mv WT Y N 1.88, 1.77, 1.62 10191, -9745 
mv WT Y Y 1.89, 1.78, 1.62 10241, -9695 
mv - Y N 1.89, 1.82, 1.78 37995, -13333 
mv - Y Y 1.92, 1.86, 1.74 41027, -13355 
ox - MMOHox; mv - MMOHmv; WT – MMOB; Ru – RuMMOB N101C; Y – included; N – omitted  
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ion exchange column. For MMOB C89A/H34C, the experimentally determined molecular weight of 
the conjugate was 50 Da greater than the predicted molecular mass. RuMMOB N101C, therefore, 
was used in further experiments. The concentration was estimated by using an extinction coefficient 
of 13500 M-1cm-1 at 452 nm. This value corresponds to the [Ru(bpy)3′]2+ center and assumes that the 
optical properties of this complex are unchanged upon ligation to the protein. The steady-state 
consumption of NADH in the absence of propylene for RuMMOB N101C was significantly higher 
than for native MMOB. Product analysis by GC, however, indicated that substrate was oxidized to 
propylene oxide even though NADH consumption and substrate oxidation appeared to be uncoupled. 
The fluorescence of RuMMOB N101C was unperturbed in the presence of MMOHox with excitation 
at either 337 nm or 450 nm. 
Photoreduction of MMOH by RuMMOB. A rhombic EPR signal was observed for MMOHmv 
with g = 1.88, 1.77, and 1.62, which is similar to previously reported values for this species.22 Weak 
EPR signals corresponding to MMOHmv were observed in samples containing MMOHox, MMOB, 
and aniline (Table A.1). The presence of a minor amount of MMOHmv has been noted previously in 
EPR studies on MMOH.22 These signals do not increase significantly in samples that contained 
RuMMOB N101C and were excited by the flash lamp. Photoinduced electron transfer therefore does 
not occur to an appreciable extent under these experimental conditions. 
 
DISCUSSION 
Photochemical methods for the reduction of metal cofactors in enzyme active sites have been 
applied extensively to heme systems, such as cytochrome P450cam14 or to monitor electron transfer 
events in cytochrome c oxidase.12,20 These one-electron processes are readily amenable to this 
methodology. The work pioneered here attempted to extend this technique to two-electron processes 
in the CBDI systems, specifically MMOH. 
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The steady-state activity of RuMMOB N101C exhibited uncoupled NADH consumption and 
substrate hydroxylation compared to native MMOB. This uncoupling could arise either from a 
perturbation of protein–protein interactions, or the redox active center conjugated to MMOB may 
influence electron shuttling into MMOH by MMOR. The site of mutagenesis, N101C, is likely to be 
close to the contact surface between MMOH and MMOB.23,24 The introduction of the positively 
charged ruthenium moiety may therefore adversely affect the formation of the MMOH–MMOB 
complex. As mentioned in Chapter 1, this complex is crucial for efficient coupling of electron 
consumption to substrate hydroxylation. Moreover, the nature of the interacting surface of this 
complex is not completely understood, with experimental evidence indicating both electrostatic25 and 
hydrophobic26 interactions. Weaker binding of RuMMOB N101C to MMOH could allow for MMOR 
to displace the regulatory protein during dioxygen activation. Substrate hydroxylation would, as a 
consequence, compete with reductive quenching of oxygenated intermediates. Under constant 
irradiation, fluorescence quenching of RuMMOB N101C proteins in the presence of MMOH was not 
observed. Binding of MMOH to RuMMOB N101C might be expected to quench the fluorescence, at 
least partially, if the attachment site of the fluorophore is near the binding interface. The absence of a 
fluorescence change therefore lends support to the aforementioned hypothesis that protein–protein 
interactions between the hydroxylase and regulatory protein are disrupted by the ruthenium complex. 
The intensity of EPR signals corresponding to MMOHmv did not increase significantly for 
photoexcited samples containing MMOHox, RuMMOB, and aniline. Reduction of MMOHox to 
MMOHmv should be more facile than reduction of MMOHmv because of the reduction potentials 
reported for these species.27 We predict therefore that photoinduced electron transfer would not be 
observed for samples containing MMOHmv because this process was not observed for samples 
containing MMOHox and RuMMOB N101C. 
The experimental design reported here requires electron transfer from [Ru(bpy)3′]2+ through the 
MMOB–MMOH interface to the diiron cluster in MMOH. The estimated distance for this ET event 
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is in excess of 20 Å. According to Marcus theory,28 ET rates decrease by approximately an order of 
magnitude for every 2 Å increase in the distance between cofactors. Therefore, the fastest possible 
ET rate would be in the range of 10 s-1.  This technique was pursued to observe the diiron active on a 
timescale faster than that of conventional mixing methods. These reduction rates, however, would be 
slower than the dead times of rapid mixing techniques. 
 
FUTURE DIRECTIONS 
Alternative strategies to photoreduce MMOH might entail tethering the photoreductant to either 
the ferredoxin domain of MMOR, or a small peptide that binds to MMOH.  The first two strategies 
have been utilized previously for studying ET from the Rieske center to the ferric heme in the 
cytochrome bc1 complex12 and for tyrosyl radical generation in ribonucleotide reductase.29 MMOR-
Fd constructs that can be used for the former strategy were previously reported.30,31 A small 
inhibitory peptide, DEDVITAALRQ, which bears sequence homology to MMOR and competes with 
MMOB for binding sites on MMOH,32 could be modified with electron donors to explore the second 
strategy. Rapid photochemical release of dioxygen under anaerobic conditions in the presence of 
MMOHred and MMOB could circumvent these difficulties. The reaction of reduced cytochrome c 
with dioxygen has been successfully examined with this approach.16 Electron transfer from 
photoreductants tethered to substrate analogues has afforded rapid reduction of the ferric heme in 
cytochrome P450cam.14  
The large substrate access channel in ToMOH could allow for a similar strategy to be employed 
as hexapolyethylene glycol can bind within this channel in an extended conformation.33 
Photoreduction from an electron donor, positioned near to the protein surface at the channel entrance, 
to the diiron center would require ET to occur at a distance of 35 Å or more.34 Such a large distance 
may hinder rapid and efficient photoinduced ET and negate the advantage of photochemical 
methods.
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ELECTRON TRANSFER FROM REDUCED TOMOC  
TO THE OXIDIZED  HYDROXYLASE 
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INTRODUCTION 
ET processes between redox partners in proteins are controlled by the surrounding protein 
framework, which prevents undesired reactions. Interprotein ET in particular requires protein 
recognition and binding events to ensure a pathway-specific process.1 Metalloenzymes that activate 
dioxygen, such as cytochromes P450,2 the CBDI enzyme family,3 and Rieske dioxygenases,4 cycle 
between redox states, and cellular reducing agents, such as NADH, supply the necessary electrons for 
this process. In the CBDI enzyme family, the diiron active site is housed in the catalytic protein, 
which does not contain any other redox cofactors.5 Other components of these enzyme systems must 
bind to this protein and transfer electrons to the diiron center to initiate the catalytic cycle. A spatially 
homologous hydrogen-bonding network in the BMMs, RNR-R2, and Δ9D is proposed to function as 
the ET pathway. In RNR-R2, W48 within this network donates an electron to the μ-1,2-
peroxodiiron(III) intermediate.6 The binding site for the ferredoxin protein that reduces Δ9D was 
determined to be in close proximity to an analogous hydrogen bonding network.7 In the BMMs, this 
network is strongly conserved, spanning ~ 12 Å from the protein surface to the diiron center.6 
Of the BMMs, the ET and protein interactions involved in the reduction of the diiron center have 
been studied the most extensively in MMO.8-11 In this system, MMOHperoxo and Q form only in the 
presence of the regulatory protein.12-14 Although MMOB facilitates the oxidative phase of the 
catalytic cycle, it inhibits ET from reduced MMOR or its ferredoxin domain, MMOR-Fd, to 
MMOH.9-11 Hysteresis has been proposed for the interaction of MMOB and MMOH, where 
conformational changes in the hydroxylase are retained after dissociation of the protein complex.9 
Allosteric changes resulting from protein–protein interactions could be transmitted across the dimer 
interface and manifested as this hysteresis. Previously, kinetic models for steady-state catalysis and 
component complex formation have invoked ternary complexes, with MMOB and MMOR binding 
on the same face of the MMOH dimer, or half-sites reactivity, where MMOB and MMOR bind 
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exclusively to opposite faces of the dimer.11 The half-sites model requires the oxidative and reductive 
phases of the catalytic cycle in each active site of the dimer to be out of phase with respect to one 
other. 
Initial characterization of ET from reduced ToMOC to oxidized ToMOH under pre-steady-state 
conditions revealed that the regulatory protein is required for rapid ET.15 Incubation of the 
hydroxylase with the regulatory protein prior to reaction with reduced ToMOC increased the ET rate 
by between one and two orders of magnitude. ToMOD could cause a conformational change on the 
hydroxylase either to favor binding of ToMOCred or perturb the reduction potentials of the diiron 
core. The latter effect is observed in MMO except that reduction of the hydroxylase is 
thermodynamically less favorable in the presence of MMOB.16-19 More intriguing, however, was the 
observation in these experiments that only ~ 50% of reduced Rieske protein was consumed in the 
reaction. Half-sites reactivity has been previously proposed in CBDI proteins, such as RNR-R2,20 
Δ9D,21 and MMO.11 To investigate the ET chemistry in this system, we monitored the 
thermodynamic distribution of electrons in mixtures containing ToMOCred, ToMOH, and ToMOD by 
EPR spectroscopy. We compared these results to spectra of samples prepared by reduction of 
ToMOH with sodium dithionite in the presence of ToMOD. The results suggest that protein-protein 
interactions play a pivotal role in gating ET to the diiron centers of the oxidized hydroxylase, with 
ToMOCred favoring the complete reduction of one active site and chemical reduction being 
indiscriminate. 
 
EXPERIMENTAL METHODS 
General Considerations. ToMO component proteins were expressed and purified as described 
in Chapter 2. Iron assays and steady state activities were conducted as described elsewhere.11,22 The 
iron content of the hydroxylases determined by the ferrozine assay was between 3.8 and 4.5 
Fe:ToMOH dimer. Instrumentation for UV/visible absorption spectroscopy and anaerobic sample 
148
preparation were as reported in Chapters 2 and 3. Chemical reagents were purchased from Sigma 
Aldrich Chemical Company. 
EPR Sample Preparation and Data Acquisition for Mixtures Containing ToMOCred. 
Samples were prepared in the anaerobic chamber with deoxygenated solutions of ToMOC, ToMOH, 
and ToMOD. A solution of ToMOC (500 μL, 350 μM) was reduced with excess sodium dithionite 
and dialyzed twice against 500 mL of 25 mM MOPS, pH 7.0, for 1 h each. Aliquots of ToMOCred 
were added to mixtures of ToMOH:2ToMOD. The combined protein solutions were each diluted to a 
final volume of 200 μL with anaerobic 25 mM MOPS buffer, pH 7.0. The concentration of 
ToMOH:2ToMOD in all samples was 100 μM, with ToMOCred concentrations ranging from 0 to 
200 μM. Samples were allowed to equilibrate for 10 min at room temperature after which they were 
transferred to quartz EPR tubes. The tubes were capped with rubber septa, removed from the 
anaerobic chamber, and immersed in liquid nitrogen. Spectra were acquired on a Bruker EMX 
Spectrometer with an ER 4102ST cavity and an Oxford ESR 900 liquid helium cryostat at 10 K. Data 
were acquired with a microwave frequency of 9.379 GHz, a power of 0.2 mW, and a modulation 
amplitude and frequency of 10 G and 100 kHz, respectively. 
EPR Sample Preparation of Chemically Reduced Hydroxylase. A solution of sodium 
dithionite was standardized with potassium ferricyanide as described elsewhere.23 Samples were 
prepared as described above, except that varying equivalents of sodium dithionite were added to 
mixtures containing ToMOH:2 ToMOD (200 μM) instead of ToMOC. The equivalents reported for 
this experiment were determined from the iron content, and not the hydroxylase concentration. 
Protein solutions were allowed to stand for 20 min after addition of the reductant. Acquisition 
parameters were identical to those reported previously. 
 
 
 
149
RESULTS 
Reduction of ToMOHox by Sub-stoichiometric ToMOCred Results in Diiron(II) Centers. To 
investigate the distribution of electrons in solutions containing ToMOCred and ToMOHox, EPR 
spectra of samples containing variable ratios of ToMOCred to ToMOH premixed with two equiv. of 
ToMOD were measured. Spectral features with g-values > 16 and < 2 have previously been 
attributed to diiron(II) and mixed-valent diiron(II,III) clusters at CBDI centers, respectively.16 These 
features are absent in the spectrum of a sample containing the oxidized hydroxylase and regulatory 
protein, which is expected for an antiferromagnetically-coupled diiron(III) center (Figure B.1, top 
panel). As ToMOCred is added, a signal at g = 16 forms and increases in intensity, even at 
substoichiometric ratios of ToMOCred to ToMOHox. Unreacted ToMOCred dominates the region at g 
= 2.0 at ratios of ToMOC to ToMOH greater than 1:1. The reduced Rieske cluster has an anisotropic 
signal with g = 2.01, 1.91, and 1.75, which is typical of the diiron(II,III) form of these centers.24,25 
The signal from unreacted ToMOCred could therefore obscure the mixed-valent signals from 
ToMOHmv. Weak features corresponding to the mixed-valent hydroxylase are observed in the 
spectrum of a sample containing one equiv. of ToMOCred and 2 equiv. of ToMOHox. 
Generation of Mixed-Valent Diiron(II,III) ToMOH by Chemical Reduction. Titration of 
oxidized hydroxylase with sodium dithionite generated mixed-valent diiron(II,III) centers as 
evidenced by a rhombic signal with g-values of 1.93, 1.87, and 1.73, which are similar to those 
reported for MMOHmv.16 Chemical reduction afforded a mixture of hydroxylases in which one active 
site was reduced by two electrons, or both active sites were reduced by one electron, as increasing 
equiv of electrons were added to the hydroxylase. The sample spectra also contained a signal at g = 
4.3 from high-spin ferric ions (not shown). The intensity of this signal decreased by almost 50% as 
increasing equiv. of electrons were added. As a consequence of reduction of adventitious free 
iron(III) in the sample, the effective concentration of reductant was lower than the calculated value. 
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Figure B.1. EPR specta for mixtures containing variable ratios 
of ToMOCred to ToMOH:2ToMOD. The EPR spectrum of 
ToMOHox (top) shows no signals around at 420 G (g ~ 16) and 
3350 G (g ~ 2). As equivalents of ToMOCred were added, a 
signal at g = 16 was observed even at low ratios of reduced 
Rieske protein to ToMOHox. The features in the vicinity of g = 2 
for ratios higher than 1:1 are similar to that of ToMOCred
(bottom). The spectrum for 2 Hox:Cred shows a signal at near g = 
2 that differs from the reduced Rieske center, and is analogous
to signals for MMOHmv. Features at g = 16 arise from diiron(II) 
centers in the hydroxylase. 
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 DISCUSSION 
Reduction to Oxidized ToMOH Proceeds Through a Half-Sites Mechanism. When allowed 
to equilibrate, electron transfer from ToMOCred to ToMOHox forms predominantly the reduced 
diiron(II) centers in the hydroxylase (Figure B.1). The mixed-valent hydroxylase is observed only at 
the lowest measured ratio of ToMOCred to ToMOH. Protein-protein interactions between ToMOC 
and ToMOH may favor reduction of the oxidized hydroxylase to form diiron(II) sites, instead of 
Figure B.2. EPR Spectra of ToMOH:2ToMOD mixtures 
reduced with one (top), two (green), three (orange), and 
four (blue) equivalents of electrons from sodium 
dithionite. The signals at g ~ 16 (420 G) are from the 
reduced diiron(II) centers, and signals near g < 2.0 (3350 
G) from the mixed-valent diiron(II,III) centers. Addition 
of increasing electrons to ToMOHox results in a 
distribution of mixed-valent and reduced centers. 
Chemical reduction contrasts that afforded by ToMOCred 
as a significant mixed-valent hydroxylase concentration 
is observed. 
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mixed-valent centers. One possibility is that ToMOH:ToMOC complex formation increases the 
reduction potential, greatly favoring electron transfer to a mixed-valent diiron(II,III) core. In T4MO, 
binding between the regulatory and the Rieske proteins was reported,26 suggesting that this complex 
might be relevant to reduction of the di(μ-hydroxo)diiron center in the hydroxylase. Binding of 
ToMOD to ToMOC could ensure accurate localization of the Rieske iron-sulfur cluster relative to the 
diiron center in the hydroxylase. 
An appreciable amount of the Rieske protein remains unreacted and dominates the spectrum at 
g ~ 2.0. The reason that the reduced Rieske protein is not completely consumed in these samples, 
even at substoichiometric ratios of ToMOC to ToMOH, is unclear. In single-turnover experiments, 
dissociation of the coordinated hydroxylated product from the oxidized hydroxylase is enhanced by 
reduction of the ferric ions (Chapter 3). Product or substrate bound to the diiron center, or within the 
active site cavity, may gate electron transfer, as observed for mononuclear iron enzymes, such as 
cytochromes P4502,27 and α-ketoglutarate.28 Given the strong signals from the Rieske protein, low 
yields of the mixed-valent state would be undetected and their presence cannot be excluded. 
By comparison, chemical reduction with sodium dithionite forms significantly greater quantities 
of the mixed-valent hydroxylase (Figure B.2). Even under these conditions and at low ratios of 
electrons to hydroxylase, reduction still affords diiron(II) sites within the hydroxylase. Because 
diiron(II) sites form in the absence of ToMOC–ToMOH protein interactions, assembly of this protein 
complex may dictate, only partially, the distribution of electrons to diiron(III,III) or diiron(III,II) 
centers. In the PHH-PHM structure, the environment around the diiron center in the protomer to 
which PHM is not bound shows similar helical distortions as those for the protomer to which PHM is 
bound.29 Such features could arise from allosteric changes transmitted across the dimer interface as a 
consequence of regulatory protein binding. MMOB is proposed to bind to MMOH at the analogous 
site on the hydoxylase,30 suggesting that regulatory proteins across the BMM family may bind at 
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spatially homologous loci on the hydroxylases. We postulate that ToMOD might modulate the 
potentials of the diiron center in the opposite protomer through allosteric effects. Protonation of the 
bridging hydroxide ligands in the oxidized hydroxylase active site is required, presumably during 
reduction, because these species are absent in crystal structures of reduced or Mn(II)-reconstituted 
forms of this protein.6,31 Structural changes at the diiron center arising from ToMOD binding to the 
opposite face of the hydroxylase may open a conserved pore, facilitating proton entry and favoring 
reduction. Mössbauer samples prepared in an analogous manner, where the hydroxylase is 57Fe-
enriched, with or without other components present, would provide a more accurate probe of the 
electron distribution within the hydroxylase upon reduction by either sodium dithionite or ToMOC. 
Half-sites Reductive and Oxidative Phases in ToMO. Half-sites reactivity during the 
oxidative phase of the catalytic cycle has been proposed for other members of the CBDI enzyme 
family. For example, the BMMs only form oxygenated intermediates in ~ 50% yield, with unreacted 
diiron(II) protein decaying by alternate uncharacterized pathways to the resting state.14,32 In Δ9D, the 
four-electron reduced desaturase forms a μ-1,2-peroxodiiron(III) intermediate quantitatively at both 
active sites, yet this intermediate is incapable of substrate desaturation under these conditions.21 
Similar control of the reductive phase has not been reported. In a half-sites mechanism in the BMMs, 
cellular reducing equivalents are used inefficiently if these hydroxylases are reduced by four 
electrons, because both active sites cannot simultaneously oxidize substrate. Therefore, strict control 
over the reducing factors prevents the complete reduction of the hydroxylases, ensuring maximal 
coupling of substrate hydroxylase to NADH consumption. 
 
FUTURE DIRECTIONS 
Here we present the first evidence that reduction of the diiron(III) centers in ToMOHox in 
complex with ToMOD by ToMOCred affords predominantly two-electron reduction of a single active 
site, instead of one-electron reduction of both diiron(III) cores. Characterization of the electron 
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transfer reaction by RFQ EPR and stopped-flow optical spectroscopy with varying amounts of 
substrate, product, or other protein components, will further elucidate the functions of protein-protein 
interactions on this half of the catalytic cycle. 
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